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Abstract 
Biosynthesis of the fungal metabolite tenellin 
Helen K Smith, MChem (Hons) 
This thesis concerns the biosynthesis o f tenellin, a bright yellow secondary metabolite of 
the fungus Beauveria bassiana. Several putative intermediates have been synthesised 
and feeding experiments performed in order to provide some insight into the 
biosynthetic pathway. 
Tenellin was originally thought to be formed from the condensation of phenylalanine 
and a polyketide moiety, however recent studies have now shown that tyrosine is the 
more direct amino acid precursor. The biosynthesis is proposed to occur by 
rearrangement o f tyrosine to 3-amino-2-(4-hydroxy)-phenylpropionic acid, in a similar 
manner to the rearrangement observed in alkaloid biosynthesis. The synthesis of this P-
amino acid is described and the subsequent incorporation study using labelled material 
discussed. The result argues against the intermediacy of this compound in the 
biosynthesis o f tenellin. 
Consequently, it is proposed that the biosynthesis o f tenellin does not include the 
rearrangement o f tyrosine, but instead proceeds via a five membered teframic acid, 
which is considered to undergo rearrangement and ring expansion to generate the 
pyridone ring o f tenellin. The putative acyl tetramic acid precursor is synthesised and 
administered to cultures o f Beauveria bassiana. Preliminary ^H N M R spectra indicate a 
possible incorporation and that the tetramic acid has a role in tenellin biosynthesis. 
Further analysis by HPLC and LCMS is described. 
The biosynthetic origin o f H-6 of tenellin has never been established. Several 
experiments, including the synthesis of [2-^H]-tyrosine, are described, but the origin of 
this proton remains unclear. 
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Chapter 1 
1 Introduction 
1.1 Use of isotopes in biosynthetic studies 
The study of the biosynthesis of metabolites made significant progress with the advent 
of radioisotopes and has been further developed by the use of stable isotopes. Putative 
precursors carrying one or more isotopic labels are administered to an organism and the 
isolated metabolite examined for evidence of isotopic incorporation. Such tracer studies 
have been fundamental to the majority of biosynthetic studies performed to date. 
It is possible to use both radio-labelled, mainly and ''*C atoms, and the stable 
isotopes ^H, '^C, '^N and '^O in these experiments. The latter can be detected by 
nuclear magnetic resonance (NMR) and/or mass spectrometric techniques and the 
former by scintillation counting. 
Radioisotope labelling has two main advantages. The isotopes are very sensitive to 
detection by scintillation counting and also have zero natural abundance so low 
enrichments can be detected. However, a high degree of radiochemical purity is needed 
in order to avoid errors from contamination of minor impurities. 
The use of stable isotopes is more common and in particular, there have been many 
biosynthetic studies carried out with '^ C labelled substrates. Incorporation of the 
administered precursor can be detected by enhancement of the resonances in the ''^ C 
NMR spectrum. Subsequent comparison to the natural abundance spectrum allows the 
enriched carbon/s to be readily determined. A common application of the '^C label is in 
the form of doubly labelled acetate, [l,2-'^C2]-acetate. Observation of the coupling 
constants in ''^ C NMR arising from adjacent '^ C nuclei enables intact acetate units in the 
resultant metabolite to be identified. For example, feeding experiments' with [1,2-
'^C2]-acetate 2 were used to show the intact incorporation of five acetates during 
tenellin 1 biosynthesis in the fungus Beauveria bassiana (Scheme 1-1). 
0 
9 11 1 3 
NaO 
B. bassiana 
Scheme 1-1 
In the '•'C NMR spectrum, satellite peaks positioned around the isolated '^ C resonances 
showed that C-2, C-3 and C-7 to C-14 all derive from intact C2 units (Scheme 1-1). The 
use of doubly labelled '^C acetate is especially useful in cases of low isotopic 
incorporation, since the satellites arising from the adjacent '^ C atoms allow lower 
enrichments to be observed (<0.1 %) . 
Deuterium (^H) has a low natural abundance (0.015 %) . As a consequence, negligible 
incorporations only slightly above the natural abundance level can be detected by 
NMR. In this respect, H-labelling is 60 times more sensitive than C labelling. 
Although the quadrupolar nature of the nucleus leads to line broadening in NMR, the 
advantages of a short relaxation time and no nuclear Overhauser effect (nOe) mean that 
determination of incorporation can be performed directly by peak integration. Such a 
feature can compensate for the poor resolution of deuterium spectra. Coupling 
constants for J ( ^ H - ' H ) are approximately one sixth of those for J ( ' H - ' H ) . 
'^O has been used effectively in some studies^ but it is not a routinely utilised isotopic 
label for exploring biosynthetic processes. Although the natural abundance of '^ O is 
low (0.037 % ) , the broadening of resonances by this quadrupolar nucleus yields poor 
quality spectra. '^N, another less frequently used nucleus, is sometimes employed for 
the labelling of amino acids, however rapid transamination processes can give results 
that are not always reliable. 
As well as the detection of atoms, incorporation studies can be used to trace the fate of 
bonds through biosynthetic pathways, for example C-H. It is possible to detect small 
changes in the '^C chemical shift due to the presence of a- and |3-substituted isotopes. 
The a-shift, an upfield shift of between 0.3 and 0.6 ppm, occurs when a deuterium is 
directly attached to the carbon-13 atom. However, reduced signal to noise ratio due to 
poor relaxation, signal multiplicity from the nuclear spin of deuterium (1=1) and loss of 
nOe, mean that this technique is not always satisfactory for quantitative measurements 
of isotope incorporation. 
The use of molecules with deuterium two bonds away from carbon, for example [l- '^C, 
2-^Hs]-acetate, leads to a P-shift effect, which is usually also an upfield shift. The 
magnitude of the p-shift is small, but is additive being approximately 0.04 ppm for each 
deuterium. Therefore, the more deuterium atoms retained, the greater the shift. The 
main advantage of this technique is that the level of incorporation can be determined 
directly from peak height as there is no p-coupling. 
This phenomenon has been useful in investigating the retention and/or loss of from 
the polyketide backbone in biosynthetic studies of polyketides. The information 
obtained can yield the identification of chain starter units and the relative amounts of 
hydrogen exchange at given sites, both of which are invaluable in probing the 
mechanistic details of a . biosynthesis. For example [2-'''C, 2-'^ H3]-acetate 2b 
incorporation into 19-0-acetylchaetoglobosin A 3, a member of the cytochalasans, was 
used to determine the starter unit of the polyketide chain (Scheme 1-2).^  '^C NMR 
showed strongly enhanced singlets for eight carbons, and two multiplet peaks for C-11 
and the 0-acetyl methyl group. Therefore, all but two of the carbons originating from 
C-2 of acetate lost most, i f not all, of their deuterium label. 
0 
OH 
2b 
Scheme 1-2 
The loss of one deuterium can occur during the normal dehydration process of 
polyketide synthesis, and exchange with the medium could account for the remaining 
loss. Thus, it is only the chain starter unit and the 0-acetyl methyl group, which retain 
the majority of the deuterium incorporation. 
The use of isotopes for studying biosynthetic pathways is generally very effective, but 
there are some limitations. For example, the administration of increased concentrations 
of the labelled precursor in order to maximise enrichments can lead to a perturbation of 
the growth of the organism. It is also possible for the substrate to be degraded en route 
by the organism or become very poorly incorporated due to difficulties of cell 
penetration. 
1.2 Metabolism 
1.2.1 Catabolism and anabolism 
Metabolism is the term used to describe the chemical transformations performed on a 
substance by an organism from the time it enters the organism until it is eliminated as 
waste products. Cells extract energy from their surroundings and by metabolite 
degradation they create the building blocks, which can then be used in the synthesis of 
complex organic molecules. Metabolism can be divided into two categories; 
catabolism, which refers to the degradation processes of complex structures and the 
associated release in energy, and anabolism, which is concerned with biosynthesis, a 
process which requires energy. The two processes are inter-related, as the small 
molecules used by the anabolic pathways in the synthesis of larger biomolecules are 
often the intermediates formed from the breakdown of substrates by catabolic 
operations. 
Although there are many reactions occurring in metabolism, the number of reaction 
types is relatively small and there are only a restricted number of molecules that play a 
central role in the biochemistry of all living organisms. 
1.2.2 Primary and secondary metabolism 
Natural products can be divided essentially into primary and secondary metabolites. 
Primary metabolites are common to all groups of living organisms and are essential to 
the survival of the cell. Secondary metabolites on the other hand, are compounds of 
limited distribution often produced by a single species and are generally peripheral to 
cell metabolism. However, they have greater significance to the well being of the 
organism as a whole. They may, for example, be a deterrent to other organisms, acting 
as defence agents or repellents. 
Secondary metabolites are often structurally complex molecules, yet they are produced 
from a relatively small number of biochemical pathways, most commonly via acetate, 
mevalonate, shikimate and the amino acids. 
1.3 Polyketides 
1.3.1 Introduction to polyketides 
Polyketides are a class of naturally occurring secondary metabolites most commonly 
produced by fungi but they are also represented in many bacteria. The route by which 
polyketides are synthesised is one of the most widespread in nature, accounting for 
compounds such as orsellinic acid,"* a structurally unexceptional aromatic or at the other 
extreme, maitotoxin 4,^  at 3422 Da, the largest secondary metabolite known. 
HO OH OH 
Bacteria, predominantly the Actinomycetes, are responsible for the production of many 
medicinally important polyketides including the antibiotic erythromycin A 5 first 
isolated in 1952 from Saccharopolyspora erythraea.^ Tylosin 6^  is produced by 
Streptomyces fradiae and is widely used in veterinary medicine. 
N(CH3) 
OH HO 
NCH3), 
"0-, / O 
There have also been complex polyketides isolated from marine organisms (e.g. 
brevitoxin 7^ ) and higher plants (e.g. anthraquinones). 
CHO 
The polyketides have attracted considerable interest due to their broad range of 
biochemical activities as antibiotics (erythromycin A 5), anti-cancer agents (daunomycin 
8^ ) and cholesterol-lowering agents (lovastatin 9'°). 
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A fundamental understanding of the biosynthesis of the polyketides was realised by 
Collie in 1907." The treatment of heptane-2,4,6-trione with base, led to the formation 
of a naphthalene derivative via a series of intermolecular aldol reactions. This was used 
as a template to establish the hypothesis for an analogous process of folding during the 
biosynthesis of aromatic compounds and polyphenols from similar polyketomethylene 
intermediates formed from head to tail coupling of acetyl units. Work carried out on the 
biosynthesis of a metabolite of the fungus Penicillium griseofulvun?^ was seminal in 
verifying this acetate hypothesis.'^ Incorporation of [l-"''C]-acetate into griseoflilvin 10, 
an antibiotic, showed a pattern consistent with the predicted folding of a heptaketide 
precursor (Scheme 1-3). 
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Scheme 1-3 
Since this research was performed, biosynthetic experiments using isotopically labelled 
acetates have been used in order to confirm the polyketide origin of many secondary 
metabolites. 
Polyketides are closely related in origin to the fatty acids produced in primary 
metabolism and it is instructive to briefly review fatty acid biosynthesis. 
1.3.2 Fatty acid biosynthesis 
Fatty acids are widely distributed primary metabolites that have important cellular 
functions such as cell membrane assembly and energy storage. The polar carboxylic 
acid head groups and long lipophilic hydrocarbon tails are essential for their structural 
role in the formation of cell membranes. Glyceride degradation provides a pool of 
acetate, which can be used in biosynthetic processes or incorporated into the 
tricarboxylic acid (TCA) cycle for the construction of other building blocks. The 
biosynthesis of fatty acids is initiated from acetyl coenzyme-A 11 (acetyl-CoA) and 
malonyl-CoA 12 and is catalysed by an enzyme complex called the fatty acid synthase 
(FAS).'^ 
The first step in fatty acid biosynthesis (Scheme 1-4) is the formation of malonyl-CoA 
12 from acetyl-CoA 11. This involves the action of acetyl-CoA carboxylase along with 
the co-factor biotin and an associated biotin carboxyl carrier protein. The second step is 
a decarboxylative condensation between acetyl-CoA and malonyl-CoA to generate an 
intermediate P-ketothioester 13. 
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All of the intermediates during fatty acid biosynthesis are anchored to an acyl carrier 
protein (ACP) which directs the biosynthetic steps by controlling the positioning of the 
intermediate acyl thioester around the catalytic sites of the FAS.''* Similar to CoA, ACP 
is linked to a phosphopantetheine moiety, which is in turn covalently bound to a serine 
residue on the protein. The carbonyl of the p-ketoacyl-ACP 13, formed from the acetyl 
and malonyl condensation by a ketosynthase (KS), is reduced by the action of a P-
ketoacyl-ACP reductase (KR) to give D-3-hydroxyacyl-ACP 14, which is subsequently 
acted upon by a dehydratase (DH), to give the a, P-unsaturated thioester 15. The 
reduction uses nicotinamide adenine dinucleotide phosphate, reduced form (NADPH), 
and is stereospecific, with the pro-AS hydrogen acting as the hydride source to deliver 
the D-alcohol. Syn elimination of water produces the (£)-unsaturated olefin. Reduction 
of the a, P-unsaturated thioester 15 by an enoyl-CoA reductase (ER) generates butyryl-
ACP 16, the first saturated intermediate, and the end product of the first cycle in fatty 
acid biosynthesis. This is then transferred to the ACP of the FAS where another 
molecule of malonyl-CoA can attack in order to initiate the cycle of enzymic reactions 
once more. This sequence continues until the optimum chain length has been reached 
and the fatty acid is released from the FAS complex by a thioesterase (Scheme 1-5). 
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There is essentially only one reaction sequence for the production of all saturated fatty 
acids, however two general types of FASs exist. Type I FASs, which are found in most 
higher organisms (except plants), consist of one multifiinctional protein which includes 
the ACP, with all of the activities on a large protein. On the other hand, Type II FASs 
of higher plants and bacteria are made up of several discrete dissociable enzymes and an 
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acyl carrier protein. Fungi and yeast have characteristics of both Type I and Type II 
FASs. 
1.3.3 Fungal polyketides 
The majority of polyketides isolated from fungal sources are aromatic. Non-aromatic 
polyketides such as cubensic acid 17'^  are rare. Cubensic acid is biosynthesised from 
eleven acetate units and eight methyl groups contributed by L-methionine (vide infra). 
COoH 
In a similar manner to fatty acid biosynthesis, there are two general types of polyketide 
synthases (PKS). Type I PKSs, are large multifunctional polypeptides containing all the 
necessary enzymic functions in distinct regions on a single large protein. Extensive 
studies on 6-methylsalicylic acid synthase (6-MSAS)'^ have shown that the gene order 
of catalytic domains is identical to that of mammalian FASs and that there is a single 
multifunctional protein in operation. 
As described previously for FASs, PKSs catalyse a sequence of decarboxylative 
condensation reactions between acyl thioesters and malonyl-CoA followed by a cycle of 
ketoreduction, dehydration and enoyl reduction activities (Scheme 1-6). However, 
unlike fatty acid biosynthesis where the FAS always performs the complete reductive 
cycle, the PKS is highly selective and can control the manner of polyketide 
modifications generating keto, alcohol, double bond and saturated units. A wide range 
of structures can therefore be created by different programming sequences. 
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In a similar approach to fatty acid biosynthesis, acetyl-CoA 11 is employed as a starter 
unit along with an extender unit, malonyl-CoA 12, to generate a P-keto ester 13. 
However, there are a few cases where other starter units, such as propionate and amino 
acids, can be used to initiate the PKS. One particularly interesting example is aurovertin 
B 18, which can incorporate either propionate or a combination of acetate and the 
methyl group of methionine to generate the first three carbon atoms. 
OCH-, 
18 
It is probable that propionate 20 is the true starter unit in aurovertin B biosynthesis and 
that methylmalonyl-CoA 19 is generated by methionine mediated methylation of 
malonyl-CoA 12 (Scheme 1-7). 
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Unlike bacterial systems, where propionate incorporation can occur at any stage, fungal 
PKSs can only utilise propionate as a chain starter unit. The use of various extender 
units, for example methylmalonate, introduces a further degree of structural complexity. 
One of the simplest polyketide structures is orsellinic acid 21. It is synthesised from an 
acetyl-CoA starter unit with three subsequent malonyl-CoA condensations (Scheme 
1-8).'* Cyclisation of the assembled poly p-keto ester via an aldol type condensation 
followed by dehydration and enolisation gives the aromatic product, orsellinic acid, after 
hydrolysis. It can be seen that there is no P-keto reductase activity present in this 
system. The biosynthesis of 6-MSA 22 is similar, however, an NADPH mediated 
carbonyl reduction results in the removal of the C-4 oxygen. Subsequent dehydration 
and enolisation steps generate 22. 
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Scheme 1-8 
A common feature of polyketide structures is the presence of methyl groups not 
accounted for by conventional polyacetate chain folding. The vast majority of these 
originate from the methyl group of L-methionine in which the donor methyl group is 
activated in the form of S'-adenosyl-L-methionine (SAM). This was first shown by 
Birch'^ in 1958 during research into mycophenolic acid 23. Feeding experiments 
14 
established that the C-5 methyl and the methoxyl carbon originate from the methyl 
group of L-methionine. 
OH 0 
23 
As previously discussed (p. I I ) , all of the methyl groups of cubensic acid 17 have also 
been shown to derive from SAM. Such C-methylations probably occur during 
polyketide assembly, by attack at the methyl group of SAM by an enolate intermediate. 
Biosynthetic experiments involving elaborated fragments of polyketide structures have 
been used to glean information about the C-methylation process. The intact 
incorporation of thioester 24 into dehydrocurvularin 25*' (Scheme 1-9), produced by 
Alternaria cinerariae, strongly suggests that the direct reduction of poly-P-keto-
thioester 26 is unlikely and that a mechanism whereby there is processive assembly of 
the polyketide is operating. The term processive describes the reduction of the P-
carbonyl, formed after each malonate condensation, to the required oxidation level 
before each subsequent malonate condensation occurs. 
H O ^ 0 . ^ . 0 . 
AcHN ^ 
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Other experiments have also been used to demonstrate a processive pathway for 
polyketide biosynthesis. Aspyrone 27 biosynthesis has been studied by NMR detection 
of ^H incorporation of deuterium labelled intermediates (Scheme 1-10).^ " The results 
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are indicative of an assembly where the status of the carbonyl is adjusted before each 
subsequent condensation. The putative intermediates were fed to Aspergillus melleus in 
the form of acyl esters 28, 29 and 30, which are able to transacylate with the ACP of the 
PKS. It is interesting to note that when the corresponding acids were fed, complete 
degradation to acetate occurred prior to any isotope incorporation. 
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It is envisaged that O- and N - methylations take place towards the end of metabolic 
pathways. 
A structurally different class of polyketide is derived from the combination of the usual 
polyacetate backbone with an amino acid. Tenellin 1, which forms the subject of this 
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thesis, is a bright yellow metabolite produced by the fungus Beauveria bassiana} Both 
tenellin and ilicicolin-H 31 from Cylindrocladium ilicicola^^ contain a 2-pyridone ring 
system derived from condensation between a polyketide component and phenylalanine. 
The structures also contain extra methyl groups, which have been shown to originate 
from L-methionine, presumably via SAM. 
OH 0 
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Other amino acids are involved in the biosynthesis of related polyketides; for example, 
glutamic acid condenses with a polyketide moiety to generate fliligorubin-A 32 in 
Fuligo septica?^ 
CH3N 
COoH 
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Another group of mixed origin polyketide metabolites are those which possess terpene 
moities. Pendent isoprenoid groups are most probably attached to phenol ring systems 
by electrophilic aromatic substitution of the corresponding isoprenoid pyrophosphate. 
Accordingly, grifolin 33,^ ^ shown below, derives from famesyl pyrophosphate and 
orcinol. 
33 
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1.3.4 Plant polyketides 
Alkaloids are largely biosynthesised from amino acids, however there are examples that 
have origins in polyketide chemistry. Isotopically labelled acetate is incorporated into 
coniine Zl}'^ a hemlock alkaloid, and pinidine 39, an alkaloid of Firms jeffreyi?^ 
The entire skeleton of coniine produced by Conium maculatum is derived from acetate. 
Labelling experiments have shown that C-2, C-2', C-4 and C-6 are enriched by [l-'^'C]-
acetate. 5-Oxo-octanoic acid 34, 5-oxo-octanal 35 and y-coniceine 36 are also readily 
incorporated into coniine 37 and appear to be advanced biosynthetic intermediates. The 
biosynthetic scheme shown in Scheme 1-11 has been proposed on the basis of these 
results. 
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Scheme 1-11 
Pinidine 39 has a similar structure to coniine and also derives from the condensation of 
acetate units. The positions at C-2, C-4, C-6 and C-9 are labelled by [1-"*C]-acetate. 
The carboxyl group at C-10 of the pentaketide precursor 38 is lost during the 
biosynthesis (Scheme 1-12). 
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Coniine and pinidine are not characteristic of the piperidine alkaloids. More generally, 
the piperidine ring of these compounds derives from lysine 40 and acetate is utilised 
exclusively to provide parts of the metabolite that are not delivered by the amino acid, 
for example, in the side-chain of N-methylpelletierine 41.^^ ['^N]-Lysine incorporation 
studies have suggested that the ring formation of 41 involves retention of the amino 
nitrogen group at C-6 and loss of the nitrogen at C-2 (Scheme 1-13). 
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The flavonoids and related compounds are a ubiquitous and structurally diverse class of 
metabolite, which have a variety of functions, such as antifeedants, pigmentation and 
molecular communication. The condensation of three malonyl-CoA units onto a 4-
coumaryl-CoA 42 starter unit provides flavone 43, the key building block in flavanoid 
biosynthesis (Scheme 1-14).^ ^ The initial step in the biosynthesis is mediated by the 
enzyme chalcone synthase, a single protein that has no co-factor requirement. This 
enzyme is one of only two polyketide-condensing enzymes that do not contain an ACP 
and utilise the CoA thioesters of the substrates directly by transacylation onto specific 
cysteine thiol sites. 
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1.3.5 Bacterial polyketides 
The Actinomycetes are the most prolific polyketide producers of all bacterial systems. 
Like fungal polyketides, many of the structures are aromatic. Many of those that are not 
feature the incorporation of propionate and butyrate derived extender units during 
polyketide assembly, results in greater alkyl fiinctionality along the carbon backbone, 
and hence some of the most complex secondary metabolites known. 
Monensin-A 46^ ^ is a polyether derived from five acetate, seven propionate and one 
butyrate subunit.'^ ^ Cascade cyclisation of a triepoxide 45 formed by epoxidation of an 
intermediate triene, and addition of molecular oxygen could account for the structure 
shown (Scheme 1-15). 
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It has been suggested that the all (£)-triene, premonensin 44, is formed by standard 
polyketide assembly and is then epoxidised to the triepoxide 45. However, all attempts 
to observe premonensin 44 in the culture broth or to cyclise synthetic material 
administered to S. cinnamonensis were unsuccessful. Therefore, the (Z)-triene, although 
not expected from usual polyketide biosynthesis, has also been considered as a valid 
intermediate. Two alternative mechanisms involving iron-mediated oxidative 
cyclisation have been proposed for polyether biosynthesis (Scheme 1-16).'^ ° These are 
epoxidation via oxygen transfer (Path A) and [2+2] cycloaddition of oxygen from a 
ferryl species (Path B). 
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A Type II PKS, a series of enzymes, which associate into a multi-enzyme complex, 
performs the assembly of many of the bacterial polyketides. However, the higher 
polyketides such as the polyethers and macrolides have a Type I PKS. Although the 
systems are different, it is essentially the same enzyme activities that perform the 
elongation and modification processes in both types of polyketide synthase. 
In the last decade, there has been a great deal of interest in the isolation and sequencing 
of genes for FAS and PKS systems. It emerges that there are similarities at the genetic 
level between the two enzyme systems, however, there are genes, for example those 
expressing enzymes for cyclisations in polyketide synthesis, which have no counterpart 
in FASs. 
1.3.6 Genetic Studies 
Genetic studies on PKSs have mainly been performed on bacterial systems, especially 
the antibiotics of the Actinomycetes, which are formed by a Type II PKS. These are 
coded for by discrete genes rather than by large open reading frames (ORFs) containing 
multifunctional PKS activities as in Type I PKSs. Actinorhodin, from Streptomyces 
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coelicolor, which has a Type II PKS, was the first system to be extensively studied.^' 
The results identified seven ORFs. Genes from the act system have been used to probe 
other PKS systems. 
The complete sequencing of 6-MSAS from Penicillium patulum^^ reveals a Type I PKS. 
The gene sequence contains an ORP, which is 5322 base pairs in length and encodes for 
1774 amino acids. The domains for the four common polyketide activities, acyl and 
malonyl transferase, ACP and 2-|3-ketoacylsynthase, were identified along with a P-
ketoreductase activity. 
The most studied Type I PKS system is that of 6-deoxyerythronolide-B synthase 
(DEBS), which produces the polyketide moiety of erythromycin. Three multifiinctional 
proteins, identified as DEBS 1, 2 and 3, have been coded and characterised (Figure 
1-1) 33 
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Each cassette has two modules with the intermediates remaining bound to the PKS 
throughout the whole sequence of biosynthetic transformations until cyclisation and 
release of 6-deoxyerythronolide-B 47. 
Tenellin 1 is proposed to be assembled in a processive manner by a Type I PKS. It is 
probable that, in a similar manner to DEBS, the transformations take place in a sequence 
of enzyme cassettes. The first cassette would perform the condensation of acetyl-CoA 
and malonyl-CoA, followed by methylation at the P-keto stage and subsequent carbonyl 
reduction. An extender malonate unit would then be added, another methylation 
performed and the ketone reduced before delivery to the second cassette. Condensations 
with a further two malonyl-CoA units would increase the chain length to the pentaketide 
required. 
OH O 
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Chapter 2 
2 Investigations into the rearrangement of phenylalanine/tyrosine in 
tenellin biosynthesis 
2.1 Amino acids in secondary metabolism 
The amino acids are involved in the biosynthesis of a wide variety of secondary 
metabolites. The alkaloids, which are derived from the aliphatic amino acids ornithine 
and lysine, or the aromatic amino acids phenylalanine, tyrosine and tryptophan, are 
found in higher plants and make up a large number of known compounds. However, 
there are still many other amino acid derived metabolites produced by bacteria and fungi 
such as chloramphenicol 48,'''* or derivatives of peptides, for example isopenicillin N 
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2.1.1 Amino acid and polyketide derived structures 
Many secondary metabolites incorporate fragments originating from different metabolic 
pathways. These have been termed 'mero-metabolites'. Examples include the 
mevalonate-shikimate derived isoprenoid quinones, the acetate-shikimate derived 
flavonoids and the ergot alkaloids, such as strychnine,^^ which is produced from 
tryptophan and mevalonate. Polyketides that contain an amino acid fragment are well 
known and some of these are discussed below. 
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The cytochalasans^^ are a class of metabolites that are inhibitors of cytoplasmic cleavage 
and consist of a highly substituted hydrogenated isoindolone ring fused to an 11- to 14-
membered macrocycle. The most biologically active structures are found to contain an 
exocyclic double bond in the isoindolone ring and an allylic alcohol fimctionality. 
There are three basic types of cytochalasan: the cytochalasins, the chaetoglobosins and 
the aspochalasins. Al l are thought to evolve from similar biosynthetic origins involving 
an amino acid and an acetate derived polyketide backbone. Any additional Ci residues 
are proposed to arise from methionine. Cytochalasin D 50 produced by Zygosporium 
masonii is found to consist of phenylalanine, nine intact acetate units and three 
methionine delivered methyl groups.^ ^ The biosynthesis probably involves initial 
formation of the nonaketide, followed by N-acylation of phenylalanine. Examination of 
deuterium incorporation from [2-'^C, 2-^H3]-acetate 2b gave the expected '^ C 
enrichments but no observed deuterium labelling apart from incorporation at C-11 and 
the methyl of the 0-acetyI group (Scheme 2-1).^^ Therefore, exchange of most, i f not 
all, of the deuterium from C-2 of acetate occurs during the biosynthesis of cytochalasin 
D. Only the polyketide chain starter unit and the acetyl methyl group retain an 
observable level of the isotopic label. 
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There is no rearrangement of phenylalanine during the biosynthesis, however 
appropriate biosynthetic investigations have revealed loss of the a-H-atom and the a-
amino group of phenylalanine in the final cytochalasin structure.'*^ It is therefore likely 
that nitrogen exchange (transamination) reactions, due to the presence of amino acid 
oxidases and aminotransferases, occur in the amino acid pool before incorporation. 
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[U-'^'Cl-Phenylpyruvic acid was incorporated into 50 at a level of 6.5 %, a similar level 
to that found for phenylalanine, indicating that transamination can occur. On the basis 
of the structure of the metabolite, it remains probable that phenylalanine is the more 
direct precursor. The transamination process could also account for the significant loss 
of tritium from administered [3-^H]-phenylalanine since p-proton exchange can occur in 
the free phenylpyruvic acid 51 (Scheme 2-2). 
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Chaetoglobosin A 54 produced by Chaetomium globosum is a closely related metabolite 
to cytochalasin D and has a biosynthesis similar to that of the cytochalasins in which 
tryptophan 52 replaces the phenylalanine residue (Scheme 2-3).'" Nine acetate, three 
methionine and one tryptophan unit are responsible for the complete structure. 
Biosynthetic experiments using [2-''^C, 2-'^ H3]-acetate 2b identified the chain starter unit 
as this was the only carbon that showed retention of all three deuterium atoms in '^ C 
NMR. Studies with ['^C, •^H3]-L-methionine 53 indicated that all three of the deuterium 
atoms were retained during incorporation into the three methyl groups of the polyketide 
moiety. 
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The pseurotins are a class of metabolites characterised by an l-oxa-7-aza-
spirol[4.4]non-2-ene-4,6-dione skeleton. They are secondary metabolites isolated from 
Pseudeurotium ovalis differing from each other by the flinctionalised side chain attached 
to the bicyclic ring. Mohr et al.^^ proposed that condensation of a phenylalanine unit 
with a polyketide moiety could account for the biogenetic origin of all the atoms. 
Pseurotin A 61 has been the subject of a biosynthetic study,'*^ and feeding experiments 
with labelled acetates, malonate, propionate, methionine and phenylalanine revealed a 
plausible biosynthetic route. The building blocks for pseurotin A 61 were found to be 
one propionate unit, four malonate units, phenylalanine and two methionine units. All 
three deuterium atoms from ['^C, ^Hs]-L-methionine were retained in both O- and C-
methylation steps. A biosynthetic route has been proposed to account for the results of 
the incorporation experiments (Scheme 2-4). Initially, propanoyl-CoA condenses in 
four successive cycles with malonyl-CoA to give a Cn-polyketide unit 55, which can 
then combine with phenylalanine to generate the enzyme bound structure 56. 
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At this point, one of two pathways can be followed depending on whether the nitrogen-
or oxygen-containing ring is assembled first. In the former case, production of the 
tetramic acid heterocycle 57 would be followed by formation of the spiro compound 59, 
probably via generation of an electrophilic site at C-5. In the second route, initial 
formation of the furenidone 58 would precede cyclisation to tetramic acid 60. Oxidation 
at C-8, C-10 and the benzylic C-atom are thought to occur as late stage transformations. 
2.1.2 The shikimate pathway 
The aromatic amino acids, phenylalanine, tyrosine and tryptophan, are biosynthesised 
via the shikimate pathway (Scheme 2-5).^ *^  The initial step is the condensation of D-
erythrose 5-phosphate 62 with phosphoenolpyruvate (PEP) 63 to yield 3-deoxy-D-
arabino-heptulosonate-7-phosphate 64 (DAHP). Loss of the phosphoryl group and 
subsequent cyclisation gives 3-dehydroquinate (DHQ) 65, which undergoes a 3-
dehydroquinase catalysed dehydration to 3-dehydroshikimate 66. An NADPH mediated 
reduction provides shikimate 67, which is then converted to shikimate-3-phosphate 68 
by the action of shikimate kinase with ATP acting as co-substrate. Reaction of the 
phosphate 68 with another PEP molecule gives 5-enolpyruvyl-shikimate 3-phosphate 69 
(EPSP), which undergoes anti-\,4 elimination of phosphate and the 6-proR proton to 
yield chorismate 70. This is performed by chorismate synthase, which has a 
requirement for reduced flavin mononucleotide (FMN). A radical mechanism is 
suggested whereby loss of the phosphate group is mediated by donation of an electron 
from the co-factor with subsequent proton loss leading to the formation of chorismate 
and regeneration of FMN. Chorismate 70 then undergoes either a chorismate mutase 
catalysed rearrangement to prephenate 71, the precursor to phenylalanine and tyrosine, 
or transformation to anthranilate 72, the first step in tryptophan production. 
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Depending upon the producing organism, the synthesis of phenylalanine 73 from 
prephenate 71 can be performed by two different pathways (Scheme 2-6). 
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2.1.3 The N I H shift 
In some organisms, including mammals, phenylalanine is converted to tyrosine by the 
action o f a phenylalanine hydroxylase (PAH). A tetrahydrobiopterin co-factor is also 
present and is oxidised to 4a-hydroxytetrahydropterin by molecular oxygen during the 
transformation. PAH is a non-haem iron containing enzyme, which has an unclear 
mechanism, although a pathway which includes the formation o f an arene oxide 
intermediate 74 has been postulated (Scheme 2-7). It was found that on treatment of [4-
^H]-phenylalanine wi th PAH, the tritium is lost from the 4-position and is transferred to 
position-3 ortho to the inserted oxygen."*"^  This process has been termed the N I H shift as 
it was discovered at the National Institute of Health laboratories in Bethesda, Maryland. 
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The proposed mechanism shows the migration of the 4-position hydrogen after the 
formation o f carbocation 75 produced by the opening of an arene oxide 74. The 1,2-
sigmatropic rearrangement gives 76, which then aromatises. Studies have shown that it 
is a kinetic isotope effect rather than a stereoselective loss of the non-migratory species 
that is in operation. For [2,3,5,6-'^H4]-phenylalanine,'*^ where a proton migrates, the 
deuterium incorporation measured is the same as for [4-^H]-phenylalanine where a 
deuteron is migrating. This was corroborated by results from feeding studies with [4-
^H]-phenylalanine where the amount o f tritium retention was higher than that for 
deuterium. 
2.1.4 Hydroxylations by Beauveria bassiana 
The selective hydroxylation o f aromatic compounds in synthetic organic chemistry is 
diff icul t to accomplish, but the use of organisms such as B. bassiana make such 
reactions readily achievable. 
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The para-methylated 77 and -deuterated 78 derivatives of Propham, an isopropyl N -
phenyl carbamate insecticide, were subjected to B. bassiana mediated hydroxylation,'*^ 
yielding benzyl alcohol 79 and the /?ara-hydroxylated compound 80 respectively 
(Scheme 2-8). The latter case showed a 46 % content at the meta position, indicating 
a 72% overall retention o f deuterium and a process consistent with the formation o f an 
arene oxide followed by an N I H shift. As expected the /Jara-methylated substrate did 
not show any evidence for the operation of an N I H shift. In both cases it is interesting 
to note, that hydroxylation was regiospecific and occurred exclusively at the para 
position o f the aromatic ring. 
H / H / 
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Scheme 2-8 
Another set of experiments demonstrated that N-benzyloxycarbonyl protected 
piperidines were hydroxylated with greater regio-selectivity than the corresponding N -
benzoyl analogues.'*^ It is thought that the selectivity in B. bassiana is not only 
determined by the distance between the carbonyl and the site of hydroxylation, but 
additionally by the distance to the aromatic side chain. This suggests that there is a 
defined aromatic binding pocket within the active site of the hydroxylation enzyme in B. 
bassiana. 
The hydroxylation o f unactivated methylene carbons in N-phosphinyl azabicyclic 
structures 81 with Beauveria bassiana (Scheme 2-9) has been shown to occur in fair to 
good yields.''^ The ability of these compounds to act as good substrates was thought to 
be due to the P=0 bond acting as a mimic o f carbonyl and sulfonyl groups by anchoring 
the substrate at the active site. 
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A l l three derivatives underwent hydroxylation to yield structures 82. However, the 
phenoxy derivative was also hydroxylated to some extent at the /?ara-position of the 
aromatic ring to give compound 83. A time course study showed that production of the 
monohydroxylated product 82 occurred initially and that the dihydroxylated product 83 
formed by conversion o f the monohydroxylated species. The products could be 
deprotected with trifluoroacetic acid in dichloromethane (TFA-DCM) and used in the 
syntheses o f natural products. 
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2.2 T h e 2-pyridone ring system 
2.2,1 Tenellin and other 2-pyridones 
Since the isolation of tenellin and related 2-pyridone metabolites, the biosynthetic 
pathways to these structures have been widely investigated. This family of compounds 
varies in complexity f rom ricinine 84,'*^  to fimiculosin 85,^ " elaborated by the fungus 
Penicillium funiculosum, to aurodox 86^' produced by the bacterium Streptomyces 
goldiniensis. 
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Some members of this group of 2-pyridones have been shown to display antibiotic 
activity, which has made them attractive targets for synthesis and biological evaluation. 
In this context, the family of elfamycin antibiotics, including aurodox 86 and 
efrotomycin 87, have been the subject o f a total synthesis by Nicolaou and co-workers.^'^ 
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Leporin A 88^ ^ f rom Aspergillus leporis contains an unusual N-methoxypyridone, and a 
polyketide derived ring system. 
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Notably the aromatic ring of the non-polyketide moiety is not phenolic. This differs 
f rom tenellin 1 and ilicicolin H 31 suggesting that the presence of the phenol is not 
essential for the generation o f the pyridone ring system. One hypothesis for the 
formation o f the pyridone ring in tenellin 1 postulates the rearrangement o f a tetramic 
acid via a quinoid intermediate {vide infra). This hypothesis could clearly not be used to 
explain the biosynthesis o f leporin A 88 as it does not contain a para-phenol moiety. 
2.2.2 Pyridone ring biosynthesis 
The biosynthesis o f ilicicolin H 31, a metabolite of the fungus Cylindrocladium 
ilicicola, has been investigated.^'* The metabolite contains two structurally significant 
moieties; a substituted pyridone ring system identical to that o f tenellin and a polyketide 
derived bicyclic decalin moiety. Usual polyketide head to tail coupling of one acetate 
and seven malonyl units accounts for the octaketide backbone, with L-methionine 53 via 
S A M providing methylation o f the polyketide at two sites to contribute the C-18 and C-
19 methyl groups (Scheme 2-10). The decalin fragment can then be formed by a series 
of aldol reactions to give the bicyclic structure. 
The average incorporation of [l,2-'^C2]-acetate 2a into the polyketide derived carbons 
was 3 % and the enrichment into the methyl groups from methionine was measured at 
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3.7 %. Ilicicolin H 31 recovered after administration of [U-'''C]-phenylalanine 73a to C. 
ilicicola had a specific activity of 13.0 |aCi/mmol giving an incorporation of 0.5 %. 
Scheme 2-10 
Feeding studies performed with [2-'^C, '^N]-phenylalanine gave a key insight into the 
biosynthetic pathway. Mass spectrometric analysis of an ion containing the pyridone 
ring and formed from the cleavage of C-7 to C-8 bond, showed a 3 % '^N enrichment. 
Further evidence for intact phenylalanine incorporation came from N M R where a '^C-
'^N spin-spin-coupling constant o f 12.5 Hz was detected. This value is consistent with a 
one bond coupling o f an sp^ hybridised carbon attached to a nitrogen. The authors 
propose therefore, that transamination to phenyl pyruvate does not occur as a 
requirement o f the biosynthesis and that phenylalanine is incorporated as an intact unit. 
Harzianopyridone 89 f rom the fungus Trichoderma harzianum possesses a 4-hydroxy-
5,6-dimethoxypyridone ring substituted at C-3 with a side chain of polyketide origin.^^ 
Incorporations f rom [1,2-'^€2]-acetate 2a revealed the involvement of a tetraketide unit, 
which forms the hexenyl chain and C-2 and C-3 of the pyridone ring (Scheme 2-11). A 
feeding experiment wi th [we//2y/-'^C]-methionine 53 established the origin of the extra 
carbons in the methyl group of the side chain and the methoxyl groups of the ring 
system. The remaining three carbons o f the pyridone ring may derive from aspartic 
acid. [U-''*C]-Aspartic acid was incorporated into 89 at a level 0.03 %, well below the 
level at which '^C N M R could be used to detect incorporation. Therefore, this proposal 
remains inconclusive and is only indicative of a possible precursor relationship. 
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The structure of nybomycin 90 has been shown to contain two pyridone rings. The 
biosynthesis was elucidated by feeding studies with [l-'^C]-acetate which showed that 
C-4, C-6, C-8 and C-10 were all labelled to an equal extent.^^ The carbons at C-6' and 
C-8' were labelled by [2-'^C]-acetate. The methyl group attached to nitrogen, C - l l ' , 
and the methylene group forming part o f the five-membered oxazoline ring, C-2, are 
both delivered by methionine 53 (Scheme 2-12). 
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The central portion o f the structure is thought to originate from shikimate or a related 
biosynthetic intermediate." Sodium [2-'''C]-pyruvate and D-[6-'^C]-glucose are 
metabolised to acetate, labelled at C-1 and C-2 respectively, and hence label the outer 
carbons o f the pyridone rings as expected. Incorporation into C-2 and C-11' also occurs 
f rom the diversion o f labelled atoms into the 'one carbon' metabolic pool. 
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Studies on the biosynthetic origin of the 2-pyridone moiety in aurodox 86 have shown 
that C-2, C-4 and C-6 are enriched by [l-'^C]-acetate, but C-3 and C-5 are not labelled 
by [2-'•'C]-acetate. The C2 units are therefore not incorporated via a conventional 
polyketide pathway and a unique mode of assembly must be in operation. 
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Tenellin 1, which forms the subject o f this thesis, also contains a pyridone ring system. 
The pyridone is known to derive from phenylalanine/tyrosine, however there is not a 
straightforward incorporation o f these units and a structural rearrangement of the amino 
acid precursor at some stage along the biosynthetic pathway is required. 
OH O 
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2.3 Biosynthesis of tenellin 
2.3.1 Metabolites of Beauveria fungi 
Beauveria bassiana is a widely distributed soil-borne fiongus and was the first 
microorganism to be recognised as an agent of animal disease.^^ Heavy losses of larval 
silkworms in the 16* and 17'^ centuries, prompted an Italian scientist, Agostino Bassi de 
Lodi, to show that the deaths o f the insects were caused by a fimgus that multiplied in 
and on the body o f the insect.^^ The ftingus is a saprophyte and known to attack a broad 
range o f insects f rom aphids to grasshoppers. There is considerable variation in host 
range and virulence between the different strains, but all attack directly through the 
insect's skin, secreting enzymes that attack and dissolve the cuticle. The fungus can 
also live endophytically in the vascular tissue of com plants thereby suppressing the 
population o f com borer pests. B. bassiana is sold as a microbial insectide, and is 
available on the market as Naturalis® and Mycotrol®. 
Vuillemin^^ established the genus Beauveria in 1912, as a general name for fungi 
previously known as Isaria, Sporotrichum or Botrytis. There are two widely recognised 
subdivisions, B. bassiana and B. tenella, distinguished by the size and shape of their 
spores. Red, yellow or green pigmentation is characteristic among these ftingi. 
The red colouration in cultures o f Beauveria is due to oosporein 91,^ " a dibenzoquinone, 
thought to be produced by oxidative dimerisation of a benzenoid intermediate formed 
from acetate and malonate condensation.^' 
OH O 
0 HO 
Inhibition o f organisms including Staphylococcus aureus and Bacillus subtilis by 
oosporein may account for the antibiotic activity of the Beauveria species.^^ 
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Tenellin 1, a yellow metabolite, was first isolated from Beauveria bassiana by El 
Basyouni et al. in 1968.*^ The structure was elucidated later by Vining^'' using 
spectroscopic and degradative techniques. In concurrent research, a structurally similar 
metabolite to tenellin 1, differing only by an additional CH=CH unit between C-7 and 
C-8, was found to be produced by Beauveria tenella. This metabolite, also yellow in 
colour, was termed bassianin 92. 
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2.3.2 Structure elucidation of tenellin 
The structure o f tenellin was solved by spectroscopic analysis and a series of 
comprehensive labelling studies.^ "*'^ "^^ '^^ ^ The polyketide nature o f tenellin was deduced 
by acetate feeding experiments,^^ which gave the expected pattern o f isotope 
incorporation. After the addition of [l,2-'''C2]-acetate 2a to B. bassiana cultures, 
tenellin labelled at five two-carbon units was isolated. Analysis by '•'C N M R showed 
pairs o f intact C2 units corresponding to C-2 and C-3, C-7 and C-8, C-9 and C-10, C-11 
and C-12, and finally C-13 and C-14 (Scheme 2-13). 
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Examination o f tenellin by '^C N M R isolated after growing cultures with K ' ^ N O S as the 
only nitrogen source established that only C-6, C-2 and C-3 were coupled to nitrogen. 
The relative values o f the Jnc-isN coupling constants, 15.0, 11.0 and 9.2 Hz respectively, 
indicate that nitrogen is geminal to C-3 and directly bonded to C-6 and C-2. The signal 
for H-6 had a JIH-I5N coupling constant o f 1.0 Hz. 
Structural analysis o f tenellin was supported by chemical evidence.^^ Alkaline 
peroxidation yielded /7-hydroxybenzoic acid and retro-aldol cleavage in refluxing 
potassium hydroxide gave 2-methylbutanal and 2,4-dimethylhex-2-enal, which were 
characterised as the 2,4-dinitrophenylhydrazones. A crystalline product, 93, was also 
obtained f rom these degradation experiments. Compound 93 had a similar spectrum to 
tenellin, but with resonances for C-8 to C-14 replaced by a single acetyl methyl peak. 
OH 0 
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The results from the labelled acetate and nitrate feeding experiments, in conjunction 
with the chemical degradative studies, indicated that the structure of tenellin must 
contain a l-hydroxy-2-pyridone moiety with a substituted acyl side-chain. The 
hydrogen at position-6 and the /?-phenol group were shown by an nOe study to be on 
adjacent carbons, the chemical shift o f C-5 in '•'C N M R consistent with the deshielding 
effect o f the aromatic ring. The chemical shifts of C-3, C-4 and C-7 in '^C N M R , in 
addition to the detection of a hydrogen bonded hydroxyl group in the ' H N M R , 
indicated the presence of the enol form of a P-diketone. 
The ' H and '^C N M R for tenellin are shown (Figure 2-1 and Figure 2-2). 
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Figure 2-1 ' H N M R of tenellin 1 
Table 2-1 ' H chemical shifts (5) and coupling constants (J Hz) for tenellin 1 
Proton multiplicity 5 
6 s 8.19 
8 d, J 15.4 8.00 
9 d, J 15.3 7.54 
11 d, J 9.5 6.00 
12 m 2.50 
13 m 1.37 
14 t, J 7.4 0.84 
15 d, J 6.4 0.99 
16 bs 1.86 
2 ' , 6' d, J 8.1 7.30 
3', 5' d, J 8.2 6.79 
N-OH s 11.75 
PhOH s 9.55 
44 
HO. 4 
6' OH O 
60 40 20 I B O 150 140 lao 100 
Figure 2-2 '^C N M R of tenellin 1 
Table 2-2 13 C chemical shifts (6) for tenellin 1 
Carbon 5 
2 157.6 
3 105.9 
4 173.0 
5 110.9 
6 140.2 
7 194.0 
8 122.6 
9 149.8 
10 132.7 
11 151.3 
12 34.6 
13 29.4 
14 11.9 
15 20.0 
16 12.3 
r 123.2 
2', 6' 130.2 
3', 5' 115.0 
4' 157.0 
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68 The absolute configuration o f tenellin was determined by a degradative process 
Catalytic ruthenium tetroxide oxidation o f a sample of tenellin yielded a mixture of 
carboxylic acid sodium salts, which were purified by acidification and lyophillisation to 
generate a mixture o f acetate 2 and 2-methylbutyrate 94 (Scheme 2-14) . After treatment 
wi th gaseous HCl under deuteriochloroform, the resultant solution was analysed by ' H 
N M R in the presence o f a chiral base. The chemical non-equivalence of the protons 
induced by the addition o f (/?,i?)-(-)-l,2-diphenyldiamino-ethane^^ to the solution was 
used to assess the absolute stereochemistry of the diastereomeric complex formed. 
Comparison o f the degradative sample with reference standards of (R)- and (5)-2-
methylbutyric acids revealed that C-12 o f tenellin has the i?-configuration. 
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Scheme 2-14 
2.3.3 Biosynthetic studies on tenellin 
Early biosynthetic experiments''^'* on tenellin 1 showed that acetate 2a efficiently 
labelled carbons 2 and 3 and carbons 7 - 1 4 indicafing a polyketide origin (vide supra). 
Isotopically labelled phenylalanines were shown to contribute the rest of the pyridone 
4 6 
and the aryl ring, and labelled methionine 53 was used to show that the two methyl 
groups, C-15 and C-16, derive from S A M (Scheme 2-15). 
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Labelling studies' showed that C-4 and C-6 o f tenellin 1 are enriched by [ l - ' ^ C ] -
phenylalanine 73b and [2-'^C]-phenylalanine 73c respectively (Scheme 2-16). 
OH O 
Scheme 2-16 
The intact incorporation o f a phenylalanine unit would indicate that a bond cleavage and 
rearrangement process must occur during the biosynthesis. 
Further support for the rearrangement hypothesis was obtained from '^C N M R analysis 
after administration o f doubly labelled [l,3-'^C2]-phenylalanine 73d (Scheme 2-17). 
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The recorded '^C NMR spectrum showed '^ C-'^ 'C coupling exclusively between C-4 and 
C-5. The contiguity of the labelled carbons and the almost equal enrichments, at C-4 
and C-5 clearly suggests that the rearrangement is an intramolecular process. 
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Scheme 2-17 
The first study investigating the incorporation of '^N into tenellin from L - [ ' ^N]-
phenylalanine^^ suggested intact incorporation of the amino acid and that transamination 
to the corresponding keto acid does not occur. However, experiments with DL-[2-'^C, 
^H, '^N]-phenylalanine^' contradicted this. The lack of coupling to '^N in the '^ C NMR 
spectrum and the absence of any indication of an intact '•^ C^H bond suggests that 
transamination to phenylpyruvate is a facile process and that previous results were 
misinterpreted. This could occur i f the nitrogen pool is significantly enriched with '^N 
from the administered precursor and that the isotope is reincorporated at a later stage. 
2.3.4 Phenylalanine versus tyrosine 
Tenellin has a C-5 phenol ring attached to the pyridone ring system, however, it is 
interesting to note that the initially reported level of radiolabelled phenylalanine 
incorporation into tenellin was significantly higher than that for tyrosine (Table 2-3).^ ^ 
Accordingly, the authors proposed that tyrosine is not a direct precursor of tenellin and 
that hydroxylation of the aromatic ring occurs after condensation of phenylalanine with 
the polyketide fragment and possibly concomitantly with ring expansion. 
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Table 2-3 % ''*C Incorporation levels of '''C-labelled phenylalanine and tyrosine 
into tenellin' 65 
Substrate 
mM |xCi/mmol 
Tenellin 
^Ci/mmol %' 
L-[2-"*C]-Phenylalanine 2 11.6 0.98 8.4 
L-[2-'''C]-Phenylalanine 2" 11.6 0.88 7.5 
L^U-'^CJ-Tyrosine 1 7.33 0.122 1.6 
" Specific incorporation estimated as 100 times specific activity of tenellin divided by specific activity of 
substrate 
The substrate was added in equal portions on the second, fourth and sixth days to give a final 
concentration of 2 mM. 
2.4 Rearrangement of phenylalanine in tenellin biosynthesis 
2.4.1 Two possible pathways for tenellin formation 
The focus of this study was to examine the details of the rearrangement of phenylalanine 
in tenellin biosynthesis. Two possible pathways have been proposed for the generation 
of the 2-pyridone ring system of tenellin (Scheme 2-18). Path A suggests that 
phenylalanine 73 undergoes a direct isomerisation to 3-amino-2-phenylpropionic acid 
95, which then couples with a polyketide moiety to form the pyridone ring. Subsequent 
hydroxylation of the nitrogen and at the /7ara-position of the aromatic ring would deliver 
tenellin. However, a process whereby a tetramic acid intermediate is formed would also 
satisfy the observed labelling experiments (path B). Para-oxygenation to a quinone 
intermediate with subsequent ring expansion and rearrangement is then postulated. This 
5-membered heterocyclic intermediate was proposed by Vining*^ and is discussed in 
Chapter 3. 
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2.4.2 Hypothesis for tenellin via a direct phenylalanine rearrangement 
The hypothesis suggested in Path A was initially considered. It was proposed that a 1,2-
carboxyl shift of phenylalanine 73 would generate 3-amino-2-phenylpropionic acid 95, 
which could then condense with a polyketide moiety to give the pyridone ring system. 
Hydroxylation of the aromatic ring by a PAH and delivery of an hydroxyl to the nitrogen 
would generate tenellin 1. 
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Scheme 2-19 
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2.4.3 Other rearrangements in secondary metabolism 
A similar phenylalanine type rearrangement to that proposed for tenellin in path A is 
found in the biosynthesis of the tropate ester moiety of alkaloids, such as hyoscyamine 
and scopolamine. The tropate skeleton is generated by a rearrangement of a 
phenylalanine derived phenylpropanoid moiety, which has been shown to be 
phenyllactate 96.^ ^ Importantly, it was found that the rearrangement does not occur 
until after condensation of phenyllactate and the tropate moiety to generate littorine, and 
that hyoscyamine 98 is formed from the direct isomerisation of littorine 97 (Scheme 
2-20). 73 
73 
97 
_Q_ 
Isomerisation OH 
98 
Scheme 2-20 
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There are structural similarities between this process and rearrangements involving co-
enzyme-Bi2 enzymes, however the occurrence of vitamin-Bi2 in higher plants is not 
proven and this is unlikely to be a B12 mediated process. 
Co-enzyme B12 plays a role in enzymic rearrangments that involve the vicinal 
interchange of a hydrogen atom and a substituent on an adjacent carbon (Scheme 2-21). 
It is thought that hydrogen abstraction from the substrate generates a radical, which may 
then undergo direct rearrangement to give the product. The hydrogen is then returned to 
the other migration terminus. 
R I Vitamin B12 J ^ 
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Scheme 2-21 
One co-enzyme B12 system that has been studied in some detail is methylmalonyl-CoA 
mutase (Scheme 2-22).^'' 
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Scheme 2-22 
This reaction is initiated by the formation of an adenosyl radical, which abstracts a 
hydrogen atom from the methyl group of the substrate. The study of methylmalonyl-
CoA mutase using a labelled substrate showed that the hydrogen that was removed was 
not scrambled with water during the rearrangement, but became relocated at C-2 of 
succinyl-CoA. Analogous reactions involving 1,2-migrations of vinyl groups are known 
to proceed via cyclopropylmethyl radical intermediates, so it is likely then that the 
thioester group in the methylmalonyl-CoA mutase system migrates via a similar 
intermediate. Thus, coenzyme B12 appears to act as a reversible free radical carrier. 
Experiments on tropic acid biosynthesis gave conflicting evidence on the role of 
coenzyme B12. An early feeding study^^ using radiolabelled phenyllactate reported a 
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vicinal interchange process, where the hydrogen removed from C-2 was apparently 
relocated at the original carboxyl site, suggesting a co-enzyme B12 type mechanism. 
However, a more recent experiment^^ using stable isotopes and '^ C NMR analysis, saw 
no evidence for a vicinal interchange process. Leete has also indicated an absence of 
co-enzyme B12 in Datura plants and therefore it would appear unlikely that this co-
factor is involved in the rearrangement of littorine to hyoscyamine during tropic acid 
biosynthesis. 
The rearrangement may be mediated by a cytochrome P450 enzyme. The generation of 
radicals by iron-oxo species is not unknown, and it has recently been shown that the 
conversion of littorine to hyoscyamine is inhibited by chlotrimazole, a recognised P450 
inhibitor. Oxygen rebound mechanisms are a feature of such systems and the fate of 
oxygen in the tropic acid system has been studied. 
In a feeding experiment with [2-^H, '^0]-hyoscyamine,^^ it was found that 71-75 % of 
the '^O was retained. The loss of label can be rationalised in several ways from Scheme 
2-23, however none of the explanations account for a loss of 25-29 %. Stereospecific 
collapse of diol 101 favouring loss of oxygen from the rebound hydroxyl over that from 
the phenyllactate would give 100 % retention, whereas loss of the hydroxyl from 
phenyllactate would give 100 % loss. Non-stereospecific collapse would give a 
retention of 50 %. I f there is no oxygen rebound mechanism operating, then aldehyde 
102 would form directly and there would be no loss of the '^0 label. Therefore, the 
level of retention of '^O is thought to occur by partial stereospecific collapse of the diol 
or from exchange of the aldehyde with the medium. 
Accordingly, it is proposed that abstraction of the V-pro-R hydrogen by an Fe(IV)-0 
species generates radical 99 which then undergoes rearrangement to 100. Formation of 
aldehyde 102 then occurs, either by quenching of the radical with a hydroxyl group from 
Fe(IV)-OH (oxygen rebound) to form hydrate 101, followed by stereospecific loss of the 
rebound hydroxyl, or directly, by dehydration of 100. The action of a dehydrogenase 
then delivers hyoscyamine. 
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P450 enzymes usually favour radical processes, however there is precedence for the 
involvement of cations emerging from Newcomb's study on substituted 
methylcyclopropane ring opening reactions (Scheme 2-24).^ * In model studies, cation 
induced ring opening of 103, followed path A where the resultant positive charge in 104 
became stabilised by the methoxyl group, rather than the phenyl ring. Conversely, 
radical induced ring opening of 105, followed path B, with ring opening favouring the 
benzyl radical 106. 
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The process occurring during littorine (tropate) isomerisation has the positive charge or 
radical moving from a benzyl position towards a methyl position and is therefore more 
suggestive of a cation type process. 
For tenellin biosynthesis, the possibility that phenylalanine rearranges in such a manner 
has been explored. DL-[3-'^C]-3-Amino-2-phenylpropionic acid 95 was synthesised'^  in 
a previous study (Russell Cox) (Scheme 2-25) and then administered to cultures of B. 
bassiana. 
2.4.4 Synthesis and feeding of DL-[3-'^C]-3-amino-2-phenylpropionic acid 95^ ^ 
The isotopic label was introduced by treatment of benzyl chloride 107 with potassium 
['•'CJ-cyanide. The benzyl cyanide 108 produced was converted to the phenylcyano-
acetic acid methyl ester 109 and then hydrogenated to yield the amine hydrochloride 
110. Base hydrolysis of the ester gave the target compound 95, which was purified by 
ion exchange chromatography. 
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Scheme 2-25 Reagents and conditions: i, [''C]-KCN, 18-crown-6, acetonitrile, 18 °C, 12 h, 90 %; ii, 
BuLi in THF, then solid CO2 and acidify with 10 % H2SO4, 38 %; iii, CH2N2; iv, H2-Pt02 in EtOH-CHClj 
(10:1), 2.5 atm, 18 °C, 18 h, 40 %; v, NaOH then H^-Dowex, 58 %. 
Analysis of tenellin isolated from a feeding experiment with DL-[3-''^C]-3-amino-2-
phenylpropionic acid 95 did not show any incorporation of label at C-5. It was 
concluded from this experiment that 95 is not an early intermediate in tenellin 
biosynthesis. 
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2.5 Tyrosine as a precursor in tenellin biosynthesis 
2.5.1 Tyrosine versus phenylalanine 
As described earlier, Vining et al.^^ reported that radiolabelled phenylalanine became 
incorporated into tenellin at considerably higher levels than tyrosine. However, 
subsequent feeding experiments in the Durham laboratory (Caragh Moore) with stable 
isotopes have shown that tyrosine is incorporated at similar levels to phenylalanine. 
[1-'^C]-Phenylalanine was incorporated into tenellin at a level of 8.5 % and [3-'^C]-
tyrosine at 6.1 %. 
In the current study, these experiments have been repeated and a similar set of 
incorporation rates obtained (Table 2-4). 
Table 2-4 % Incorporation of phenylalanine and tyrosine into tenellin 
Days after inoculation 
when precursor was fed 
Level of incorporation 
into tenellin {%f 
0 5.9 
DL- [ 1 -' •'C] -phenylalanine 3 6.4 
4 4.8 
3 5.8 
DL-[3-'^C]-tyrosine 4 3.8 
5 3.8 
° Tenellin was extracted 7 days after inoculation of cultures. 
Figure 2-3 shows the '^C NMR spectra for one of each of the feeding experiments with 
[l-'''C]-phenylalanine and [3-'^C]-tyrosine. Tenellin extracted after a feeding 
experiment with [l-'^C]-phenylalanine (middle spectrum) showed incorporation of label 
at 6 173 corresponding to C-4 of tenellin. Incorporation of [3-'^C]-tyrosine (bottom 
spectrum) into tenellin was indicated by enrichment at the C-5 resonance at 5 111. 
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Figure 2-3 '^C NMR spectra of tenellin : natural abundance (top), after feeding with 
[l-'^C]-phenylalanine (middle), after feeding with [3-'^C]-tyrosine (bottom) 
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The results suggest that tyrosine and phenylalanine are equally efficient precursors to 
tenellin and raises the possibility that perhaps it is tyrosine and not phenylalanine that 
undergoes a direct rearrangement during the early stages of tenellin biosynthesis. This 
is structurally satisfactory as tyrosine carries the phenol ring system found in tenellin. 
2.5.2 The revised tyrosine hypothesis 
The hypothesis for the biosynthesis of tenellin can be re-written to account for the 
hydroxylation of phenylalanine 73 to tyrosine 111, by a phenylalanine hydroxylase 
(PAH), and subsequent rearrangement to the P-amino acid 112 (Scheme 2-26). 
Condensation with the polyketide unit would furnish tenellin as before. 
PAH 
73 111 
H O ^ / O 
112 
OH O 
N " 0 
1 
Scheme 2-26 
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In order to test the validity of this revised hypothesis, whereby tyrosine and not 
phenylalanine is the more immediate precursor to tenellin, it proved necessary to 
synthesise an isotopically labelled sample of the putative precursor 3-amino-2-(4-
hydroxyphenyl)propionic acid 112 for use in a feeding experiment. Clearly, a synthetic 
route to 112 had to be considered. 
2.5.3 Synthesis of [3-'^C]-3-amino-2-(4-hydroxyphenyl)propionic acid 112a 
A similar strategy to that used by previous workers to prepare 3-amino-2-
phenylpropionic acid 95^ ^ was used (Scheme 2-27). 
CH3O 
113 
0 > ^ ^ 0 H 
112 
CH3O 
CHaO' 
CH3O 
N 
114 
0.^ , O E t 
115 
O,^ . O E t 
NH3*cr 
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Scheme 2-27 Reagents and conditions: i, KCN, Nal, (CH3)2CO, reflux, 24 h, 94 %; ii, NaH, THF, 
0 °C, then CO(C2H50)2, reflux, 1 h, 55 %; iii, H2-Pt02, CHCI3, EtOH, 2.5 atm, 40 h, 94 %; iv, IM BBr^ in 
DCM, -78 °C to 0 °C, 12 h, then IM NaOH then H^-Dowex, 42 %. 
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/?-Methoxybenzyl chloride 113 was reacted with sodium or potassium cyanide to yield 
4-methoxybenzyl cyanide 114 in high yield. The use of this starting material obviated 
the requirement for protection of the phenolic hydroxyl group later in the synthesis. 
Q l O T 0 1 
Deprotection of aromatic methyl ethers ' ' is widely reported and with many different 
reagents, therefore it was anticipated that the cleavage of this ether would not prove too 
difficult. The resultant nitrile 114 was purified by column chromatography over silica 
gel. Treatment of 114 with NaH and diethyl carbonate*'*'^ ^ gave the ethyl carbonate 115. 
This reaction proved problematic and was performed a number of times (Table 2-5) 
until an optimal set of conditions was established. Only moderate yields could be 
obtained even after such optimisation. The deprotonation was carried out using a 
variety of reaction times and either sodium hydride or sodium ethoxide as base. The 
nitrile was stirred with a base and appropriate solvent for between 0 and 60 min before 
the addition of diethyl carbonate. Deprotonation with sodium hydride in tetrahydrofiiran 
for 30 min was found to give the highest yields. Variable product to starting material 
ratios could be obtained by altering the reflux time. The results suggested a 
decarboxylation, as longer reaction times appeared to decrease the product yield. In all 
cases, some starting material was recovered from the reaction, although this could be 
minimalised by using a five-fold excess of diethyl carbonate. To show that there was no 
difficulty with deprotonation, D 2 O was added to quench the anion. The presence of the 
deuterium atom was then determined by ' H NMR analysis. The geminal proton at C-2 
could be seen as a triplet at 6 3.57 in the ' H NMR spectrum indicating coupling to a 
deuterium atom. In the '^ C NMR spectrum, C-2 was also coupled to the deuterium as 
evidenced by a triplet for this signal. Therefore, it was concluded that the problems 
experienced are due to either the low reactivity of the electrophile or a decarboxylation. 
Reactions were also attempted with ethyl chloroformate and solid C O 2 (entries 8-10), 
but these were unsuccessful. Thus, work on the diethyl carbonate reactions was 
continued in order to improve the yield. 
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Table 2-5 Reaction conditions employed for the conversion of 114 to 115 
No. Reagent 
Deprotonation 
(0°C) 
Conditions Yield 
(%) 
1 diethyl carbonate NaH, THF, 30 min reflux 4 h 64 
2 diethyl carbonate NaH, THF, 30 min reflux 2 h 55 
3 diethyl carbonate NaH, THF, 0 min reflux 4 h 0 
4 diethyl carbonate NaH, THF, 45 min reflux 8 h 0 
5 diethyl carbonate NaH, THF, 1 h reflux 8 h 0 
6 diethyl carbonate Na, (C2H5)20 reflux 2h 10 
7 diethyl carbonate Na, (C2H5)20 reflux 8 h 8 
8 ethyl chloroformate NaH, THF, 30 min reflux 4 h 0 
9 ethyl chloroformate NaH, THF, 0 min reflux 4 h 0 
10 carbon dioxide NaH, THF, 30 min stir 6 h 0 
11 diethyl carbonate NaH, THF, 30 min reflux 1 h 53 
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The next step required the conversion of the nitrile 115 to an amine 116. Hydrogenation 
of the nitrile was initially attempted using a palladium on carbon catalyst. ' H N M R 
analysis showed a complex spectrum indicating a mixture of products, so the use of this 
catalyst was abandoned. Fortunately, utilisation of platinum oxide^^ under hydrogen gas 
at 2.5 atm gave the desired product. I f the reaction was carried out using chloroform as 
a co-solvent with ethanol, the resultant amine was generated directly as the 
hydrochloride salt. This proved ideal for purification as the product was a white powder 
and could be collected after filtration of the catalyst and evaporation of the solvent. 
The remaining step in the synthesis required the cleavage of the methyl ether. To 
examine the efficacy of the various possible ether cleavage reagents, test reactions were 
carried out on 0-methyl tyrosine 117. 
C H 3 O ' 
117 
It emerged that the methyl ether could be cleaved using hydriodic acid^^ in acetone and 
methanol, when treated under pressure in a Carius tube at 200 °C. However, on several 
occasions the tube ruptured and the product was lost. The harsh conditions also resulted 
in heat induced decomposition and significant purification of the product was required, 
resulting in low yields. Reactions with trimethylsilylbromide (TMSBr) or 
trimethylsilyl-iodide (TMSI), produced in situ from sodium iodide and 
trimethylsilylchloride (TMSCl) were unsuccessfiil. Hydrogen bromide (48 % solution 
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in acetic acid) proved effective but product yields were low. 
Eventually, the most efficient reagent for the deprotection of 116 was found to be boron 
tribromide (BBrs).^" Time constraints led to this reagent being tested directly on 116. 
When a solution of 116 in dichloromethane and BBrs was stirred at -78 °C and allowed 
to warm to room temperature overnight, cleavage of the ether occurred. Subsequent 
stirring in I M sodium hydroxide solution was required in order to hydrolyse the ethyl 
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ester and give the desired product in a moderate yield. Purification of the resultant p-
amino acid was performed by ion-exchange chromatography over H^-Dowex. 
This first series of experiments was performed with unlabelled sodium cyanide in order 
to verify the feasibility of the synthetic route. Once efficient protocols had been 
established, labelled potassium ['^C]-cyanide was used in the synthesis. The reactions 
were carried out as described for the unlabelled material to produce [3-'^C]-3-amino-2-
(4-hydroxyphenyl)propionic acid 112a in 20.2 % overall yield. 
The coupling of the methylene protons with the '^ C isotopic label can be seen by 
NMR (Figure 2-4). The pair of doublet of doublets at 6 2.85 and 5 3.0 corresponding to 
the protons at C-3 is coupled to another pair of doublet of doublets at 6 3.35 and 6 3.5, 
with a coupling constant of 145.7 Hz. The C-2 proton is superimposed on one of the 
methylene resonances at 5 3.5 and there is a characteristic pair of doublets at 6 6.75 and 
6 7.04 indicating a para-substituted aromatic. 
3 1. 
H O ^ O 
1T> 
H-2 
3 
NH2 
112a 
Figure 2-4 ' H NMR of [3-'^C]-3-amino-2-(4-hydroxyphenyl)propionic acid 112a 
It can be seen that the integral of the aromatic signal at 6 6.75 is lower than the other 
aromatic resonance. This is possibly due to deuterium exchange with the NMR solvent. 
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In the '^C NMR, the presence of the '^ C label in [3-'^C]-3-amino-2-(4-
hydroxyphenyl)propionic acid is indicated by the intense peak at 5 42.5 (Figure 2-5). 
Unfortunately, the acquisition of the spectrum is terminated once one of the peaks 
reaches a certain height, so the unlabelled peaks are small. 
H O ' 4 
2' NH2 
C-2',6' 
C-1 C-4' 
C-3',5' 
c - r 
C-2 
C-3 
1 « « 21 120 100 I ppa 
Figure 2-5 '^ C NMR of [3-'^C]-3-amino-2-(4-hydroxyphenyl)propionic acid 112a 
[3',5'-^H2]-3-Amino-2-(4-hydroxyphenyl)propionic acid 112b was also prepared. 
Heating 112 in deuterated acid and water under pressure for 3 h produced 112b in 
moderate yield. The product was found to be >95 % deuterated by ' H NMR. 
O.^ . O H 
112 112b 
Scheme 2-29 Reagents and conditions: i, DCI/D2O, Carius tube, 80 °C, 3 h, 64 %. 
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It was also found that [3',5'-^H2]-3-amino-2-(4-hydroxyphenyl)propionic acid could be 
generated by utilising deuterated hydrobromic acid (DBr/CD3CD20D) in the final ester 
hydrolysis step of the synthesis. This material was also found to be >95 % deuterated by 
NMR. 
2.5.4 Feeding of [3-^^C]-3-amino-2-(4-hydroxyphenyl)propionic acid 112a to 
Beauveria bassiana 
[3-'^C]-3-Amino-2-(4-hydroxyphenyl)propionic acid 112a was administered to two 
culture flasks of Beauveria bassiana at a final concentration of 5 mmol. The bright 
yellow cultures were extracted with acetone on day 10 and tenellin (25 mg) was 
isolated. The ^^ C NMR spectrum recorded was indicative of tenellin, but unfortunately, 
no '^C incorporation of the labelled material could be detected. 
2.5.5 Feeding of [3',5'-^H2]-3 -amino-2-(4-hydroxyphenyl)propionic acid 112b to 
Beauveria bassiana 
The deuterium labelled material 112b was fed to cultures of Beauveria bassiana to a 
final concentration of 5 mmol. The mycelia produced by two flasks of ftmgus were 
combined and tenellin extracted in the usual manner. After Soxhlet extraction and 
work-up, tenellin (30 mg) was isolated as an orange/yellow powder. '^ H NMR analysis 
of the sample did not indicate any deuterium incorporation. 
From these results it was concluded that 3-amino-2-(4-hydroxyphenyl)propionic acid 
112 is not a relevant precursor in tenellin biosynthesis and the production of the 
secondary metabolite must be elaborated by another biosynthetic pathway. 
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2.6 A refined hypothesis involving tyrosine in tenellin biosynthesis 
2.6.1 3-Hydroxy-2-(4-hydroxyphenyl)propionic acid 118 
The hypothesis tested to this point assumes a direct rearrangement of tyrosine. In view 
of the failure of incorporation of the synthetic intermediates 95 and 112, the possibility 
of a transamination occurring before rearrangement was now considered. It has been 
shown (Chap 2.3.3) that there was no intact incorporation of the isotopes from [2-'^C, 
^H, '^N]-phenylalanine indicating a facile transamination process. 
I f we now consider the possibility of transamination occurring as a requirement before 
the rearrangement of tyrosine, then a new putative intermediate 118 is formed. 
PAH 
73 111 
Transamination and 
Rearrangement 
H O . ^.0 
118 
OH O 
N " 0 
Scheme 2-30 
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The hydroxy acid, 3-hydroxy-2-(4-hydroxyphenyl)propionic acid 118, was now 
examined as a putative precursor to tenellin and therefore emerged as a new target for 
synthesis. 
The revised hypothesis is shown in Scheme 2-30. 
2.6.2 Transamination of phenylalanine 
Pyridoxal 5'-phosphate (PLP) 119 is involved in all aminotransferase reactions of amino 
acids. It is a co-enzyme derived from vitamin Be (pyridoxine) which ftmctions as an 
electron sink and can covalently attach amino acids via an aldehyde moiety at position 
C-4. 
p ' C 
- O - P - O - C H 2 A ^ O H 
H 
119 
When no substrate is present, the aldehydic linkage is bound to the transaminase 
enzyme through a Schiff base 120 to the s-amino group of a lysine residue at the active 
site. An a-amino group of an amino acid can displace the lysine forming an aldimine 
structure 121. The addition of the amino acid increases the acidity of the a-proton, 
which is lost to give a quinonoid intermediate 122, the pyridine ring acting as a sink for 
the electrons. Reprotonation produces a ketimine 123, which can be hydrolysed to 
release the keto-acid 124 and pyridoxamine 5'-phosphate 125 (Scheme 2-31). 
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2.6.3 Pyranone formation in tenellin biosynthesis 
The proposal that 3-hydroxy-2-(4-hydroxyphenyl)propionic acid 118 is a precursor in 
tenellin biosynthesis implicates the pyranone structure 126 as an intermediate. I f the 
hydroxy acid condenses with the polyketide unit then pyranone 126 will be formed. It 
can be envisaged that a nitrogen containing compound, possibly ammonia or 
hydroxylamine, could attack at the carbonyl and open, the pyranone ring. Intramolecular 
nitrogen attack at the newly formed carbonyl in 127 could then form the six membered 
ring 128, which could undergo loss of water to generate the pyridone ring system and 
deliver tenellin. 
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Many pyranone structures are known to occur in natural products. They can be a-or y-
pyranones, depending on whether the carbonyl is ortho or para to the heterocyclic 
oxygen. 
The coumarins are widespread and contain an a-pyrone system. They are often evolved 
from shikimate via p-coumaric acid but can also derive from acetate. Umbelliferone 
129, the UV-absorbing component of many suntan preparations and psoralen 130, a 
furanocoumarin, are shikimate derived 23 
HO O " 0 
129 
O " O 
130 
A fused fiiran ring is a common feature of these structures and in this case is derived 
from the alkylation of umbelliferone 129 with dimethylallyl pyrophoshate (DMAPP). 
Loss of three carbons then generates psoralen 129 (Scheme 2-33). 
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In contrast, the metabolite 4,7-dimethoxy-5-methylcoumarin 131 from the fimgus 
Aspergillus variecolor is derived from acetate (Scheme 2-34).^' 
CH3 OCH3 CH3 O 
S C o A 
CH3O 
Scheme 2-34 
The flavones and isoflavones, for example rotenone 132, are y-pyrones. The 
biosynthesis of rotenone from phenylalanine via cinnamic and />-coumaric acids has 
been shown in biosynthetic studies (Scheme 2-35).^ ^ 
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2.6.4 Origin of the nitrogen atom 
Tracing the fate of the nitrogen atom in natural products has been the focus of many 
studies. Transamination processes remove the nitrogen atom from amino acid donors, 
and re-incorporation of ammonia can occur at a significant level. For example, 
phomazarin 134 has a tricyclic structure and is derived from nine intact acetate units. 
The nitrogen is thought to be incorporated into structure 133 (Scheme 2-36). 
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Scheme 2-36 
The insertion of nitrogen into a diacid precursor 135 is thought to account for the 
structure of the antibiotic kinamycin D 136. Labelling studies have shown that C-6 is 
lost during the biosynthesis and C-5 (*) becomes the carbon of the N-cyano group 
(Scheme 2-37).'^ 
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2.6.5 Synthesis of 3-hydroxy-2-(4-hydroxyphenyl)propionic acid 118 
Two strategies were considered for the synthesis of 3-hydroxy-2-(4-
hydroxyphenyl)propionic acid 118. The first of these is shown below (Scheme 2-38). 
H O 
O H 
O 
HO 
O C H , 
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O C H , 
O C H , 
140 
O C H , 
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Scheme 2-38 Reagents and conditions: i, CH3OH, H2SO4, reflux, 12 h, 75 %; ii, 4-methoxybenzyl 
chloride, Bu4N^r, K 2 C O 3 , (CH3)2CO, 60 °C, 48 h, 57 %. 
This route involved the protection of 4-hydroxyphenylacetic acid 137 followed by the 
introduction of a C H 2 O H fiinctional group at position-2 by condensation with 
paraformaldehyde. It was envisaged that deprotection would then generate the desired 
hydroxy acid. 
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4-hydroxyphenylacetic acid methyl ester 138 could be generated in good yield from the 
reaction of the corresponding acid 137 with methanol and sulfiiric acid. In order to 
protect the phenol, the ester was treated with 4-methoxybenzyl chloride and potassium 
carbonate in acetone,^ ^ giving the desired product 139 as a white crystalline material. 
The next step was to introduce the hydroxymethyl group adjacent to the carbonyl. 
Accordingly, the jt?-methoxybenzyl ether 139 was deprotonated with sodium hydride and 
then treated with paraformaldehyde.^^ Two products formed in a ratio of approximately 
1:1 as determined by ' H NMR. One was the desired hydroxymethyl product 140 and 
the other was the methyl acrylate 141, which clearly arose after dehydration of 140. 
Hydroboration of the acrylate 141 was now considered as a method for the synthesis of 
140. To perform the hydroboration, the mixture of products 140 and 141 was initially 
stirred in acid to convert all of the material to the alkene. However, during this process 
the material decomposed, so the hydroboration could not be performed. 
OCH3 
141 
The reaction was repeated with a shorter reaction time, and a mixture of starting 
material 139 and traces of product 140 was isolated. In view of the difficulty with this 
reaction, an alternative approach to 118 was considered. 
Since the P-amino acid 3-amino-2-(4-hydroxyphenyl)propionic acid 112 was already in 
hand, conversion of the NH2 to OH by diazotisation would clearly provide a route to 
furnish 118 in a single step (Scheme 2-39). 
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Scheme 2-39 Reagents and conditions: i, 2M H2SO4, 2M NaN02, 0 °C, 3 h, then room temp., 12 h; ii, 
2 M N a O H , 2h,41 %. 
The diazotisation of a-amino acids to a-hydroxy acids is well documented.^ ^ It has 
been used in the preparation of a-hydroxy ketones, which are usefial as chiral synthons 
or stereodirecting groups in organic synthesis, and also in the synthesis of a-hydroxy 
carboxanilides.^^ No such reactions for P-amino acids could be found in the literature. 
It was not clear at the outset i f this reaction would be successfial particularly as loss of 
nitrogen from the diazo compound 118, could clearly promote elimination. 
Alternatively, the initially formed protonated P-hydroxy acid may be prone to 
elimination also and could potentially generate 143 (Scheme 2-40). 
142 143 
Scheme 2-40 
Nevertheless, the reaction was attempted under standard diazotisation conditions.'"^ 
The amino acid was stirred in a mixture of 2M sulfuric acid and sodium nitrite at 0 °C 
for 3 h and then at room temperature overnight. After filtration and removal of solvent, 
a brown oil was produced. 
It was found that after the diazotisation reaction, the hydroxy acid 118 was not the major 
product. The chemical shift of the methylene protons, a pair of doublet of doublets at 5 
4.35 and 4.97 (Figure 2-6) was instead indicative of the formation of the P-lactone 
144.'°' 
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Figure 2-6 ' H NMR of lactone 144 
Presumably once the diazonium ion 142 has formed, an intramolecular attack of the 
carboxylate results in loss of nitrogen to yield the 4-membered lactone 144 (Scheme 
2-41). 
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Scheme 2-41 
The corresponding product, an a-lactone 145, is a transient intermediate in a-amino 
acid diazotisations. However, this intermediate is short lived due to ring strain. 
Consequently, the a-lactone 145 is readily hydrolysed to the a-hydroxyacid 146 under 
aqueous acidic conditions (Scheme 2-42). This reaction proceeds with overall retention 
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of configuration as there are formally two inversions of configuration occurring during 
the process. 
N2^  0 
H H 
145 
Scheme 2-42 
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In order to generate the desired hydroxy acid 118, the P-lactone was stirred without 
purification in aqueous NaOH for 2 h. After this time ' H NMR analysis showed an 
upfield shift, to 5 3.65 and 3.87, in the AB signal corresponding to the methylene 
protons (Figure 2-7) indicating that hydrolysis had occurred. 
H a & H b 
r S He 
Figure 2-7 ' H NMR of hydroxy acid 118 
1 ppa 
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This is consistent with ring opening and greater shielding of the protons. Further 
characterisation revealed that the correct product had been generated. 
The synthesis was repeated with [3-'^C]-labelled amino acid, prepared as in Scheme 
2-27, to give the corresponding '"'C labelled hydroxy acid (Scheme 2-43). The chemical 
shift of C-3 had shifted from 6 42 in the amino acid to 8 63 in the hydroxy compound. 
0<^0H 
H O ^ N H , 
112a 
O ^ ^ O H 
118a 
Scheme 2-43 Reagents and conditions: i, 2M HCl , 2M NaNOj, 0 °C, 3 h, then room temp., 12 h; ii, 
l M N a O H , 2 h , 44%. 
2.6.6 Feeding of [3-^^C]-3-hydroxy-2-(4-hydroxyphenyl)propionic acid 118a to 
Beauveria bassiana 
[3-'^C]-3-Hydroxy-2-(4-hydroxyphenyl)propionic acid 118a was administered to B. 
bassiana at a final concentration of 3 mmol. Tenellin (31 mg) was extracted from the 
fungal mycelia and '^C NMR spectra recorded. There was no enhancement of any peaks 
in the '^C NMR spectrum and hence no evidence of incorporation of the administered 
material. 
2.6.7 Summary 
From the feeding studies performed with 112 and 118, it is probable that both 3-amino-
2-(4-hydroxyphenyl)propionic acid 112 and 3-hydroxy-2-(4-hydroxyphenyl)propionic 
acid 118 are not relevant intermediates in the early stages of tenellin biosynthesis. 
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However, it cannot be discounted that these labelled substrates were not able to 
permeate the cell membrane or were degraded before incorporation could occur. The 
absence of an incorporation from these two substrates together with the earlier study 
with 3-amino-2-phenylpropionic acid 95 indicates that the rearrangement process which 
occurs during tenellin biosynthesis is unlikely to involve a rearrangement similar to that 
occurring in tropic acid formation (littorine to hyoscyamine). 
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Chapter 3 
3 A tetramic acid as an intermediate in tenellin biosynthesis 
3.1 Introduction 
3,1.1 The tetramic acids 
The tetramic acids are a family of structures incorporating the five-membered nitrogen 
containing ring 147. They occur in many natural products and have received 
considerable attention due to the large number of molecules of this class that exhibit 
biological activity. The members of this group range from antibiotics and cytotoxins to 
fungicides and pigments. 
N 
H 
147 
3.1.2 Properties of tetramic acids 
Tetramic acid 147 has a pKa = 6.4'°^ and is a much weaker acid than the oxygen 
equivalent, tetronic acid 148.'°^ Therefore, it is less highly enolised, existing mainly in 
the 2,4-diketo form. 
HO, 
N' 0 ^0-^0 
H 
147 148 
Derivatives with a 3-acyl substituent have lower pKa values and show complete 
enolisation. They exist as two sets of rapidly interchanging internal tautomers (a and b). 
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which arise from proton transfer within the molecule, and two sets of rapidly 
interconverting external tautomers (c and d) resulting from rotation of the side chain 
(Scheme 3-1) 102 
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H 
O H 
H 
Scheme 3-1 
Exchange between the two types of structures (a b and c d) is slow and can be observed 
on the NMR time-scale. The coupling constants and chemical shifts can be used to give 
information on the population of the tautomeric forms. Enolic carbons resonate at a 
lower frequency than the corresponding keto carbons, and hydrogen bonded carbonyl 
carbons at a higher frequency to free carbonyl g r o u p s . T h e exo-eno\ d was found to 
be the most predominant tautomer'"'* indicated by the presence of a lower frequency C-6 
enol resonance and a C-2 hydrogen bonded carbonyl resonating at a higher frequency. 
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Tenellin 1 contains a 3-acylpyridone ring moiety. Vining^^ proposed that the 
biosynthesis of tenellin could proceed via tetramic acid 149 (Scheme 3-2) after 
condensation of phenylalanine and a polyketide fragment. 
OH O 
Scheme 3-2 
3.1.3 Biosynthesis of the tetramic acid moiety 
Tetramic acids are known to be derived from polyketides and L-amino acids. 
Erythroskyrine 150, a polyenoyltetramic acid, which has antibiotic activity against some 
species of Staphylococcus, is derived from acetate, malonate and L-valine.'°^ Attempts 
to identify the origin of the N-methyl group were inconclusive. Notably 5-
adenosylmethionine did not label this N-Me group. Several fuligorubin A related 
metabolites, such as the phenol substituted tetramic acids 151-153 from the slime mould 
Leocarpus fragilis}^^ are derived from L-tyrosine and an acetate generated polyketide 
component. 
O O H 
150 
HO 
O O H 
// W 
RN 
151 R = H, n = 0 
152 R = H, n - 3 
153 R = CH3, n = 3 
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In the antibiotic malonomicin 154, the tetramic acid moiety is derived from one acetate 
unit and L-2,3-diaminopropanoic acid (L-DAP).'°^ Succinic acid, carbon dioxide and L -
serine contribute the side chain. 
H 2 N ^ 
O HO HN " O 
CO2H 
154 155 
Other tetramic acid containing compounds include tirandamycin 155, which has 
attracted much synthetic interest due to its inhibitory action on bacterial RNA 
polymerase. The high activity of this compound above other 3-acyltetramic acids is 
thought to be a consequence of the 2,9-dioxabicyclo[3.3.1]none or the dienoyl 
functionality. 
One of the simplest structures in this class is the 3-acyltetramic acid, tenuazonic acid 
156, which has been isolated from a number of fungal species 109 
Degradation studies performed on 156, gave L-isoleucine as product after ozonolysis 
and acidic hydrolysis. The authors'*'^  proposed that there are two potential pathways for 
the formation of tenuazonic acid 156 (Scheme 3-3). The first requires the condensation 
of the carboxyl group of L-isoleucine 157 with the a-methylene carbon of the p-ketoacid 
followed by ring closure as a result of amide bond formation (Path A). The second 
possibility is the generation of the amide bond initially, and condensafion of the a-
methylene carbon and carboxyl group occurring as the second step (Path B). The 
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trapping of N-acetoacetyl-L-isoleucine 158 indicates that the latter mechanism applies 
and that the initial step is the formation of the amide bond (Path B). 
O H 
Path A 
Condensation 
157 PathB 
Annide bond 
formation 
Amide bond 
formation Condensation 
Scheme 3-3 
Although tenuazonic acid has a wide range of biological activities,"° its toxicity makes 
it of limited value. Isopropyl 159, isobutyl 160, and n-propyl 161 analogues of 
tenuazonic acid resulted from feeding studies with L-valine, L-leucine and L-norvaline 
respectively. These compounds were found to have similar, but less potent activity to 
tenuazonic acid itself 
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159 R=/-Pr 
160 R=/-Bu, 
161 R=«-Pr 
The antifungal antibiotic ilicicolin H 31 is known to derive from phenylalanine and a 
polyketide unit.^ '* Feeding studies carried out to explore the origin of the atoms of 
ilicicolin H have already been discussed (Chap 2.2.2). 
O H O ^ 
H 
31 
From the results obtained, it was proposed that the biosynthesis of ilicicolin H proceeds 
via a tetramic acid intermediate (Scheme 3-4) in a similar maimer to that suggested for 
tenellin. This proposal is essentially derivative of that developed by Vining for tenellin 
(see Chap 3.1.4). 
It was postulated that the decalin moiety of ilicicolin H 31, formed from the 
condensation of a polyketide, couples with phenylalanine to afford the five-membered 
intermediate 162. Para-oxygenation of the aromatic ring to the quinone intermediate 
163 would provide the required oxygen at C-4'. A ring expansion and rearrangement 
would then be necessary to afford the pyridone ring structure of ilicicolin H. The results 
from incorporation studies with labelled acetate, methionine and phenylalanine gave a 
pattern consistent with such a hypothesis. 
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162 
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Scheme 3-4 
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3.1.4 Vining's hypothesis for tenellin biosynthesis 
Vining proposed a hypothesis for the biosynthesis of tenellin as detailed below (Scheme 
3-5). 65 
73 
Q O 
149 
9 0 
164 
O H O 
N "0 
O H 
Scheme 3-5 
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The results from a feeding experiment using [l,3-'^C2]-phenylalanine 73d have 
previously been discussed (Chap 2.3.3). It was found that the '^ C labels from the 
administered precursor became incorporated at positions 4 and 5 in tenellin. The 
contiguous nature of these labels in the isolated metabolite indicates that a 
rearrangement of the phenylalanine has occurred. 
Mechanisms that have been proposed for this hypothesis could involve either a cation or 
a radical process and are discussed in the next section (chap. 3.1.5) 
3.1.5 Putative mechanisms for the proposed tetramic acid rearrangement in 
tenellin biosynthesis 
The mechanism proposed by Vining^^ could proceed via a cationic species. Para-
hydroxylation, by oxidation to quinone 164 primes migration of the C-4, C-5 bond 
yielding the dihydropyridone cation 165. Loss of a proton from position-5 would then 
create the pyridone ring structure found in tenellin 1 (Scheme 3-6). 
0 0 OH 0 
Rearrangement and + 
tautomerisation i 
OH 
164 165 
Scheme 3-6 
OH 0 
N "0 
OH 
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A weakness with this hypothesis is the formation of the unstabilised cation 165. The 
lone pair of electrons on nitrogen is associated with the amide bond and will not 
obviously be able to stabilise the adjacent positive charge. 
An alternative hypothesis for this rearrangement proposes a radical mechanism 
involving a one electron oxidation (Scheme 3-7). The radical 166 is possibly more 
favourable than the cation 165 as stability could be derived from the aromatic ring. 
Attack of the radical at the carbonyl carbon followed by bond cleavage and 
rearrangement could yield the dihydropyridone radical 167. Loss of a hydrogen atom 
from this species could then generate tenellin 1. 
166 
Rearrangement and 
tautomerisation 
167 
OH 0 
N "0 
Scheme 3-7 
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3.1.6 P450 mediated rearrangements 
There may be some similarity between the mechanism of tenellin formation and the P450 
mediated rearrangement of flavanones 168 to isoflavones 171. 1,2-Aryl migration in 
this system is known to be initiated by isoflavone synthase, a P450 iron containing 
enzyme, which requires dioxygen and NADPH. An oxygen rebound mechanism has 
been proposed (Scheme 3-8)"' whereby radical 169 is quenched by an hydroxyl radical 
from Fe(IV)-OH. A dehydratase then generates the isoflavanone 171. Cell free extract 
studies showed that the hydroxyl group in 170 was labelled from O2. 
Fe(V)=0 
HO^ ^ O . 
0 
168 
OH 
Fe(IV)-OH 
HO 
OH 
HO 
Rearrangement 
OH 
169 
Fe(IV)-OH 
Fe(lll) ^ 
oxygen 
rebound 
O^ ^OH 
Scheme 3-8 
Other researchers have suggested a different mechanism, which accounts for the 
presence of the free p-hydwxyl group in the migratory aromatic ring. In experiments 
with /?-methoxylated substrates, it was found that demethylation of the ether was 
required before the rearrangement would occur. On these suppositions a new 
intermediate, spirodienone 172, was postulated."^ 
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172 
An oxygen rebound mechanism remains most probable with an Fe(III)-OH species 
attacking the spirodienone to give the corresponding hydroxyl compound and Fe(III), 
which can then be reactivated after the binding of another substrate molecule. 
3.1.7 Testing of Vining's hypothesis 
The validity of the hypothesis proposed by Vining^^ was tested in Durham by 
OA 
incorporation experiments with labelled tetramic acid 149. The synthesis (Scheme 
3-9) of this compound involved the coupling of the protected phenylalanine 173 with an 
acetonide 174 to give the P-ketoamide 175, which could then be cyclised under 
Dieckmarm conditions to the tetramic acid 176. Straightforward N-deprotection yielded 
the desired product 149 as a mixture of diastereoisomers. 
[2-'^C]-Tetramic acid 149a was then fed to cultures of Beauveria bassiana over several 
days. There was no evidence by '^ C NMR of any incorporation into C-4 of the isolated 
tenellin. In order to increase the sensitivity of the analysis by mass spectrometry, 
[p/jewyZ-^Hs]-tetramic acid 149b was also prepared and administered to the fungus. 
Again, there was no detectable incorporation into tenellin. It was therefore concluded 
that tetramic acid 149 is not an intermediate on the biosynthetic pathway of tenellin. 
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CH30 
CHgO ^ OCH3 
176 
149a • = '^C, R = 'H 
149b. = '^C, R = ^H 
Scheme 3-9 Reagents and conditions: i, toluene, PPTS, reflux, 3h, 42 %; ii, tBuOK, /BuGH, 30 min, 
92 %; iii, T F A , 5 min, 92 %. 
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These experiments were performed prior to the more contemporary discovery that 
tyrosine is an equally efficient precursor to tenelHn as phenylalanine (see chapter 2.5.1). 
It is now concluded that the first step in the biosynthesis of tenellin is para-
hydroxylation of the aromatic ring of phenylalanine, which therefore infers the para-
hydroxylation of all ensuing substrates on the pathway, including tetramic acid 149. 
Therefore in retrospect, it is not surprising that tetramic acid 149 is not accepted as an 
intermediate in tenellin biosynthesis. Tetramic acid 177 now emerges as the more 
relevant intermediate for study. 
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3.1.8 New tetramic acid hypothesis 
Vining's hypothesis outlined in section 3.1.4 can now be modified to account for the 
new role of tyrosine 111 in the biosynthesis of tenellin. The revised hypothesis is as 
shown in Scheme 3-10. In the first step, phenylalanine 73 is hydroxylated by a 
phenylalanine hydroxylase to yield tyrosine 111, which can then undergo condensation 
with a polyketide moiety to generate the tetramic acid derivative 177. Ring expansion 
and rearrangement would then afford tenellin 1 (section 3.1.5). 
73 
PAH 
177 
OH O 
N "0 
1 
Scheme 3-10 
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The tetramic acid 177 became a key synthetic target of this project in order to conduct a 
feeding study to test this modified hypothesis. Clearly, a synthesis amenable to isotopic 
labelling had to be developed. 
A similar general strategy to that utilised for the synthesis of 149 was adopted. 
3.2 Synthesis of tetramic acid 177 
3.2.1 General synthetic methods towards tetramic acids 
The first tetramic acid synthesis was completed by Gabriel"^ in 1914. Diethyl 
sodiomalonate was reacted with phthalimidoisobutyryl chloride 178 to give product 179 
which cyclised on treatment with acid to the 3-ethoxycarbonyl tetramic acid 180 
(Scheme 3-11). 
EtO 
OH 
^ C O C I i 
NPhth PhthN COzEt 
COzEt ii 
HO2C 
178 179 
Scheme 3-11 Reagents and conditions: i, diethyl sodiomalonate; ii, cone. H2SO4. 
A popular technique for tetramic acid preparation involves Dieckmann cyclisation of an 
N-acetoacylated amino acid 182, formed from an amino acid ester 181 and diketene, as 
shown in Scheme 3-12."'' This is a particularly useful method for accessing 3-acyl 
derivatives, such as 183, as it is advantageous to form the highly polar heterocycle 
towards the end of a synthetic route due to the difficulties associated with the 
manipulation and purification of these compounds. 
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HgN XOaEt 
181 
EtOzC 
182 183 
Scheme 3-12 Reagents and conditions: i, diketene; ii, NaOCHs. 
A cyclisation procedure involving N-hydroxysuccinimide esters of N-protected amino 
acids 184 (Scheme 3-13) has also been reported for the synthesis of 3-substituted 
tetramic acids 186."^ Under basic conditions, the esters undergo in situ cyclisation after 
C-acylation with active methylene compounds 185. Optically active tetramic acids have 
been obtained from L-amino acid precursors. 
R NH O 
184 
H ,C 
CO2R" 
185 
CO2R" 
RO 
R ' ^ N ^ O 
186 
Y = COCH3, COPr, COPh 
CO2CH3, COjEt, SO2CH3 
R = Bn, (CH3)3C 
R' = H,CH3 R"=CH3,Et 
Scheme 3-13 Reagents and conditions: i, NaH, benzene, room temp. 
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In the previous examples, it can be seen that elaboration of the molecule is performed 
initially and cyclisation occurs as the final step. However, it is also possible to form the 
3-substituted products by acylation after formation of the heterocyclic ring. Kohl' was 
the first to attempt this strategy in the synthesis of magnesidin (188, 189), a magnesium 
containing antibiotic. Acylation was achieved by reaction of the acyltetramic acid core 
187 with an acyl chloride and boron trifluoride-etherate (Scheme 3-14). Unfortunately, 
loss of the product during the basic work-up led to low yields. 
C H s C H ^ N ^ O 
H 
187 
CH3CH" ^N' ^0 
Ac 
188 R = (CH2)4CH3 
189 R = (CH2)6CH3 
Mg 2+ 
Scheme 3-14 Reagents and conditions: i, RCOCl, BF3.0Et2; ii, AcjO, NaOAc, MgClj. 
This methodology was investigated further by Jones who improved the yield by 
introducing a neutral work-up procedure. The products were isolated as the boron 
difluoride complexes, which could then be released with methanol to give the 3-
acyltetramic acids in 50-78 % yield. Titanium tetrachloride could also be used but 
poorer yields were obtained. 
Yoshii"* described an interesting reaction in which 3-acyltetramic acids were 
synthesised from the corresponding 4-0-esters (Scheme 3-15). Exposure of the 0-
acylated tetramic acids 190 to base, initiated rearrangement to the 3-substituted products 
191. 
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R' N 
X 
O 
o. 
R' N 
X 
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O 
//-OH 
R' N 
191 
R' = H, 'Pr, Bn 
R"= 'Pr, Bn, CH=CHCH=CHCH3 
X = H, Bn 
Scheme 3-15 Reagents and conditions: i, R"C02H, DCC, DMAP; ii, EtjN. 
The syntheses of streptolydigin and tirandamycin 155 derivatives"^ have been 
performed by methods involving the cyclisation of the tetramic acid ring both prior and 
subsequent to the elaboration of the 3-acyl side chain. Low product yields were 
obtained from the route involving the acylation of unsubstituted 2,4-pyrrolidiones, so 
the cyclisation of P-ketoamides via an intramolecular Claisen condensation is preferred. 
Amino acid esters 193 were condensed with dienoylacetyl esters, for example 192, 
produced from the corresponding dienoic acids, to give the 3-dienoyl tetramic acid 
derivatives 194 in moderate yield (Scheme 3-16). 
O O 
^OCjHs + RNHCH2COOC2H5 
192 193 
OH 
0 
o-
194 
R = CH2C6H5, cyclohexyl 
Scheme 3-16 Reagents and conditions: i, NaOEt or NaOMe. 
The synthesis of the tetramic moiety of erythroskyrine 150'^ *^  was completed from N-
methyl (5)-valine methyl ester 199 and a functionalised t-hutyl thioester 198 (Scheme 
3-17). The reaction between phosphonate ester 195 and aldehyde 196 produced diene 
197 in >30:1, E:Z selectivity, which then underwent reduction with sodium borohydride 
and dehydration. A subsequent diisobutylaluminium hydride (DIBALH) reduction and 
Homer-Wadsworth-Emmons type reaction with phosphonate ester 195 yielded the 
100 
thioester 198. Coupling with the valine derivative 199 and cyclisation under Lacey-
Dieckmann conditions gave the tetramic acid 201, which was found to exist as a mixture 
of enol forms in a 4:1 ratio. 
' B u S 
W V-l w w 
OEt 
SnBu^ SnBu3 
195 196 
o o 
' B u s ' 
0 OH 
197 
II - VI 
198 
VII 
"SnBua 
NH 0 
-s^ 0CH3 
199 
S n B u , 
200 
VIII 
SnBua 
Scheme 3-17 Reagents and conditions: i, ?-BuOK, THF, room temp, then 196, -78 °C to 0 °C, 30 
min; ii, NaBH4, MeOH-/PrOH, -10 °C to -5 °C over 15 min; iii, AcjO, DMAP, DCM, room temp., 10 
min; iv, DBU, THF, -30 °C to room temp, over 2 h; v, DIBALH, toluene, -78 °C, 10 min; vi, 195, t-
BuOK, THF, room temp, then aldehyde, -78 °C to 0 °C, 30 min; vii, 199.HC1, Et3N, CF3C00Ag, THF, 0 
°C, 40 min; viii, CHjONa, MeOH, 25 °C, 90 s. 
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A Stille'^' coupling between the tetramic acid 201 and a suitably protected fliran 
derivative, followed by subsequent deprotection in formic acid yielded the synthetic 
erythroskyrine 150, which gave analytical data in good accordance wdth the natural 
product. 
In a similar manner, the synthesis of fiiligorubin A 32 was achieved (Scheme 3-18).'^^ 
Condensation of the (i?)-glutamic acid derivative 202 and a suitable polyene P-
ketothioester 203 in the presence of silver(I) trifluoroacetate followed by cyclisation 
with potassium r-butoxide and deprotection with formic acid gave enantiomerically pure 
fiiligurobin A 32. 
'BUO2C 
CO2CH3 
202 
'Bus 
203 
CO2H 
32 
Scheme 3-18 
The conversion of pyrones to tetramic acids has been achieved by reaction of halo-
derivatives with sodium/7-toluenesulfonamide and sodium methoxide (Scheme 3-19).'^^ 
6-Bromomethylpyrone 204 was treated with sodium p-toluenesulfonamide in 
tetrahydrofuran (THF) to generate sulfonamide 205, which underwent fission of the 
pyrone ring and accompanying ring closure of the nitrogen heterocycle to give 206. It 
is thought that the opening of the pyrone ring removes any steric constraints that could 
102 
hinder formation of the pyrrolidone ring. Base induced ester hydrolysis followed by 
decarboxylation in refluxing toluene gave the 3-acyltetramic acid 207, which was found 
to exist in solution as the dienolic tautomer. 
COjCHa 
B r - ^ ° Y ° _ L ^ T o s H N ^ ° Y ° " . 
E t 0 2 C ^ Y ' ^ E t 0 2 C ^ ^ 
OCH3 OCH3 
204 205 206 
^ O C H s 
^ O C H 
207 
Scheme 3-19 Reagents and conditions: i, NaNHTos, THF, 20 °C; ii, NaOMe, MeOH, reflux; iii, 
NaOH (aq), 25 °C. 
It is also possible to introduce the nitrogen atom using sodium azide. This yields an 
azidomethylpyrone intermediate, which can be reduced to an aminomethylpyrone by 
hydrogenation.'^^ Protection as the tosylate gives 205, which can then be treated in the 
same way as described above in order to deliver 207. 
Combinatorial methods have also contributed to the wide range of tetramic acid 
syntheses (Scheme 3-20).'^ "* An Amberlyst resin (OH" form) 208 was found to promote 
the cyclisation of acylated amino acid derivatives 209 to the corresponding 
pyrrolidinediones 210. A particular advantage of this method is that the cyclised 
compounds remain tightly bound to the resin enabling other chemicals present to be 
washed away. Stirring of 211 in acid removed the bound material to give the fi-ee 
tetramic acid 212, which was collected by filtrate evaporation. 
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Scheme 3-20 
Other methods to tetramic acids include intramolecular Wittig reactions of y-
acylphosphonium ylides,'^^ rearrangement of spiro p-lactams (Scheme 3-21)'^^ and 
radical cyclisation of propargyl bromoamides.'^^ 
C O O H 
CONHCH3 
0 
( 
P 
NCH3 
COOCH3 
Scheme 3-21 Reagents and conditions: i, DCC, DCM; ii, CH2=C=0, AC2O, 50 °C; iii, NaOCHj, 
CH3OH, reflux, 16 h. 
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3.2.2 Proposed synthetic route to tetramic acid 177 
The route proposed for the synthesis of tetramic acid derivative 177 is outlined below 
(Scheme 3-22). This follows a common strategy towards the formation of this class of 
compound and has been used in the preparation of many 2,4-pyrrolidinedione ring 
systems. It involves the condensation of a protected a-amino acid and in this case the 
diketene derivative 174'^ ^ to give a P-ketoamine, which would then undergo cyclisation 
to the tetramic acid 177. 
o 0 
OCH3 ^ | j " ^ ^ r - ^ ' ^ Y ^ 0 C ' ^ 3 
PGO 
f f Y " Y^0CH3 
NHPG 
PGO 
HQ 
HO 
O 
I 
PG 
HO 
I 
H 
177 
174 
o o 
l ^ ^ V / ^ ^ O C H a 
o 
PG = protecting group 
Scheme 3-22 
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3.2.3 Protection strategy 
An initial objective of the synthesis was to select suitable protecting groups for the 
route. These groups were required to be stable to all steps in the reaction sequence as 
well as being easily removed under mild conditions at the end of the synthesis. To test 
the suitability of different protecting groups a model system was selected. The tetramic 
acid derivative 213, with a truncated acyl moiety containing a 3-acetyl group, emerged 
as an appropriate model target. 
HO li 
H 
213 
It was surmised that the absence of the polyketide moiety should not affect the 
chemistry at the nitrogen and phenolic oxygen centres. The synthesis of 213 was 
achieved in a similar manner to that shown in Scheme 3-22, by the reaction of the 
protected amino acid derivative 214 with 2,2,6-trimethyl-4H-l,3-dioxin-4-one 215 
(Scheme 3-23). 
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In the first step, tyrosine 111 was readily converted to the methyl ester hydrochloride 
216 by refluxing in methanol and thionyl chloride (Scheme 3-24).'^^ After cooling, the 
addition of diethyl ether led to precipitation of the product, which could be collected by 
filtration to give 216 as a white powder in high yield. 
OCH3 
NH3 CI 
111 216 
Scheme 3-24 Reagents and conditions: i, SOCI2, MeOH, reflux, 3 h, 97 %. 
The next step involved protection of the amine. It has been shown that short chain N-
acylated derivatives can be cyclised to the corresponding tetramic acids without the use 
of a nitrogen protecting group. However, during the previous synthesis of tetramic acid 
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80 149, the N-unprotected longer chain derivative 217 was fovind to undergo ester 
hydrolysis to 218 rather than cyclisation as expected (Scheme 3-25). For this series, 
cyclisation appears to demand nitrogen protection. 
HO, 
149 
O 0 
218 
Scheme 3-25 
Similarly, during the formation of tetramic acids reported by DeShong et it was 
found that the condensation of phosphonate 219 derived anions with aldehydes was 
unsuccessful when the nitrogen was unprotected. N-benzyl derivatives readily 
underwent reaction with an appropriate aldehyde and potassium ^butoxide to afford the 
N-alkyl tetramic acids 220 (Scheme 3-26). 
P(0Et)2 
R = H 
R=Bn(OCH3)2 . R 
219 220 
Scheme 3-26 
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Several syntheses of tetramic acids have reported the use of a 2,4-dimethoxybenzyl 
group for nitrogen protection.'^'''^^ Reaction of the amino nitrogen with 2,4-
dimethoxybenzaldehyde forms an imine which can be reduced by sodium 
cyanoborohydride to the desired amine. Attempted reactions to generate 221 fi-om 
tyrosine methyl ester hydrochloride 216 under these conditions were unsuccessful 
(Scheme 3-27). 
NH3 ^ c r / \ H O ^ ^ (^^^ 
0 
0CH3 
O C H , 
OCH3 
216 221 
Scheme 3-27 Reagents and conditions: i, 2,4-dimethoxybenzaldehyde, MeOH, room temp., 30 min; 
ii, NaCNBHj, room temp., 16 h, then HCl (aq). 
This method was abandoned and other N-protecting groups were explored. 
3.2.4 N-Boc-0-2,6-dichlorobenzyl protection 
r-Butoxycarbonyl (Boc) is a common protecting group for amino acids,'•'^  particularly in 
the synthesis of peptides. Addition of di-r-butyl dicarbonate in r-butanol'^ '* to the free 
base of tyrosine methyl ester, generated the N-Boc derivative 222 in high yield (Scheme 
3-28). 
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Scheme 3-28 Reagents and conditions: i, SOCI2, MeOH, reflux, 3 h, 97 %; ii, K2CO3 (aq); iii, 
(800)20, /-BuOH, Et20, room temp, 30 min, 92 %. 
An oxygen protecting group was now required. A previous attempted synthesis of the 
tetramic acid derivative 177 in DurhamError! Bookmark not defined, had investigated 
the suitability of a p-methoxybenzyl and a benzyl group. Unfortunately, both protecting 
groups were found to be unsuitable. The reaction of N-protected tyrosine methyl ester 
221 with /?-methoxybenzyl chloride produced the desired protected amino acid 223 as 
required, however complete cleavage of the protected ether was observed in the 
subsequent reaction of 223 with the diketene adduct. The mild acidic conditions due to 
the presence of pyridinium jpara-toluene sulfonate (PPTS) were thought to be 
responsible. Condensations without PPTS were tried, but no reaction ensued (Scheme 
3-29). 
Deprotonation of the amine with sodium hydride prior to reaction with the diketene did 
not produce the desired product either. 
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CHgO 
CH3O 
223 
OCH3 
R = 2,4-dimethoxybenzyl R' 
Scheme 3-29 Reagents and conditions: i, p-methoxybenzyl chloride, K2CO3, (Bu)4NI, DMF, 60 °C, 
3 d; ii, 174, PPTS, toluene, reflux, 2 h; iii, 174, toluene, reflux, 2 h. 
The tyrosine methyl ester was then protected as the benzyl ether 224, which was found 
to be stable to the acidic conditions of the reaction with the diketene adduct and also to 
all successive reactions in the synthesis. However, the benzyl group was insufficiently 
labile to be removed in the final step (Scheme 3-30). Extended deprotection times with 
TFA^' led to decomposition. The presence of double bonds in the side chain of the 
tetramic acid excludes the use of hydrogenation, a frequently used method for the 
deprotection of benzyl ethers 135 
111 
HO 
OCH3 
NHR 
0 
OCH3 
NHR 
224 
R = 2,4-dimethoxybenzyl 
HO, 
N 
H 
149 
Scheme 3-30 Reagents and conditions: i, benzyl bromide, K2CO3, DMF, 60 °C, 2 d; ii, TFA, room 
temp., 30 min. 
From these observations it was anticipated that a substituted aromatic having 
intermediate reactivity between a benzyl and /»-methoxybenzyl group would fulf i l the 
requirements needed for an effective protecting group. 2,6-Dichlorobenzyl groups have 
been used for the protection of tyrosine in other syntheses, chiefly because of their low 
incidence of rearrangement during cleavage,'^ ^ a common feature of tyrosine chemistry, 
but also due to their ease of removal.'^^ 0-Benzyltyrosines 225 are frequently found to 
undergo intramolecular rearrangement to the corresponding 3-benzyltyrosines 226 
during deprotection in acidic conditions (Scheme 3-31). 
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CO2H 
slow 
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Scheme 3-31 
NH 
CO2H 
+ 
CO2H 
NH2 
111 
.139 Cation scavengers, for example thioanisole,'^^ anisole''^ ^ and dimethylsulfide'''° are 
often used in order to suppress these side reactions (Scheme 3-32). 
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R - C H 2 - 0 — C H 2 
S(CH3)2 
CH2-S(CH3)2 
J \ ^ C l 
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Scheme 3-32 
Accordingly, the 2,6-dichlorobenzyl group was investigated as a potential phenol 
protecting agent in the synthesis of 177. 
The reaction of the N-^-butyloxycarbonyl tyrosine methyl ester 222 with 2,6-
dichlorobenzyl chloride and potassium carbonate in dimethylformamide (DMF) 
afforded the protected amino acid 227 in good yield (85 %) (Scheme 3-33). The 
reaction was initially performed in acetone, but DMF was found to increase the 
solubility of the reagents and improve the yield. Washing the organic extracts 
repeatedly with water removed any residual traces of DMF. 
Once the amino acid had been protected, acetoacylation of the nitrogen was required in 
order to form the p-ketoamine. Diketene adduct, 2,2,6-trimethyl-4H-l,3-dioxin-4-one 
215, was reacted with the protected tyrosine 227 and pyridinium /7ara-toluene sulfonate 
for 3.5 h and the product subsequently purified by column chromatography. ' H N M R 
analysis showed that the Boc group had almost entirely cleaved during the reaction. 
Although Boc groups are known to be acid labile, cleavage generally occurs under 
stronger acid conditions. A different N-protecting group was thus required. 
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Scheme 3-33 Reagents and conditions: i, 2,6-dichlorobenzyl chloride, K2CO3, DMF, reflux, 48 h, 
85 %; ii, 2,2,6-trimethyl-4H-l,3-dioxin-4-one, PPTS, toluene, reflux, 3.5 h. 
3.2.5 N-2,6-dichlorobenzyI-0-2,6-dichIorobenzyl protection 
At this stage of the synthesis the 2,6-dichlorobenzyl group was considered for both O-
and N-protection. Initially, sole protection of the nitrogen was attempted using either 
triethylamine''" or diisopropylethylamine''*'^ as the base, however reactions were 
unsuccessful resulting in the recovery of starting material only. Since reaction of the 
nitrogen alone proved difficult, a one step, dual protection strategy was adopted. The 
standard reaction conditions for 0-protection were employed, but with 2 equivalents of 
2,6-dichlorobenzyl chloride. After work-up, the major product was identified as N-2,6-
dichlorobenzyl-0-2,6-dichlorobenzyl tyrosine methyl ester 229. The yield of 60 % is 
moderate, but was acceptable as this reduced the synthetic scheme by one step and was 
equivalent to two protection steps of approximately 77 % yield. 
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Following the previous protocol, the protected tyrosine 229 was reacted with the acetone 
diketene adduct 215 to give the N-acetoacylated compound 230. Analysis of the 
product by ' H NMR showed both protecting groups to have remained intact (Scheme 
3-34). 
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Scheme 3-34 Reagents and conditions: i, 2,6-dichlorobenzyl chloride (2 equivalents), K2C O3, DMF, 
60 °C, 12 h, 60 %; ii, 2,2,6-trimethyl-4H-l,3-dioxin-4-one, PPTS, toluene, reflux, 2 h, 74 %; iii, tBuOK, 
tBuOH, 25 °C, 30 min, 97 %. 
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Compound 230 was then cyclised via a Lacey-Dieckmann cyclisation'"^ using 
potassium r-butoxide."'* Lacey found that treatment of the DL-alanine ethyl ester with 
diketene yielded the corresponding acetoacetamide, which could then be cyclised to the 
acyltetramic acid with sodium ethoxide in ethanol/benzene. Cyclisation occurs very 
quickly and extended reaction times lead to racemisation.^ '*'* In the event, an orange 
product 231 was isolated fi"om the reaction mixture after work-up. Excess /-butanol was 
removed azeotropically with hexane. 
Q 1 
The protected acyltetramic acid 231 was then treated with trifluoroacetic acid (TFA) at 
room temperature in an attempt to cleave the dichlorobenzyl groups. After 1 h, NMR 
analysis showed that neither group had been removed. Other systems using 
TFA/thioanisole/trifluoromethylsulfonic acid (TFMSA),''*^ and TFA/chloroform were 
also attempted. Again, no reaction had occurred. Longer reaction times or higher 
temperatures resulted in decomposition of the tetramic acid. Deprotections with 
TMSCl, TMSBr,^^ eerie ammonium nitrate (CAN)"*^ and acetic acid were also 
unsuccessftal. 
HO 
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Scheme 3-35 Reagents and conditions: i, IM BBrj in DCM, -78 °C to room temp., 24 h. 
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Finally, boron tribromide^" was found to be effective for the removal of the phenol 
protecting group to yield compound 232, but this reagent did not cleave the N-2,6-
dichlorobenzyl group (Scheme 3-35). This could perhaps be due to steric hindrance 
from the two chlorine atoms, impeding the attack of a bromide ion in close proximity to 
the tetramic acid ring. The phenolic hydroxyl oxygen is clearly more accessible 
presumably facilitating ether cleavage. 
Although the inability to cleave the nitrogen protecting group was disappointing, it was 
notable that an effective 0-protection/deprotection strategy had been established. The 
2,6-dichlorobenzyl group has been shown to be appropriate for the protection of the 
phenolic oxygen in this synthesis. It is easily introduced, is stable to all reaction steps, 
and can be readily removed in the final step with BBrs under mild conditions. 
A nitrogen protecting group was however still required. 
3.2.6 N-2,4-dimethoxybenzyl-0-2,6-dichlorobenzyl protection 
At this point it appeared appropriate to re-examine 2,4-dimethoxybenzyl as a nitrogen 
protecting group. The reaction with 2,4-dimethoxybenzaldehyde was repeated as 
previously described but with the addition of magnesium sulfate (MgS04) to the 
mixture. 
0CH3 
NH3" C I ' 
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OCH, 
OCH, 
OCH, 
Scheme 3-36 Reagents and conditions: i, 2,4-dimethoxybenzaldehyde, MgS04, MeOH, room temp., 
24 h; ii, NaBH4, MeOH, 0 °C, 1 h, 66 %. 
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The removal of the water formed in the reaction was believed to shift the equilibrium in 
favour of the imine 233 (Scheme 3-36) and although yields were still not high, 
reproducible amounts of product 221 could now be obtained. 
Previously, sodium cyanoborohydride had been used as the reducing agent, however the 
use of sodium borohydride removed the potential hazards associated with the production 
of hydrogen cyanide gas formed during the acidic work-up. 
The successftil synthesis of 221 proved a very important result as it allowed the project 
to move forward. Earlier work^' had already established that the 2,4-dimethoxybenzyl 
group is stable to all reaction steps and can be readily cleaved at the end of the sequence 
by TFA. Therefore, in conjunction with a 2,6-dichlorobenzyl 0-protecting group, an 
appropriate protection strategy appeared to be in place. It was anticipated that two 
separate deprotection steps, firstly using boron tribromide and then trifluoroacetic acid 
would give the desired product. 
Accordingly, tyrosine methyl ester 216 was prepared as previously described and the 
product then stirred with 2,4-dimethoxybenzaldehyde and MgS04 in methanol. The 
resultant imine was reduced with sodium borohydride to give N-2,4-dimethoxybenzyl 
tyrosine methyl ester 221 as a white powder (Scheme 3-37). 
Protection of the phenolic hydroxyl as before gave the protected tyrosine derivative 234, 
which was then reacted with the acetone diketene adduct 215. The product 235 was 
cyclised by treatment with potassium ^-butoxide in ^butanol for 30 minutes at room 
temperature to give 236 as an orange solid. Due to the high polarity of this compound, 
no purification was attempted. Deprotection of the phenol with BBra in DCM was 
complete in 6 h and analysis of the product concluded that substantial cleavage of the 
methyl ethers of the N-protecting group had also occurred. The N-2,4-dimethoxybenzyl 
protected tetramic acid 237, which was then stirred for 1 hour in TFA^' in order to yield 
the desired tetramic acid 213 in 33 % overall yield from tyrosine (Scheme 3-37). 
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Scheme 3-37 Reagents and conditions: i, S O C I 2 , MeOH, reflux, 3 h, 97 %; ii, 2,4-dimethoxy-
benzaldehyde, MgS04, MeOH, room temp., 12 h then NaBH4, MeOH, 0 °C, 1 h, 66 %; iii, 2,6-
dichlorobenzyl chloride, K 2 C O 3 , DMF, 60 °C, 24 h, 81 %; iv, 2,2,6-trimethyI-4H-l,3-dioxin-4-one, PPTS, 
toluene, reflux, 3 h, 79 %; v, /BuOK, iBuOH, 25 °C, 30 min, 98 %; vi, IM BBr, in DCM, -78 °C to room 
temp., 6 h, 99 %; vii, TFA, room temp., 1 h, 85 %. 
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Now that suitable protection and deprotection strategies had been developed in the 
model system, a synthesis of the tetramic acid 177 could be addressed (Scheme 3-38). 
Clearly to succeed in the total synthesis, the acetone diketene adduct derivative 174 had 
to be prepared. 
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Scheme 3-38 
3.2.7 Synthesis of acetone diketene adduct 174 
The desired side chain had previously been prepared in Durham.*" (£)-2,4-Dimethyl-
hex-2-enal 242 was synthesised in two steps by an aldol condensation method reported 
by Wittig'"*^ (Scheme 3-39). Primarily the imine, (1,1-dimethyl-N-propylidene) 
ethylamine 240,''** was produced from the dropwise addition of propionaldehyde 239 to 
^-butylamine 238 followed by addition of potassium hydroxide and overnight 
refrigeration. The product was distilled from the reaction mixture to give a moderate 
yield of a clear, colourless oil. This compound proved unstable and it was generally 
prepared prior to use and i f necessary stored over molecular sieves in the fi-eezer. 
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Scheme 3-39 Reagents and conditions: i, 0 °C then KOH, 5 °C, 12 h, 49 %; ii, BuLi, THF, -78 °C 
then 241, 0 °C, 4 h; (C02H)2, 72 h, room temp., 60 %. 
The second step involved lithiation of imine 240 using butyllithium at -78 °C, followed 
by a condensation with 2-methylbutyraldehyde 241. This gave the aldimine adduct, 
which decomposed on addition of oxalic acid to the more stable aldehydic trans olefin 
242'^ ^ (Scheme 3-39). This aldehyde 242 was stable to storage at -10 °C but was 
generally purified just prior to use by column chromatography over silica gel. 
The phosphonate ester 244, which was required for the coupling reaction with aldehyde 
242, was synthesised from acetone diketene adduct 215 via the 4-chloro-derivative 
(Scheme 3-40).'^ '^  Accordingly, deprotonation of 2,2,6-trimethyl-4H-l,3-dioxin-4-one 
215 by lithium diisopropylamide (LDA) formed a yellow precipitate, which was 
transferred by cannula to a stirring mixture of hexachloroethane in THF at -55 °C. The 
resultant deep purple reaction mixture was quenched with acid and extracted into 
solvent to yield a brown oil after work-up. This material was purified by column 
chromatography utilising an increasing elution gradient of ethyl acetate in diethyl ether 
to give 2,2-dimethyl-6-chloromethyl-l,3-dioxin-4-one 243'^° as a colourless oil. Early 
fractions from the column were found to contain excess unreacted hexachloroethane. 
For optimum yield the anion was rapidly transferred to the stirred mixture of 
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hexachloroethane in order to prevent decomposition from warming. Pre-cooling the 
cannula prior to use also proved beneficial. 
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Scheme 3-40 Reagents and conditions: i, LDA, THF, -78 °C, C2CU, THF, -55 °C, Ih, 69 %; ii, 
HP(0)(0Et)2, NaH, THF, 0 °C, 1 h 30, 52 %; iii, LHMDS, THF, -78 °C to room temp, over 4 h, then 
room temp., 8 h, 43 %. 
Synthesis of the phosphonate ester 244 was not straightforward. Initial reactions were 
performed with potassium /-butoxide and diethyl phosphite in DMF, the latter two then 
being removed from the reaction mixture by d i s t i l l a t i o n . T h e reported reduced 
pressure could not be achieved, so the temperature had to be increased for distillation to 
occur. NMR analysis of the distillation residue showed that decomposition of the 
phosphonate ester, most likely due to the elevation in temperature, had occurred. 
Deprotonation of diethyl phosphite was subsequently accomplished using NaH in THF, 
a lower boiling solvent that could be removed easily at the rotary evaporator. 2,2-
Dimethyl-6-chloromethyl-l,3-dioxin-4-one 243 was then added dropwise to the anion 
and the solution stirred at 0 °C for 30 min. After work-up, the product 244 was purified 
by column chromatography over silica gel. Absorption onto silica and washing with 
copious amounts of petroleum ether removed any remaining diethyl phosphite before 
elution of the product from the column with ethyl acetate. The low yield obtained could 
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be due to the formation of other products during the reaction. During studies on the 
alkylation of a, P-unsaturated carbonyl compounds, Smith'^' observed products fi-om a-
and y-alkylation. Deprotonation of 215 and trapping with n-pentyliodide, gave the a-
and y-substituted products in a 2:3 ratio. 
Phosphonate ester 244 was added to a solution of lithium hexamethyldisilazane 
(LHMDS) generated in situ from butyllithium and hexamethyldisilazane in THF."'* The 
orange/red anion which formed was stirred for 20 min then freshly purified £-2,4-
dimethyl-2-hexenal 242 was added and the mixture stirred until the reaction had gone to 
completion. Purification gave the product 174 as a yellow oil in moderate yield. 
Although this synthesis required careful manipulation, an optimal protocol was 
developed and the synthesis of the long chain tetramic acid 177 could now be addressed. 
3.2.8 Coupling of protected tyrosine 234 and polyketide moiety 174 
The successful synthesis of the desired tetramic acid 177 was accomplished by the 
coupling of 174 with the protected tyrosine derivative 234 (Scheme 3-41). 
Accordingly, 2,2-dimethyl-6-(£',£'-3,5-dimethylhepta-l,3-dienyl)-l,3-dioxin-4-one 174 
was reacted with N-2,4-dimethoxybenzyl-0-2,6-dichlorobenzyl tyrosine methyl ester 
234 and pyridinium /(arfl-toluene sulfonate in toluene. The product was purified by 
column chromatography and could be seen by NMR to exist as a mixture of tautomers. 
The cyclisation was performed as before with potassium ^butoxide to give an orange 
product upon which no purification was attempted. Treatment with BBrs cleaved the 
dichlorobenzyl ether to give the N-protected phenol compound 247, which was 
subsequently stirred in TFA to remove the 2,4-dimethoxybenzyl group. The desired 
tetramic acid, 5-(4-hydroxy)benzyl-3-(£',£'-4,6-dimethyl-octa-2,4-dienoyl)-4-hydroxy-
1,5-dihydro-pyrrol-2-one 177 was isolated as an orange oil. 
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Scheme 3-41 Reagents and conditions: i, PPTS, toluene, reflux, 2 h, 89 %; ii, fBuOK, ?BuOH, 25 °C, 
30 min, 79 %; iii, IM BBr, in DCM, -78 °C to room temp., 6 h; iv, TFA, room temp., 1 h, 89 %. 
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Figure 3-1 ' H NMR spectrum of acyltetramic acid derivative 177 
The ' H NMR spectrum of the acyltetramic acid derivative 177 is shown above (Figure 
3-1). The hydrogens attached to saturated carbons can be seen on the right hand side, at 
lower chemical shifts, and the aromatic and olefinic protons at higher shifts. The para-
substituted aromatic ring is indicated by the pair of doublets at 6 6.6 and 6.9. This 
spectrum is fiilly assigned in chapter 5.7.22. 
3.2.9 Synthesis of labelled tetramic acid 
Now that a route had been developed to the desired tetramic acid, it was necessary to 
carry out the synthesis incorporating an isotopic label. The same route as that employed 
for the production of 177 was followed, using commercially available [3',5'-'^H2]-
tyrosine as the starting material to produce the [3',5'-^H2] labelled tetramic acid 177a 
(Scheme 3-42). The product was found by ' H NMR to be approximately 85 % 
deuterated with an overall yield of 13.5 %. 
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The ' H N M R spectrum of 177a (Figure 3-2) is very similar to that recorded for the 
unlabelled sample (Figure 3-1). The major difference can be seen in the aromatic 
region. There has been some loss of deuterium label during the synthesis, indicated by 
the small doublet at 5 6.6, however the majority of material is deuterated, so the 
aromatic 2', 6' protons now resonate as a singlet at 6 6.9. 
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Figure 3-2 ' H N M R spectrum of labelled tetramic acid derivative 177a 
' H - ' H C O S Y analysis assisted in the interpretation of the 1-D proton spectrum. The 
crosspeaks allow adjacent hydrogens to be identified (Figure 3-3). 
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The protons resonating at the lowest frequency (highest field) can be seen as a triplet, 
indicating that they are adjacent to a C H 2 group and hence these protons belong to the 
methyl group of C-14. The crosspeak indicates coupling with the multiplet at 5 1.38, 
which is therefore due to the adjacent C H 2 at C-13. Coupling between the doublet at 5 
0.99 and the multiplet at 5 2.52 shows that these are the CH3 of C-16 and the CH of C-
12. It is also possible to see coupling to a smaller signal (13 %) at 6 2.65, which arises 
from racemisation of the chiral centre. The singlet at 5 1.86, corresponding to the 
methyl group of C-15, couples to the doublet at 6 5.69, an olefinic resonance. There are 
no hydrogens on adjacent carbon atoms, so the coupling must be over 4 bonds. The 
doublet also couples to the proton at C-12, so therefore must be due to the proton at C-
11. 
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Figure 3-3 ' H - ' H COSY of labelled tetramic acid 177a 
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The doublet of doublets at approximately 5 3.0 show coupling to the broad singlet at 
5 4.0 only. These are the methylene protons adjacent to the aromatic ring and the proton 
next to nitrogen respectively. The smaller doublet at 6 6.66 and the singlet at 6.98 are 
the aromatic protons. The majority of the compound is deuterated, however a small loss 
of the label (~15 %) has occurred during the synthesis. The two remaining protons of 
the molecule, on C-8 and C-9 of the double bond, resonate at 6 7.48 and 7.14, 
respectively and show coupling to each other only. 
3.2.10 Feeding of labelled tetramic acid derivative 177a to B. bassiana 
Labelled tetramic acid 177a was administered to cultures of 3-day old Beauveria 
bassiana. On day 10 the mycelia were subjected to Soxhlet extraction and tenellin (25 
and 17 mg) isolated as a yellow/orange powder. Two feeding experiments were 
performed simultaneously and each worked-up separately to give two samples of 
tenellin for analysis. The solid was then analysed by NMR. 
The NMR spectra recorded of the two samples of isolated tenellin are shown in 
Figure 3-4 and Figure 3-5. The spectrum in Figure 3-4 shows a broad signal, which may 
contain two peaks with chemical shifts of 6 6.6 and 5 6.8. The ratio of these peaks is 
approximately 3:2 respectively. The second spectrum (Figure 3-5) also indicates two 
unresolved peaks in this region. The approximate ratio of the peaks is again about 3:2, 
however in this case favouring the dovmfield resonance. A possible explanation for the 
two peaks is the presence of both deuterium labelled tenellin and the administered 
deuterium labelled tetramic acid in the samples analysed. The respective chemical shifts 
for the proton resonances of the 3', 5'-phenyl protons in unlabelled tenellin and the 
unlabelled tetramic acid are 5 6.6 and 5 6.8 respectively. 
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Figure 3-4 NMR spectrum of tenellin after incorporation experiment 1 
Figure 3-5 NMR spectrum of tenellin after incorporation experiment 2 
Purification of these tenellin samples was attempted by reverse-phase preparative 
HPLC. Reference samples of purified tenellin were found to contain a number of peaks, 
thought to be due to several tautomeric forms, all of which eluted soon after injection, 
most probably with the solvent front. Peak separation was poor, so purification could 
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not be attempted using this system. Increasing the polarity of the solvent and reducing 
the flow rate had little effect on the chromatographic resolution. Therefore purification 
could still not be achieved. The injections of tenellin thus far had been performed in 
methanol. Using the mobile phase (water; methanol, 30:70) as the injecting solvent 
improved the separation of the peaks considerably. Some peaks still eluted after a short 
time, but a single peak thought to be tenellin eluted after 18 min. Samples of the 
synthetic tetramic acid were then analysed. Several small peaks thought to be impurities 
were eluted soon after injection with a main peak eluting after 16 min. The sample of 
tenellin from the feeding experiment with the labelled tetramic acid gave a similar 
profile to the reference sample of tenellin but with a peak at 16 min also. This 
additional peak was thought to be the synthetic tetramic acid. 
An augmentation of the M+2 peak in the mass spectrum of tenellin from the feeding 
experiment would indicate incorporation of the administered tetramic acid. Analysis of 
these samples by electrospray mass spectrometry was then addressed. A peak at 370, 
corresponding to [M+H]^ was dominant with two other major peaks at 354 and 330. 
Selective ion monitoring on these three peaks showed that fragments 354 and 330 were 
eluted early from the column and that the peak for 370 came after approximately 18 
min, the retention observed for tenellin by HPLC. MS-MS of the molecular ion peak at 
370, showed a major peak at 352. No peaks at 354 and 330 were detected, so it is 
deduced that these are impurities in the sample and do not arise from the fragmentation 
of the tenellin molecule. In general, the tenellin from the feeding experiments produced 
a similar MS profile to the standard tenellin sample. In addition to peaks from the 
unknowns of mass 330 and 354, and the peak (18 min) with mass 370, a peak at 16 min 
with a molecular weight of 358 was detected. This was tentatively assigned as [M+H]^ 
for the administered labelled acyltetramic acid, which was expected to be residual in the 
sample. This is consistent with the two peaks observed in the NMR spectrum. LC-
MS analysis of the labelled tetramic acid showed a peak of molecular weight 358 at 16 
min supporting our assignment. This chromatogram did not show any indication of 
mass peaks at 330 or 354. 
In order to gain further information on a possible incorporation it was necessary to 
calculate the relative proportions of M to M+2 in both the standard tenellin sample and 
the tenellin extracted from the feeding experiment. The M+2 peak, 372, for the standard 
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sample was estimated to be 3.7 % of the molecular mass ion. This was a fairly good 
approximation to the theoretical value of 3.86 % calculated from known natural 
abundance isotope values. The sample of tenellin from the labelled feeding experiment 
showed an M+2 that was 6.83 % of the molecular mass ion. 
Table 3-1 Values of M+2/M ions in mass spectrometric analysis of tenellin samples 
M+2/M (%) 
Theoretical value 3.86 
Tenellin Standard 3.70 
Feeding experiment 6.83 
Although there are errors to these values and the results are not conclusive there is some 
indication that incorporation could have occurred. The possible role of the acyltetramic 
acid 177 in the biosynthesis of tenellin remains uncertain and ftirther study is required. 
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Chapter 4 
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4 Additional feeding experiments 
4.1 Investigation into the origin of H-6 in tenellin 
4.1.1 Feeding studies with phenylalanine and phenyllactic acids 
The biosynthetic origin of the hydrogen atom at position 6 of the pyridone ring of 
tenellin 1 has never been established. 
OH 0 
The current understanding of the biosynthesis of tenellin suggests that H-6 arises from 
the proton attached to C-2 of tyrosine, an atom which should derive directly from 
phenylalanine. However, feeding studies '^ have shown that there is no incorporation of 
deuterium label from [2-''^ C, ^H, '^ N]-phenylalanine. This could be due to loss of the 
deuterium during the formation of the pyridone ring or because of transamination of the 
amino acid to phenylpyruvate during the biosynthesis. Claims for the latter explanation 
are to some extent substantiated from results of a [2-'^C, ^H, '^ N]-phenylalanine feeding 
experiment that showed exclusive incorporation of the '^ C label into tenellin without ^H 
or '^N. Cleavage of the '^C-'^N bond suggests that transamination is a significant 
process. 
Previous feeding experiments have shown that phenyllactic acid 96 is not an 
intermediate in the biosynthesis of tenellin 1 (Scheme 4-1). 
134 
OH 
OH O 
N "O 
96 
Scheme 4-1 
However, i f phenylalanine is hydroxylated to tyrosine before the postulated 
transamination process then the intermediate would be /7-hydroxyphenyllactic acid. 
Therefore, isotopically labelled p-hydroxyphenyllactic acid was prepared in order to test 
the validity of this hypothesis (Scheme 4-2). The introduction of deuterium at the 2-
position and at the 3' and 5'-positions of the aromatic ring was readly achieved. 
D OH/D D OH 
248 249a 249c 
Scheme 4-2 Reagents and conditions: i, N a B D 4 , HjO, 0 °C, 1.5 h then 1M HCl , 86 %; ii, 35 % DCl 
in D2O, Carius tube, 80 °C, 6 h, 99 %. 
Deuterium was incorporated at C-2 by the reduction of hydroxyphenylpyruvate 248 with 
sodium borodeuteride (Scheme 4-2). Quenching, extraction and removal of the solvent 
gave the product 249a in high yield as a white powder. Deuterium was also 
incorporated into the 3' and 5' positions of the aromatic ring by dissolving [2-^H]-
hydroxyphenyllactic acid 249a in deuterated aqueous hydrochloric acid and heating for 
6 hours in a sealed tube. Compound 249b was generated in a very good overall yield. 
A feeding study into tenellin was performed with these labelled hydroxyphenyllactic 
acids. Accordingly, solutions of 249a and 249b were administered portionwise to 
cultures of Beauveria bassiana over several days. Tenellin was extracted as a yellow 
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powder on day 10 and subjected to analysis by ^H NMR. The tenellin isolated from 
cultures fed with 249b showed a low incorporation of the deuterium atoms at positions 
3' and 5' (broad signal at 5 6.8), but no enrichment from the 2-^ H atom. A peak at 5 8.2 
consistent with [^H]-formate, was also present (Figure 4-1). It was hypothesised that 
formate may be generated from oxidative cleavage of the aromatic ring. 
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Figure 4-1 NMR of tenellin extracted from cultures fed with [2,3',5'-^H2]-p-
hydroxyphenyllactic acid 249b 
There was no apparent deuterium incorporation into the tenellin from culture flasks fed 
with 249a, suggesting that the deuterium at C-2 is lost during the biosynthesis. 
The observed incorporation of deuterium from positions 3' and 5' indicates that p-
hydroxyphenyllactic acid can become metabolised into tenellin. Loss of the a-
deuterium atom can be explained by transamination back and forth to tyrosine via p-
hydroxyphenyl pyruvate. However, it is perhaps unlikely that all of the label would 
have been lost by this process if /7-hydroxyphenyllactic acid is a closer intermediate to 
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tenellin than tyrosine. It remains possible that this label is instead lost during the 
formation of the pyridone ring. 
4.1.2 Feeding studies with labelled tyrosines 
It has been established that both tyrosine and /7-hydroxyphenyllactic acid are 
intermediates in the biosynthesis of tenellin although the more direct precursor of the 
two is uncertain. If a transamination process is responsible for the loss of deuterium, 
then the absence of an incorporation of deuterium from [2-^Hi]-/?-hydroxyphenyllactic 
acid would implicate tyrosine as the closer substrate. 
[2-^Hi]-DL-Tyrosine 111a was synthesised in order to perform a feeding experiment. 
4.1.3 Synthesis of [2-^Hi]-DL-tyrosine 111a 
[2-'^Hi]-DL-Tyrosine 111a was synthesised as outlined (Scheme 4-3). 
The addition of phosphorus tribromide (PBrs) to p-methoxybenzyl alcohol 250 in 
pyridine and diethyl ether yielded the benzyl bromide derivative 251 as a colourless oil 
(Scheme 4-3).'" This was used directly in the next step without fiarther purification. 
Deprotonation of the diethyl acetamidomalonate was performed in a solution of sodium 
ethoxide produced from sodium and ethanol and then p-methoxybenzylbromide 251 was 
added. The addition of water precipitated the product as shiny, white crystals in high 
yield.'^ •^ Hydrolysis of the ethyl esters and spontaneous decarboxylafion of 252 was 
initiated by deuterium bromide, prepared in situ from D 2 O and PBr3. ' H NMR analysis 
of the product 111b indicated that deuterium had become exchanged into C-2 and at 
posifions 3' and 5' in the aromatic ring. Refluxing 11 lb in hydrochloric acid for an 
extended period induced exchange and washout of the aromatic deuterium labels to give 
the desired [2-^Hi]-DL-tyrosine 111a. 
137 
MeO 
OH 
MeO 
Br 
MeO' 
250 251 
I Y peo2Et 
NHAc 
252 
CO2H 
D NH2 
111b 
IV 
HO 
CO2H 
^ D NH2 
111a 
Scheme 4-3 Reagents and conditions: i, PBr,, pyridine, EtiO, room temp., 2 h, 87 %; ii, dietiiyl 
acetamidomaionate, Na, EtOH, 0 °C, 5 h, 91 %; iii, PBr,, D2O, 0 °C to room temp, then 252, reflux, 2 h, 
85 %; iv, 2M HCl , reflux, 37 h, 32 %. 
4.1.4 Feeding of [2-^Hi]-DL-tyrosine 111a to Beauveria bassiana 
The [2-'^Hi]-DL-tyrosine 111a prepared above was fed to cultures of Beauveria 
bassiana. After ten days, tenellin was extracted following the usual protocol to give a 
yellow solid (33 mg). ' H NMR showed tenellin to be present in the sample, however ^H 
NMR analysis of the resultant material did not indicate any incorporation of the 
deuterium label. 
To corroborate this result, a feeding experiment with [3',5',2-'^H3]-DL-tyrosine 111b 
was also performed. Previous feeding studies indicated that the 3', 5' aromatic 
deuterium atoms of tyrosine are incorporated into tenellin at a sufficient level to be 
detected by NMR. Successful incorporation of the aromatic labels from this labelled 
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precursor would indicate that the lack of deuterium incorporation from the 2-position is 
due to loss of the proton during the biosynthesis and not due to the inability of the 
substrate to permeate the cells. Therefore, administration of the putative intermediate 
and extraction of the tenellin was performed as above. '^ H NMR analysis of the isolated 
tenellin showed incorporation of the aromatic deuterium atoms at 5 6.74, as expected 
(Figure 4-2). A very small amount of deuterium incorporation had also occurred into 
the polyketide starter unit, C-14. However, there was no detectable incorporation at C-6 
in tenellin from the 2-'^ H atom of 111b. 
CO2H 
OH 0 
J 
I • • I I ' I ' ' I ' I ' • I • • ' ' I ' • ' I [ ' ' • ' I ' • ' ' I ' • • I I ' ' ' I I I I • • I I • ' • I • I ' • I • I • ' I I I ' 
11 10 9 8 7 S 5 4 3 Z 1 -0 p p B 
Figure 4-2 ^H NMR of tenellin extracted from feeding experiment with [3',5',2-^ H3]-
tyrosine 
The lack of incorporation at H-6 in tenellin from all of the described experiments is 
illustrative of a loss of hydrogen from this position during the formafion of the pyridone 
ring. If this is the case, the hydrogen located at position-6 of tenellin must be delivered 
by some other route. 
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4.1.5 Delivery of H-6 by NADPH 
The possible introduction of H-6 into tenellin from NADPH 253 was considered. 
NADPH is the reduced form of nicotinamide adenine dinucleotide phosphate 254 
(NADP^) (Scheme 4-4). NADPH is an electron donor almost exclusively employed for 
reductive biosynthetic processes. 
H ^ H H 
rrSr -CONHz f^^Sr-C0NH2 
I I • + H* + 2e" 
R R 
253 254 
R=adenonine dinucleotide phosphate 
Scheme 4-4 
Sodium [^Hi]-formate and [1-^H2, 2-'^ H3]-ethanol were added separately to cultures of 
Beauveria bassiana at the time of subculture in an attempt to label up the co-factor 
NADPH as NADP^H. This should allow any hydride insertions from the co-factor into 
tenellin to be detected by ^ H NMR. 
Tenellin extracted from cultures supplemented with [^Hi]-sodium formate showed 
incorporation at 5 0.93 and 1.79 in the resultant ^H NMR spectrum, indicative of 
isotopic labelling of the C-15 and C-16 methyl groups. 
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Figure 4-3 H NMR of tenellin extracted from cultures fed with [ Hi]-sodium 
formate 
The methyl groups at C-15 and C-16 have previously been shown to originate from L -
methionine (Chap 2.3.3), therefore the C H 3 group of methionine has become labelled 
from [^Hi]-formate and then transferred to the polyketide backbone. This is most 
probably achieved via tetrahydrofolate 255, a carrier of activated one carbon atom units 
in metabolism. 
N 
N CH 
H ' 
OH " HN 
2 / = ) COO" 
^ ^ ^ ^ ^ C - N - C - C H z - C H j C O O " 
H 
255 
Formate can add to tetrahydrofolate 255 to give N'°-formyl-tetrahydrofolate 256, which 
loses water and undergoes two NADPH reductions to N^-methyl-tetrahydrofolate 257. 
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In contrast, those cultures supplemented with [1-^H2, 2-^H3]-ethanol showed deuterium 
incorporation at 5 0.73 in the resultant NMR of tenellin. 
CD3CD2OH 
O H O 
Figure 4-4 NMR of tenellin extracted from cultures fed with [ 1 - H 2 , 2 - H 3 ] -
ethanol 
This enrichment is consistent with deuterium incorporation at C-14 of tenellin, the 
methyl group of the acetate starter unit of the polyketide backbone. Incorporation at this 
site implies metabolic oxidation of the administered ethanol to acetate. It is noteworthy 
that there is no incorporation into any of the other acetate derived carbons of the 
polyketide chain. The requirement for activation to malonyl CoA in those cases perhaps 
effects rapid exchange of the acidic deuterium atoms with the medium and hence lead to 
isotope wash-out. 
Although some interesting results have been obtained from the experiments described in 
this chapter, the biosynthetic origin of the H-6 proton of tenellin remains unclear. 
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In light of the feeding experiments with phenylalanine, tyrosine, phenyllactate and p-
hydroxyphenyllactate, a current working hypothesis describing the metabolic 
relationships between these metabolites can be formulated as summarised in Scheme 
4-6. The route by which phenylalanine is incorporated into tenellin via tyrosine does 
not appear to be straightforward and is an area that requires further study. 
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Chapte r 5 
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5 Experimental 
5.1 General methods 
NMR spectra were recorded on either a Varian Gemini Mercury 200 ( ' H at 199.991 
MHz, '^C at 50.288 MHz), a Varian Gemini Unity 300 ( ' H at 299.908 MHz, '^ C at 
75.412 M H Z ) , a Varian VXR 400S ( ' H at 399.970 MHz, '^ C at 100.572 MHz) or a 
Varian 500 ( ' H at 499.779 MHz, '^ C at 125.683 MHz). Chemical shifts are quoted in 
ppm relative to CDCls, D 2 O , DMSO or C D 3 O D . Coupling constants are given in Hz. 
IR spectra were recorded neat or as KBr discs on a Perkin Elmer Paragon 1000 or FT 
1720X machine. Mass spectra were acquired using a VG Analytical 7070E mass 
spectrometer operating at 70 eV. High resolution mass spectra were recorded on a VG-
Zab spectrometer. HPLC analysis was performed on a Varian Star 9012 solvent 
delivery pump and peaks recorded by a Varian Star 9050 variable wavelength UV-VIS 
detector at 254 nm. LCMS analysis was performed by injection using a Gilson 
autosampler and a Hewlett Packard 1050 pump, and spectra recorded using a finnagan 
Matt MS TSQ7000. A Hypersil BDS C-18 5 ^ column (250 x 4.6 mm) was used for 
HPLC and LCMS analysis. Melting points were recorded using Gallenkamp apparatus 
and are uncorrected. Reactions were performed under nitrogen gas. Solvents were 
routinely dried and distilled under nitrogen prior to use. THF and diethyl ether were 
distilled from sodium benzophenone, dichloromethane fi-om calcium hydride and 
ethanol and methanol from magnesium turnings and iodine. Flash column 
chromatography was performed over Fluka silica gel-60 (35-70 [im) and ion exchange 
chromatography over 50WX8-400 Dowex-H*. 
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5.2 Production, isolation and analysis of tenellin 
5.2.1 Growth of Beauveria bassiana 
The culture of Beauveria bassiana (Bals.) Vuill. (No. 110.25) was obtained from the 
CBS culture collection, Oosterstrat, Delft, Netherlands. 
Regularly, growth was initiated by the transfer of a small amount of Beauveria 
bassiana, from a ftangal slant stored at 4 °C, into a 250 ml Erlermieyer flask containing 
50 ml of sterile production medium. The flask was then shaken in the dark at 200 rpm 
(3 cm eccentricity) and 32 °C. After 10 days, a 2 ml aliquot of this production medium 
was used to inoculate another sterile production medium flask, which was incubated 
under the same conditions. New production medium flasks were subcultured from 10 
day old production medium flasks. Labelled substrates were added to cultures on day 
three after inoculation, or on days 3, 4 and 5 for pulse feeding experiments, immediately 
prior to tenellin production indicated by a vivid yellow colouration. The cultures were 
incubated for another seven days before harvesting the tenellin produced. 
5.2.2 Production medium 
To distilled water (990 ml) was added D-mannitol (50 g), K N O 3 (5 g), K H 2 P O 4 (1 g), 
MgS04.7H20 (0.5 g), NaCl (0.1 g), CaCb (0.1 g), FeS04.7H20 (20 mg) and a mineral 
ion solution (10 ml) containing C U S O 4 . 5 H 2 O (40 mgl"'), B(0H)3 (6 mgl''), 
(NH4)6Mo7024.4H20 (4 mgf'), MnS04.H20 (7.5 rngf') and ZnS04.7H20 (880 mgf'). 
50 ml portions were sterilised in 250 ml Erlenmeyer flasks plugged with cotton wool. 
5.2.3 Isolation of tenellin 
The mycelia of Beauveria bassiana were obtained by centrifiigation (14,000 rpm, 20 
min, 20 °C), washed with water and then exhaustively extracted by Soxhlet extraction 
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with acetone. Reduction in vacuo of the yellow extracts yielded an orange solid, which 
was dissolved in dichloromethane and repeatedly washed with brine to remove sugars 
and other water solubles. I M HCl was added to assist in the separation of the layers. 
The organic phase was dried (MgS04) and the dichloromethane removed at the rotary 
evaporator. The yellow/orange solid was then triturated with hexane and filtered to give 
tenellin as a yellow solid. 10-30 mg of tenellin were produced from each flask 
5.2.4 Analysis of tenellin 
NMR spectra of tenellin were recorded in DMSO-de for ' H and '^ C NMR and DMSO or 
CHsOHfor^HNMR. 
5H(250.1 M H Z ; DMSO-de) 0.84 (3H, t, J 7.2, H-14), 0.99 (3H, d, J 6.4, H-15), 1.37 (2H, 
m, H-13), 1.86 (3H, s, H-16), 2.51 ( IH, m, H-12), 6.00 ( IH, d, J 9.3, H-11), 6.79 (2H, 
d, J 8.2, Ph), 7.30 (2H, d, J 8.1, Ph), 7.55 ( IH, d, J 15.3, H-9), 8.01 ( IH, d, J 15.4, H-8), 
8.19 ( I H , s, H-6), 9.55 ( IH , s, OH), 10.35 ( IH, s, OH), 11.75 ( IH, bs, OH). 
6c(100.6 MHz; DMSO-dg) 11.9 (C-14), 12.5 (C-16), 20.0 (C-15), 29.7 (C-13), 34.7 (C-
12), 106.0 (C-3), 111.0 (C-5), 115.2 (C-3', 5'), 123.1 (C-1'), 124.5 (C-8), 130.4 (C-2', 
6'), 132.7 (C-10), 140.4 (C-6), 150.1 (C-9), 151.3 (C-11), 156.3 (C-4'), 157.6 (C-2), 
172.2 (C-4), 193.9 (C-7). 
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5.3 Feeding experiments 
5.3.1 Feeding of [l-"C]-phenylalanine 73b 
[1-'^C]-Phenylalanine (137 mg, 0.82 mmol) was added to distilled water and the pH 
adjusted to pH 6. An aliquot (5 ml) of the solution was added to a different production 
flask of B. bassiana on each of days 0, 3 and 4. Three batches of tenellin were extracted 
on days 10, 11 and 12. 5c(DMSO-d6) 172.7 ('^C-4, enriched). Incorporations were 
measured at 5.9, 6.4 and 4.8 % for tenellin isolated on days 10, 11 and 12 respectively. 
5.3.2 Feeding of [3-"Cl-tyrosine 11 Id 
[3-'^C]-Tyrosine (150 mg, 0.82 mmol) was added to distilled water and the pH adjusted 
to pH 6. An aliquot (5 ml) of the solution was added to a different production flask of 
B. bassiana on each of days 3, 4 and 5. Three batches of tenellin were extracted on days 
10, 11 and 12 respectively. 8c(DMSO-d6) 111.1 ('^C-5, enriched). Incorporations were 
measured at 5.8, 3.8 and 3.8 % for tenellin isolated on days 10, 11 and 12 respectively. 
5.3.3 Feeding of [3-'^C]-3-amino-2-(4-hydroxyphenyl)propionic acid 112a 
[3-'^C]-3-Amino-2-(4-hydroxyphenyl)propionic acid (100 mg, 0.55 mmol) was 
administered to cultures of Beauveria bassiana on days 3, 4 and 5 to a final 
concentration of 5 mmol. Tenellin (25 mg) was extracted on day 10 and analysed by 
'^C NMR. No incorporation could be seen in the spectra recorded. 
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5.3.4 Feeding of [3',5'-^H2]-3 -amino-2-(4-hydroxyphenyl)propionic acid 112b 
[3',5'-^H2]-3-Amino-2-(4-hydroxyphenyl)propionic acid (98 mg, 0.54 mmol) was fed to 
cultures on days 3, 4 and 5 to a final concentration of 5 mmol. The tenellin produced 
(30 mg) was extracted on day 10. ^H NMR analysis of the metabolite showed no 
apparent deuterium incorporation. 
5.3.5 Feeding of [3-'^C]-3-hydroxy-2-(4-hydroxyphenyl)propiDnic acid 118a 
[3-'^C]-3-Hydroxy-2-(4-hydroxyphenyl)propionic acid (37 mg, 0.20 mmol) was 
administered to cultures on days 3, 4 and 5 after subculture to a final concentration of 3 
mmol. After 10 days, tenellin (31 mg) was extracted and subjected to '^C NMR. There 
was no enhancement of any peaks in the NMR spectrum and hence no incorporation of 
the synthesised material. 
5.3.6 Feeding of 5-(4-(hydroxy)-[3',5'-^H2]-benzyl-3-(£:^-4,6-diniethylocta-2,4-
dienoyl)-4-hydroxy-l,5-dihydro-pyrrol-2-one 177a 
5-(4-(Hydroxy)-[3',5'-^H2]-benzyl-3-(E,E-4,6-dimethylocta-2,4-dienoyl)-4-hydroxy-l,5-
dihydro-pyrrol-2-one (25 mg, 0.07 mmol) was dissolved in ethanol and administered to 
cultures of 3-day old Beauveria bassiana. On day 10 the mycelia were subjected to 
Soxhlet extraction and the tenellin produced analysed by ^H NMR. Two feeding 
experiments were performed simultaneously and each worked up separately to give two 
batches of tenellin (25 and 17 mg). 
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5.3.7 Feeding of [2-^Hi]-4-hydroxyphenyllactic acid 249a 
[2-^Hi]-4-Hydroxyphenyllactic acid (95 mg, 0.52 mmol) was dissolved in distilled water 
(3 ml). The solution was pulse fed to two production medium cultures on days 3, 4 and 
5 to a final concentration, in each flask, of 5 mmol. Tenellin (40 mg) was isolated after 
extraction on day 10. No observable enrichment could be seen by ^H NMR. 
5.3.8 Feeding of [3',5'-^H2]-4-hydroxyphenyllactic acid 249b 
[3',5'-^H2]-4-Hydroxyphenyllactic acid (95 mg, 0.52 mmol) was dissolved in distilled 
water (3 ml). The solution was pulse fed to two production medium cultures on days 3, 
4 and 5 to a final concentration, in each flask, of 5 mmol. Isolation on day 10 gave 
tenellin (59 mg) as an orange/yellow powder. 52H(DMSO-d6) 6.79 (Ph C^H, enriched). 
5.3.9 Feeding of [2,3',5'-^H3]-4-hydroxyphenyllactic acid 249c 
[2,3',5'-^H3]-4-Hydroxyphenyllactic acid (96 mg, 0.52 mmol) was dissolved in distilled 
water (3 ml). The solution was pulse fed to two production medium cultures on days 3, 
4 and 5 to a final concentration, in each flask, of 5 mmol. Tenellin (44 mg) was isolated 
after extraction on day 10. 52H(DMSO-d6) 6.79 (Ph C^H, enriched). No incorporation 
of the proton at C-2 was detected. 
5.3.10 Feeding of [2-^Hi]-tyrosine 111a 
P-'^Hi]-Tyrosine (86 mg, 0.53 mmol) was added to distilled water (1 ml) and the pH 
adjusted to pH 6. The solution was pulse fed to two flasks of B. bassiana on days 3, 4, 
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5 and 6 to a final concentration in each flask of 4.5 mmol. After 10 days, tenellin (50 
mg) was isolated. ^H NMR indicated that no incorporation had occurred. 
5.3.11 Feeding of [2,3',5'-%]-tyrosine 111b 
[2,3',5'-^H3]-Tyrosine (95 mg, 0.52 mmol) was added to distilled water (1 ml) and the 
pH adjusted to pH 6. The solution was pulse fed to two flasks of B. bassiana on days 3, 
4 and 5 to a final concentration in each flask of 4.5 mmol. After 10 days, tenellin (50 
mg) was isolated. 62H(DMSO-d6) 6.76 (Ph C^H, enriched). No incorporation of the 2-
•^ H deuterium was indicated. 
5.3.12 Growth oi Beauveria bassiana with pHi]-sodium formate 
[^Hi]-Sodium formate (35 mg, 0.5 mmol) was added to two production medium flasks 
at the time of subculture at a concentration of 10 mmol. On day 10, tenellin (31 mg) 
was isolated as an orange/yellow powder. 52H(DMSO-d6) 0.92 (•^ H-15, enriched), 1.79 
(^H-16, enriched). 
5.3.13 Growth oi Beauveria bassiana in [1-^H2, 2-^H3]-ethanol 
[1-^H2, 2-^H3]-Ethanol (0.03 ml) was added to two production medium flasks at the time 
of subculture at a concentration of 10 mmol. On day 10, tenellin (20 mg) was isolated 
as an orange/yellow powder. 52H(DMSO-d6) 0.73 (^H-14, enriched). 
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5.4 Synthesis of 3-amino-4-(hydroxy)phenylpropionic acid 112 
5.4.1 4-Methoxyphenylacetonitrile 114*^ '' 
C H 3 O 
To a stirred solution of 4-methoxybenzyl chloride 113 (2.0 g, 12.8 mmol) in dry acetone 
(10 ml) was added finely ground and dried (105 °C) sodium cyanide (939 mg, 19.2 
mmol) and sodium iodide (72 mg, 0.48 mmol). The mixture was heated to reflux for 12 
h and then the solution was filtered to remove any unreacted cyanide. The acetone was 
removed in vacuo to yield a brown oil which was purified over silica gel (petroleum 
ether: diethyl ether, 3:1) to give a yellow oil (1.60 g, 85.2 %) . 
6H(200 MHz; C D C I 3 ) 3.69 (2H, s, C H 2 ) , 3.81 (3H, s, O C H 3 ) , 6.90 (2H, d, J 8.6, Ph), 
7.25 (2H, d, J 8.8, Ph); 6c(100.6 MHz; C D C I 3 ) 22.8 (CH2), 55.3 (OCH3), 114.5 (Ph 
CH), 118.1 (CN), 121.7 (Ph C), 129.1 (Ph CH), 159.3 (Ph C O C H 3 ) ; Un,ax(neat)/cm-' 
3036, 3003, 2958, 2936, 2837, 2248 (CN), 1613, 1586, 1513, 1251, 813; m/z (EI) 148 
([M+H]^ 37.1 % ) , 147 ( [ M ] ^ 100 % ) , 121 ([M-CN]^ 65.6 %) , 107 ( [ M - C H 2 C N ] ^ 17.3 
% ) , 78 ([PhH]^ 40.3 % ) , 77 ([Ph]"*", 65.6 %) . 
5.4.2 Cyano-(4-methoxyphenyl)acetic acid ethyl ester 115*'' 
0.^ .OEt 
C H 3 O 
To a sfirred suspension of NaH (60% in mineral oil, 272 mg, 6.80 mmol) in dry 
tetrahydroftiran (THF) (20 ml) at 0 °C was added 4-methoxyphenylacetonitrile 114 (500 
mg, 3.40 mmol) and the mixture stirred for 30 min. Diethyl carbonate (522 mg, 4.42 
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mmol) was then added and the reaction mixture heated to reflux for 4 h. The reaction 
was quenched with I M HCl (50 ml) and the THF removed in vacuo. The aqueous 
solution was extracted with ethyl acetate (3x 30 ml), washed with brine (3x 15 ml) and 
dried (MgS04). Evaporation gave the crude product, which was purified over silica gel 
(hexane:diethyl ether, 4:3) to yield cyano-(4-methoxyphenyl)acetic acid ethyl ester as a 
yellow oil (480 mg, 64.4 % ) . 
5H(200 M H Z ; C D C I 3 ) 1.28 (3H, t, J 7.0, C H 2 C H 3 ) , 3.82 (3H, s, ArOCHa), 4.22 (2H, q, J 
7.4, C H 2 C H 3 ) , 4.65 ( I H , s, CH), 6.90 (2H, d, J 8.8, Ph), 7.38 (2H, d, J 8.6, Ph); 
6c(100.6 MHz; CDCI3) 13.9 (CH2CH3), 42.9 (CH), 55.3 (OCH3), 63.2 (CH2CH3), 
114.6 (Ph CH), 115.9 (CN), 121.8 (Ph C), 129.1 (Ph CH), 160.1 (Ph COCH3), 165.2 
(CO); Umax(neat)/cm-' 2982, 2833, 2251 (CN), 1737 (CO), 1608, 1584, 1510, 1248, 
1026; m/z (EI) 219 ( [ M ] ^ 15.3 % ) , 147 ([M+H-C02Et]^ 33.1 %) 146 ([M-C02Et]^ 
100.0 % ) , 132 ([M+H-C02Et-CH3]^ 18.5 % ) , 116 ([BnCN]^ 7.5 % ) , 78 ([Ph+H]^ 4.5 
% ) , 77 ([Ph]^ 7.3 % ) , 29 ([CH2CH3]^ 50.9 % ) . 
5.4.3 Ethyl 3-amino-2-(4-methoxyphenyl)propionate hydrochloride 116*^ ' 
OEt 
C H 3 0 - - - ^ " ' ^ 
A solution of cyano-(4-methoxyphenyl)acetic acid ethyl ester 115 (814 mg, 3.72 mmol) 
in ethanol (40 ml) and chloroform (8.2 ml) was shaken under H2 (2.5 atm) with 
platinum oxide (40 mg) for 18 h. The catalyst was removed by filtration and the solvent 
removed in vacuo to give a solid which was washed with diethyl ether (20 ml), collected 
by filtration and then dried to give the product as a white powder (916 mg, 95.0 % ) , mp 
ca 230°C (decomp.). 
5H(200 M H Z ; D 2 O ) 1.06 ( 3 H , t, J 7.2, C H 2 C H 3 ) , 3.25 ( IH, dd, Jvic 7.8, Jgem 13.5, 3 - H B ) , 
3.49 ( IH , dd, Jvic 7.2, Jgen, 13.3, 3 - H A ) , 3.70 ( 3 H , s, O C H 3 ) , 3.94 ( IH, t, J 7.2, C H ) , 4.07 
(2H, q, J 7.2, C H 2 C H 3 ) , 6.92 (2H, d, J 8.8, Ph), 7.17 (2H, d, J 8.8, Ph); 5c(100.6 MHz; 
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D 2 O ) 13.0 (CH2CH3), 40.9 ( C H 2 ) , 47.8 (CH), 55.3 (OCH3), 62.8 (CH2CH3), 114.9 (Ph 
CH), 126.4 (Ph C), 129.5 (Ph CH), 159.1 (Ph COCH3), 173.0 (CO); Umax(neat)/cm-' 
3100 (br NH3*), 2926, 2852, 1724 (CO), 1599, 1508, 1365, 1205, 825; m/z (EI) 224 
( [M+H]^ 1.2 % ) , 223 ( [ M ] ^ 4.6 % ) , 195 ([M+H-CH2CH3]^ 12.1 % ) , 194 ([M-
CH2CH3]^ 100.0 % ) , 150 ([M-C02CH2CH3]^19.3 % ) , 121 ([Bn(0CH3)]^ 46.2 % ) , 92 
([BnH]^ 4.9 % ) , 91 ([Bn]^ 21.3 %) 78 ([PhH]^ 11.4 %) , 77 ([Ph]^ 29.5 % ) ; Anal. 
Calcd for C12H18NO3CI: C, 55.49; H, 6.98; N, 5.39. Found: C 55.29, H 7.01, N 5.30. 
5.4.4 3-Amino-2-(4-hydoxyphenyl)propionate hydrobromide 112'^ ^ 
NH3 BR 
Ethyl 3-amino-2-(4-methoxyphenyl)propionate hydrochloride 116 (500 mg, 1.93 mmol) 
was stirred under reflux for 2 h in a solution of 48 % hydrogen bromide (5 ml) in acetic 
acid (5 ml). After cooling, evaporation in vacuo yielded the product as a pale brown 
solid (105 mg, 29.7 % ) , mp ca 230 ° C (decomp.) (lit. 242-244 ° C ) . '^ ^ 
5H(299.9 MHz; D 2 O ) 3.15 ( IH , dd, Jvic 7.8, Jgem 12.8, 3-HA), 3.38 ( IH, dd, Jvic 7.8, Jgem 
12.8, 3-HB) , 3.78 ( IH, t, J 7.5, C H ) , 6.76 (2H, d, J 8.1, Ph), 7.07 (2H, d, J 8.7, Ph); 
6c( 100.6 MHz; D 2 O ) 41.2 ( C H 2 ) , 48.1 (CH), 116.1 (Ph CH), 126.4 (Ph C), 129.6 (Ph 
CH), 155.7 (Ph COH), 175.4 (CO); Umax(neat)/cm"' 3455 (NH), 3020 (br, OH), 1722, 
1592, 1479, 1214, 833. 
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5.4.5 3-Amino-2-(4-hydoxyphenyl)propionate 112'^ ^ 
Ethyl 3-amino-2-(4-methoxyphenyl)propionate hydrochloride 116 (456 mg, 1.76 mmol) 
was stirred in dichloromethane (DCM) (13 ml) at -78 ° C and I M boron tribromide in 
DCM (4.5 ml, 4.50 mmol) was added. The solution was stirred overnight and allowed 
to warm to room temperature. I M NaOH (5 ml) was added, the mixture stirred for 1 h 
and then neutralised. Evaporation in vacuo gave a brown solid, which was purified by 
ion-exchange chromatography over 50WX8-400 Dowex-H"^, using I M NaOH as the 
eluent. Recrystallisation (EtOH/HjO) gave the product as a white solid (139 mg, 36.4 
% ) , mp ca 220 ° C (decomp.) (lit. 242-244 ° C ) . ' ^ ^ 
5H(200 M H Z ; D 2 O ) 2.82 ( IH , dd, Jvic 7.4, Jgem 12.6, 3-HA), 3.06 ( IH, dd, Jvic 7.6, Jgem 
12.6, 3-HB) , 3.40 ( IH, t, J 7.6, C H ) , 6.62 (2H, d, J 8.4, Ph), 7.08 (2H, d, J 8.4, Ph); 5c 
(50.3 MHz; D 2 O ) 41.1 ( C H 2 ) , 48.1 (CH), 115.2 (Ph CH), 126.7 (Ph C), 129.8 (Ph CH), 
155.4 (Ph COH), 173.3 (CO); Umax(KBr)/cm-' 3450 (br), 2992, 2942, 2840, 1740, 1612, 
1513, 1268, 834. 
5.4.6 [l-'^C]-4-Methoxyphenylacetonitrile 114a 157 
C H 3 O ' 
To a stirred solufion of 4-methoxybenzyl chloride 113 (2.0 g, 12.8 mmol) in dry acetone 
(20 ml) was added finely ground and dried (105 °C) potassium ['^C]-cyanide (1.10 g, 
16.7 mmol, 99 atom% '•'C) and sodium iodide (72 mg, 0.48 mmol). The mixture was 
heated under reflux for 12 h and then the solution was filtered to remove any unreacted 
cyanide. The acetone was reduced in vacuo to yield an orange oil which was purified 
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over silica gel (petroleum ether: ethyl acetate, 3:1) to give the product as a colourless oil 
(1.78 g, 94.1 % ) . 
8H(499.8 MHz; C D C I 3 ) 3.69 (2H, d, J 11.0, CH2), 3.82 (3H, s, OCH3), 6.90 (2H, d, J 
8.5, Ph), 7.23 (2H, d, J 8.6, Ph); 5c(125.7 MHz; CDCI3) 22.6 (d, Jcc 57.9, CH2), 55.3 
(OCH3), 114.5 (Ph CH), 118.2 (CN, enriched), 121.8 (Ph C), 129.1 (Ph CH), 159.3 (Ph 
COCH3); Umax(neat)/cm-' 3040, 2930, 2837, 2191 (CN), 1613, 1586, 1513, 1249, 812; 
m/z (EI) 149 ( [M+H]^ 9.5 % ) , 148 ( [ M ] ^ 100.0 % ) , 147 ([M-H]^ 54.6 % ) , 133 ([M-
CH3]^ 47.7 % ) , 117 ([M -OCHs]^ 29.0 %) , 107 ([M-CH2 '^CN]^ 30.4 % ) , 77 ([Ph]^ 
50.0 % ) , 27 ([ '^CN]^ 3.3 % ) ; Found 148.0718, C9H9NO (M^) requires 148.0718. 
5.4.7 [3-^C]-Cyano-(4-methoxyphenyl)acetic acid ethyl ester 115a 
O^^ ^OEt 
C H 3 O 
To a suspension of NaH (60 % in mineral oil, 169 mg, 4.4 mmol) in dry THF (5 ml) at 
0 °C was added [l-'^C]-4-methoxyphenylacetonitrile 114a (501 mg, 3.39 mmol) and the 
mixture stirred for 30 min. Diethyl carbonate (4.9 ml, 33.6 mmol) was added and the 
reaction mixture refluxed for 1 hour. The reaction was quenched with I M HCl (10 ml) 
and the THF removed in vacuo. The aqueous solution was extracted into ethyl acetate 
(3x 15 ml), the organic layer was washed with brine (3x 10 ml) and dried (MgS04). 
Evaporation gave a residue, which was purified by kugelrohr distillation (-100 °C, 0.75 
mmHg), to yield the product as a colourless oil (410 mg, 55.1 %) . 
6H(400 M H Z ; C D C I 3 ) 1.28 (3H, t, J 7.2, C H 2 C H 3 ) , 3.82 (3H, s, OCH3), 4.24 (2H, 2x q, 
J 7.2, CH2CH3), 4.65 ( I H , d, J 10.4, CH), 6.93 (2H, d, J 8.8, Ph), 7.37 (2H, d, J 8.8, 
Ph); 5c(100.6 MHz; CDCI3) 13.9 (CH2CH3), 42.9 (d, J^c 62.2, CH), 55.4 (OCH3), 63.2 
(CH2CH3), 114.7 (Ph CH), 115.88 (CN, enriched), 118.4 (Ph C), 129.1 (Ph CH), 160.2 
(Ph COCH3), 165.3 (CO); Umax(neat)/cm-' 3024, 2983, 2840, 2198 (CN), 1745 (CO), 
1601, 1587, 1513, 1255, 836; m/z (EI) 220 ( [ M ] ^ 17.3 %) , 148 ([M-C02CH2CH3]^ 
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27.5 %), 147 ([M-H-C02CH2CH3]^ 100.0 %), 133 ([M+H-C02CH2CH3-CH3]^ 17.5 
%), 91 ([Bn]^ 8.2 %), 77 ([Ph]^ 7.5 %), 29 ([CH2CH3]^ 7.3 % ) ; Found 220.0929, 
C12H13NO ( M ^ ) required 220.0929. 
5.4.8 Ethyl [3-^C]-3-amino-2-(4-methoxyphenyl)propionate hydrochloride 116a 
OEt 
C H 3 0 - -
A solufion of [3-'^C]-cyano-(4-methoxyphenyl)acetic acid ethyl ester 115a (663 mg, 
3.01 mmol) in ethanol (33 ml) and chloroform (6.6 ml) was shaken under H 2 (2.5 atm) 
with platinum oxide (33 mg) for 64 h. The catalyst was then filtered off and the solvent 
removed in vacuo to give a solid which was triturated with diethyl ether, collected by 
filtration and dried to give the product as a white powder (734 mg, 93.5 %) , mp ca 
230°C (decomp.). 
6H(200 M H Z ; D 2 O ) 1.04 (3H, t, J 7.2, CH2CH3), 3.27 ( IH, ddd, Jvic 7.6, Jgem 13.3, J,3C-H 
147.1, 3-HA ) , 3.51 ( I H , ddd, Jvic7.6, Jgem 13.3, J.JC-H 147.1, 3-HB) , 3.69 (3H, s, OCH3), 
3.87 ( I H , m, C H ) , 4.06 (2H, q, J 7.2, C H 2 C H 3 ) , 6.90 (2H, d, J 8.4, Ph), 7.17 (2H, d, J 
8.4, Ph); 5c(100.6 MHz; D 2 O ) 12.7 ( C H 2 C H 3 ) , 40.8 ( C H 2 , enriched), 47.8 (d, Jcc 40.1, 
CH) , 55.1 (OCH3), 62.5 (CH2CH3), 114.8 (Ph CH), 126.4 (Ph C ) , 129.6 (Ph CH), 158.9 
(Ph COCH3), 173.1 (CO). 
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5.4.9 [3-^C]-3-amino-2-(4-hydoxyphenyl)propionate 112a 
Ethyl [3-'^C]-3 -amino-2-(4-methoxyphenyl)propionate hydrochloride 116a (100 mg, 
0.38 mmol) was stirred in DCM (3 ml) at -78 °C and a solution of boron tribromide ( I M 
in DCM, 1 ml, 1.00 mmol) added. The solution was stirred for 12 h and allowed to 
warm to room temperature. I M NaOH (2 ml) was added and the mixture stirred for 1 h. 
The solution was then neutralised and evaporated in vacuo to give a brown solid, which 
after purification over Dowex-H^ yielded the product as a white solid (35 mg, 41.7 %) , 
mp ca 230 °C (decomp.). 
6H(299.9 M H Z ; D2O) 3.11 ( IH, ddd, h,, 7.5, Jgen, 12.9, J^C-H 145.4, 3-HA), 3.26 ( IH, 
ddd, Jvic 7.5, Jgem 13.2, Ji3c-H 145.7, 3-HB), 3.53 ( IH, m, CH), 6.74 (2H, d, J 8.1, Ph), 
7.04 (2H, d, J 7.5, Ph); 5c(50.3 MHz; D2O) 42.5 (CH2NH2, enriched), 50.6 (d, Jcc 36.9, 
CH), 116.1 (Ph CH), 129.2 (Ph C), 129.6 (Ph CH), 155.2 (Ph COH), 178.7 (CO); 
Umax(KBr)/cm-' 3404 (br), 3260, 2979, 2928, 1729, 1511, 1259, 816. 
5.4.10 [3',5'-^H2]-3-amino-2-(4-hydoxyphenyl)propionate 112b 
A solution of ethyl 3-amino-2-(4-methoxyphenyl)propionate 116 (99 mg, 0.46 mmol) in 
D2O (2 ml) and 20% DCI/D2O (4 ml) was placed in a Carius tube. After freezing with 
liquid nitrogen, the tube was evacuated and then allowed to warm to room temperature. 
This was repeated twice to ensure that all dissolved gases were removed. Finally the 
tube was cooled, evacuated again and then sealed before inserting into a strong, metal 
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pipe. This was then placed into the furnace. After 3 h at 80 °C, and once the furnace 
had cooled, the pipe was removed. The Carius tube was cooled with liquid nitrogen and 
then opened. Evaporation in vacuo yielded the product as a cream coloured solid (77 
mg, 64.2 % ) . No fUrther purification was attempted, mp ca 230 °C (decomp.). 
5H(200 M H Z ; D2O) 3.15 ( IH, dd, Jv.c 7.4, Jgem 13.2, 3-HA), 3.31 ( IH, dd, Jvic 7.6, Jgem 
13.2, 3-HB), 3.78 ( IH , t, J 8.6, CH), 7.09 (2H, s, Ph); 5c(100.6 MHz; D2O) 41.0 (CH2), 
48.1 ( C H ) , 116.1 (t, J 25.8, Ph C^H), 126.5 (Ph C ) , 130.06 (Ph C H ) , 155.8 (Ph C O H ) , 
175.8 ( C O ) ; Umax(neat)/cm-' 3403 (brNH & OH) 1724, 1588, 1473, 1217, 834. 
5.5 Synthesis of 3-hydroxy-4-(hydroxy)phenyIpropionic acid 118 
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5.5.1 4-Hydroxyphenylacetic acid methyl ester 138 
OCH, 
A few drops of H2SO4 were added to a solution of 4-hydroxyphenylacetic acid 137 (2.0 
g, 13 mmol) in dry methanol (20 mi). The mixture was refluxed for 12 h and then 
reduced in vacuo to give a brown oil. The residue was dissolved in diethyl ether (50 ml) 
and washed with saturated Na2C03 solution (3x 25 ml) to remove any unreacted acid. 
After drying (MgS04), reduction in vacuo gave a brown oil (1.64 g, 75.1 %) . 
6H(250 MHz; CDCI3) 3.48 (2H, s, CH2), 3.62 (3H, s, CH3), 6.65 (2H, d, J 8.8, Ph), 7.0 
(2H, d, J 8.8, Ph); 5c(100.6 MHz; CDCI3) 40.2 (CH2), 52.1 (OCH3), 115.5 (Ph CH), 
125.8 (Ph C), 130.4 (Ph CH), 154.8 (Ph COH), 172.8 (CO); Umax(neat)/cm"' 3355 (br, 
OH), 3027, 2949, 1704 (CO), 1615, 1514, 1340, 1215, 1147, 850; m/z (EI) 167 
( [M+H]^ 2.2 % ) , 166 ( [ M ] ^ 27.6 % ) , 108 ([Bn(OH)+H]^ 6.3 %) , 107 ([Bn(OH)]^ 
100.0 % ) , 77 ([Ph]^ 30.2 % ) , 59 ([C02CH3]^ 7.6 %) . 
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5.5.2 2-(4-(4-Methoxybenzyloxy)-phenyl)acetic acid methyl ester 139 
OCH. 
OCH-, 
A mixture of 4-hydroxyphenylacetic acid methyl ester 138 (1.0 g, 6.02 mmol), 
tetrabutylammonium iodide (2.43 g, 6.59 mmol), 4-methoxybenzyl chloride (1.09 g, 
6.96 mmol) and potassium carbonate (1.81 g, 13.12 mmol) in dry acetone (50 ml) was 
stirred at 60 °C for 48 h. After this time, the reaction mixture was allowed to cool to 
room temperature and the acetone was removed in vacuo. Water (50 ml) was then 
added and the solution was extracted into diethyl ether (3x 50 ml). The combined 
organic extracts were washed with I M NaOH (Ix 20 ml) and brine (Ix 20 ml) and then 
dried (MgS04). Removal of the solvent in vacuo gave a yellow/brown solid, which was 
recrystallised from ethanol to generate the product as a white crystalline solid (0.98 g, 
56.9 % ) , mp 60 °C. 
6H(250 MHz; CDCI3) 3.57 (2H, s, CH2CO2CH3), 3.68 (3H, s, CO2CH3), 3.82 (3H, s, 
ArOCH3), 4.97 (2H, s, CH2O), 6.90 (2H, d, J 2.0, Ph), 6.93 (2H, d, J 2.0, Ph), 7.20 (2H, 
d, J 8.0, Ph), 7.33 (2H, d, J 8.0, Ph); 6c(100.6 MHz; CDCI3) 40.3 (CH2), 52.0 
(CO2CH3), 55.3 (ArOCH3), 69.8 (CH2O), 114.0 (Ph CH), 114.9 (Ph CH), 126.2 (Ph C), 
129.0 (Ph C), 129.2 (Ph CH), 130.3 (Ph CH), 157.5 (Ph CO), 159.4 (Ph CO), 172.3 
(CO); Un,ax(neat)/cm-' 3004, 2951, 2836, 1738 (CO), 1611, 1511, 1241, 1152, 830; m/z 
(EI) 287 ([M+H]", 0.4 % ) , 286 ( [ M ] ^ 1.8 % ) , 166 ([M+H-Bn(0CH3)]^ 4.0 % ) , 121 
([Bn(0CH3)]^ 100.0 % ) , 107 ([Bn(OH)]^ 14.5 %) , 78 ([PhH]^ 5.8 % ) , 77 ([Ph]^ 4.9 
% ) , 59([C02CH3r, 1.5%). 
161 
5.5.i 3-Hydroxy-2-(4-hydroxyphenyl)propionic acid 118 
3-Amino-2-(4-hydroxyphenyl)propionic acid 112 (100 mg, 0.55 mmol) was stirred in 
water (1 ml) and cooled to 0 ° C . 2M H2SO4 (0.5 ml) and 2M sodium nitrite solution 
(0.5 ml) were added and the mixture was stirred at 0 ° C for 3 h and then at room 
temperature for 12 h. The reaction mixture was extracted into EtOAc (3x 10 ml), the 
combined organic extracts were dried (MgS04) and the solvent was removed in vacuo 
to yield a brown oil. I M NaOH (5 ml) was added and the solution stirred at room 
temperature for 1 h to hydrolyse the lactone formed and give the desired product as a 
brown oil (41 mg, 40.7 % ) . 
5H(299.9 M H Z ; D2O) 3.45 ( IH, t, J 7.8, C H ) , 3.65 ( IH, dd, Jvic 7.5, Jgem 10.8, 3-HB), 
3.87 ( IH , dd, Jvic 7.5, Jgem 10.8, 3-HA), 6.71 (2H, d, J 8.4, Ph), 7.07 (2H, d, J 8.4, Ph); 
5c(50.3 MHz; D 2 O ) 40.2 (CH), 63.1 ( C H 2 O H ) , 116.1 (Ph CH), 129.5 (Ph C), 129.7 (Ph 
CH), 160.1 (Ph COH), 176.1 (CO). 
5.5.4 [3-^C]-3-hydroxy-2-(4-hydroxyphenyl)propionic acid 118a 
A solution of 3-['^C]-amino-2-(4-hydroxyphenyl)propionic acid (52 mg, 0.29 mmol) in 
water (0.2 ml) was stirred and cooled to 0 °C. 2M H2SO4 (0.2 ml) and 2M sodium 
nitrite solution (0.2 ml) were added and the mixture was stirred at 0 °C for 3 h and then 
at room temperature for 12 h. After this time, the reaction mixture was extracted into 
EtOAc (3x 10 ml), the combined organic extracts were dried (MgS04) and the solvent 
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was removed in vacuo to yield a brown oil. I M NaOH (3 ml) was added and the 
solution stirred for 1 h to hydrolyse the lactone formed and give the desired product as 
an orange/brown oil (23 mg, 44.0 % ) . 
5H(299.9 M H Z ; D2O) 3.63 ( IH, t, J 7.4, CH), 3.85 ( IH, m, JBC-H 140.7, 3-HA), 4.02 
( IH , m, J,3c-H 140.7, 3-HB), 6.90 (2H, d, J 8.4, Ph), 7.24 (2H, d, J 8.4, Ph); 6c(50.3 
M H Z ; D2O) 39.7 (d, Jcc 25.3, CH), 63.1 (CH2OH, enriched), 116.3 (Ph CH), 129.7 (Ph 
C), 129.8 (Ph CH), 157.9 (Ph COH), 176.1 (CO). 
5.6 Synthesis of lactic acids 249 
5.6.1 4-Hydroxyphenyllactic acid 249 71 
To a stirred solution of sodium borohydride (NaBH4) (113 mg, 2.99 mmol) in water (7.5 
ml) at 0 ° C was added 4-hydroxyphenylpyruvic acid 248 (364 mg, 2.02 mmol) as an 
emulsion in water (15 ml). Stirring was continued at room temp for 1.5 h. Excess 
NaBH4 was destroyed by the addition of 10 % aqueous HCl (5 ml). The aqueous 
solution was reduced in vacuo to 5 ml and extracted into ethyl acetate (3x 25 ml). The 
organic extracts were dried (MgS04) and the solvent was removed to produce an off-
white solid (95 mg, 83.1 % ) . 
5H(400 M H Z ; D2O) 2.74 ( IH , dd, Jv,c 7.6, Jge„, 14.0, 3-HA), 2.89 ( I H , dd, Jvic 4.8, Jge^ 
14.0, 3-HB), 4.30 ( IH, dd, Jvic 4.8, Jvic 7.6, C H ) , 6.67 (2H, d, J 8.4, Ph), 6.99 (2H, d, J 
8.8, Ph); 5c(100.6 MHz; D2O) 38.8 (CH2), 71.4 (CH), 115.5 (Ph CH), 128.7 (Ph C), 
130.9 (Ph CH), 154.4 (Ph COH), 177.3 (CO); Un,ax(KBr)/cm-' 3476 (br, OH), 3219, 
3026, 2952, 2927, 1723 (CO), 1615, 1599, 1513, 1233, 833; 
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5.6.2 [2-^H]-4-HydroxyphenyIlactic acid 249a^ 
D OH 
[2-'^H]-4-Hydroxyphenyllactic acid was prepared via a method similar to 4-
hydroxyphenyllactic acid 249 using hydroxyphenylpyruvic acid (362 mg, 2.01 mmol) in 
H2O (20 ml) and sodium borodeuteride (147 mg, 3.52 mmol) in H2O (10 ml). The 
product was recrystallised from ethyl acetate/chloroform to yield the product as a white 
powder (317 mg, 86.1 % ) , mp 120 °C. 
5H(400 M H Z ; D2O) 2.77 ( IH , d, J 14.4, 3-HA), 2.92 ( IH, d, J 14.4, 3-HB), 6.71 (2H, d, J 
8.4, Ph), 7.03 (2H, d, J 8.4, Ph); 5c(100.6 MHz; D2O) 38.8 (CH2), 71.5 (m, C^H), 115.5 
(Ph CH), 128.8 (Ph C), 130.9 (Ph CH), 154.4 (Ph C O H ) , 177.6 (CO); u„ax(KBr)/cm-' 
3474, 3256 (br), 3024, 2954, 2926, 1739 ( C O ) , 1599, 1516, 1236, 834; m/z (EI) 183 
( [ M ] ^ ^H, 4:3 % ) , 182 ( [ M ] ^ 0.2 % ) , 138 ([M-C02H]^ ^H, 3.2 %) , 107 ([M-
c 2 H ( O H ) C 0 2 H ] ^ 100.0 % ) , 77 ([Ph]^ 10.1%). 
5.6.3 [3',5'-^H2]-4-HydroxyphenyIlactic acid 249b^ 
D 
A solution of 4-hydroxyphenyllactic acid 249 (100 mg, 0.55 mmol) in 35 % DCI/D2O 
(0.5 ml) and D2O (0.5 ml) was placed in a Carius tube. The solution was treated in a 
similar marmer to 3-amino-2-(4-hydroxyphenyI)propionate 112 (5.3.10) and then heated 
to 80 °C for 6 h. After cooling, the solution was saturated with NaCl and extracted into 
ethyl acetate (4x 10 ml). The organic extracts were dried (MgS04) and the solvent was 
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removed in vacuo. The product was recovered as a white solid (79 mg, 78.1 %) . The 
material was found to be approximately 56 % deuterated as determined by ' H N M R . 
6H(400 M H Z ; D2O) 2.76 ( I H , dd, Jgem 7.2, Jvic 14.0, CH2), 2.91 ( IH, dd, Jgem 4.8, Jvic 
14.4, CH2), 4.32 ( IH , dd, Jvic 4.8, Jvic 7.2, C H ) , 6.69 (44 %) (2H, d, J 8.8, Ph), 7.00 (56 
%) (2H, s, Ph); 6c(100.6 MHz; D2O) 38.8 (CH2), 71.4 (CH), 115.5 (m, Ph CH and 
PhC^H), 128.7 (Ph C), 130.8 (Ph CH), 154.3 (Ph COH), 177.3 (CO); Umax(KBr)/cm-' 
3463 (br), 3246, 3032, 2956, 2928, 1738 ( C O ) , 1580, 1508, 1237, 834; m/z (EI) 185 
([M+H]^ ^H2, 19.4 % ) , 184 ( [ M ] ^ ^Hi, 10.3 %) , 183 ( [M]^ ^H, 3.7 %) , 182 ( [M]^ 3.1 
% ) , 167 ([M-OH]^ ^H2, 96.5 % ) , 151 ([M+H-(0H)2]^ ^Ri, 13.9 % ) , 139 ([M-C02H]^ 
^H2, 100.0 % ) , 109 [M -CH(0H)C02H]^ ^Hj, 38.7 %) . 
5.6.4 [2,3',5'-%]-4-Hydroxyphenyllactic acid 249c^ 
D OH 
A solution of [2-^H]-4-hydroxyphenyllactic acid 249a (101 mg, 0.55 mmol) in 35 % 
DCI/D2O (1 ml) and D2O (1 ml) was placed in a Carius tube. The solution was treated 
in a similar maimer to 3-amino-2-(4-hydroxy)phenylpropionic acid (5.4.10) and was 
then heated to 80 °C for 6 h. After cooling, the solution was saturated with NaCl and 
was extracted into ethyl acetate (4x 10 ml). The organic extracts were dried (MgS04) 
and the solvent was removed in vacuo. The product was obtained as a white solid (101 
mg, 98.9 % ) . Deuterium incorporation was 94 % in the para positions as determined by 
' H N M R . 
6H(200 MHz; D2O) 2.66 ( IH , d, Jgem 14.0, CH2), 2.83 ( IH, d, Jgem 14.0, CH2), 6.62 (6 
%) (2H, d, J 8.2, Ph), 6.93 (94 %) (2H, s, Ph); 6c(100.6 MHz; D2O) 38.6 (CH2), 71.2 
(m, CH), 115.6 (m, Ph CH and PhC^H), 128.6 (Ph C), 130.8 (Ph CH), 154.4 (Ph COH), 
177.4 (CO); Umax(KBr)/cm-' 3474 (br), 3258, 3034, 2960, 2928, 1742 (CO), 1476, 1242, 
1094,832. 
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5.7 Synthesis of tetramic acid 177 
5.7.1 DL-Tyrosine methyl ester hydrochloride 216'^ ^ 
NH3 CI 
Thionyl chloride (2.2 ml, 30.4 mmol) was added dropwise to dry, distilled methanol (20 
ml) and the solution was stirred rapidly at -5 °C. DL-Tyrosine 111 (5.0 g, 27.6 mmol) 
was added and the solution heated under reflux for 3 h. After cooling, the solution was 
diluted with diethyl ether (60 ml), resulting in the precipitation of the product. The 
white solid was collected by filtration, washed with diethyl ether (50 ml) and dried to 
yield the product as the hydrochloride salt (6.19 g, 97.0 %) , mp 191 °C (decomp.) (lit. 
189-190 °C)'^^ 
5H(400 M H Z ; D2O) 3.06 ( I H , dd, Jvic 7.6, Jge^ 14.8, CH2), 3.09 ( IH , dd, Jvic 5.6, Jgen, 
14.8, CH2), 3.70 (3H, s, OCH3), 4.23 ( IH, dd, Jvic 6.0, Jvic 7.2, CH), 6.75 (2H, d, J 8.4, 
Ph), 7.01 (2H, d, J 8.4, Ph); 5c(100.6 MHz; D2O) 34.9 (CH2), 53.7 (OCH3), 54.3 (CH), 
116.1 (Ph CH), 125.5 (Ph C), 131.0 (Ph CH), 155.4 (Ph COH), 170.3 (CO); 
Omax(KBr)/cm"' 3303 (br, NH2), 3002, 2877, 1746 (CO), 1613, 1590, 1517, 1240, 838; 
m/z (EI) 196 ([M+H]^ 0.9 % ) , 195 ( [ M ] ^ 7.5 %) , 136 ( [ M - C 0 2 C H 3 ] \ 31.7 %) , 107 
([Bn(OH)]^ 100.0 % ) , 91 ([Bn]^ 16.0 % ) , 88 ( [CH(NH2)C02CH3]^ 35.3 % ) , 77 ([Ph]^ 
17.4%). 
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5.7.2 N-(tert-Butoxycarbonyl)-DL-tyrosine methyl ester 233'^° 
O 
. .^--K.^ NHBOC 
HO 
A solution of tyrosine methyl ester hydrochloride 216 (2.0 g, 8.64 mmol) in water (4 ml) 
was mixed with a solution of K2CO3 (1.19 g, 8.64 mmol) in water (4 ml) and after 10 
min the precipitated tyrosine methyl ester was collected by filtration and washed with 
water. A solution of /-butanol (4 ml) in ether (6 ml) was added, followed by dropwise 
addition with stirring of di-^er^-butyl dicarbonate (1.93 ml, 8.40 mmol) over 15 min. 
Complete dissolution was evident after 10 min, but after a fiirther 5 min precipitation 
occurred. The solution was diluted with ether (15 ml), washed with water (3x 15 ml), 
dried (MgS04) and the solvent removed in vacuo. The crystalline residue was 
redissolved in toluene (400 ml) and the solvent removed under reduced pressure. The 
solid material was dissolved in toluene (80 ml), hexane (20 ml) was added and the solid 
left to recrystallise at room temperature. After 1 h, the product was collected by 
filtration as a white powder (2.21 g, 92.2 %) , mp 139-140 °C (lit. 143-144 °C).'^' 
5H(400 M H Z ; CD3OD) 1.39 (9H, s, (CH3)3), 2.80 ( I H , dd, Jvic 8.4, Jgen, 13.6, CH2), 2.97 
( I H , dd, Jvic 5.6, Jgem 13.6, CH2), 3.67 (3H, s, OCH3), 6.70 (2H, d, J 8.4, Ph), 7.00 (2H, 
d, J 8.4, Ph); 5c(100.6 MHz; CD3OD) 28.7 (C(CH3)3), 38.0 (CH2), 52.5 (CH3), 58.8 
(CH), 80.6 (C(CH3)3), 116.2 (Ph CH), 128.9 (Ph C ) , 131.2 (Ph C H ) , 157.4 (Ph COH), 
157.8 (NHCO), 174.4 (CO); Un,ax(KBr)/cm"' 3370 (br, OH), 3359 (NH), 2983, 2956, 
1734 (CO), 1686 (CO), 1517, 1228, 1062, 805; m/z (EI) 296 ([M+H]^ 1.5 %) , 295 
( [ M ] ^ 0.5 % ) , 239 ([M+H-C(CH3)3]^ 0.6 % ) , 195 ([M+H-C02C(CH3)3]^ 2.6 %) , 181 
([(OH)PhCH2CH(NH2)C02H]^ 32.8 % ) , 108 ([(OH)BnH]^ 98.0 % ) , 107 ([Bn(OH)]^ 
98.0 % ) , 77 ([Ph]^ 9.6 % ) , 57 ([C(CH3)3]'', 100.0 %) . 
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5.7.3 N-(/er/-ButoxycarbonyI)-0-(2,6-dichlorobenzyI)-DL-tyrosine methyl ester 
O 
OCH3 
/ • ^ J NHBoc 
U 
A mixture of N-(rer/-butoxycarbonyl)-DL-tyrosine methyl ester 222 (1.50 g, 5.08 mmol), 
2,6-dichlorobenzylchloride (1.19 g, 6.09 mmol) and K2CO3 (2.11 g, 15.3 mmol) in 
acetone (20 ml) were refluxed for 3 d. After cooling, water (15 ml) was added and the 
acetone was removed at the rotary evaporator. The aqueous phase was extracted with 
ethyl acetate (3x 20 ml), the combined organic extracts dried (MgS04) and the solvent 
removed in vacuo. The product was then purified by column chromatography over 
silica gel (hexane: diethyl ether, 3:2) to yield a white powder (1.95 g, 84.5 % ) , mp 
111.5-112.5 °C (lit. 108-109 °C).'^' 
6H(200 MHz; CDCI3) 1.37 (9H, s, C(CH3)3), 2.84 ( IH, dd, Jvic 8.8, Jgem 13.8, CH2), 3.05 
( IH, dd, Jvic 5.7, Jgem 14.0, CH2), 3.68 (3H, s, OCH3), 4.33 ( IH, dd, Jvic 5.8, Jvic 8.4, 
CH), 5.24 (2H, s, OCH2), 6.94 (2H, d, J 8.6, Ph), 7.14 (2H, d, J 8.4, Ph), 7.28-7.45 (3H, 
m, Ph); 6c(100.6 MHz; CDCI3) 28.3 (C(CH3)3), 37.4 (CH2), 52.2 (OCH3), 54.5 (CH), 
65.1 (CH2O), 79.9 (C(CH3)3), 115.0 (Ph CH), 128.4 (Ph CH), 128.7 (Ph C), 130.3 (Ph 
CH) , 130.4 (Ph CH) , 132.1 (Ph C), 137.0 (Ph C), 155.1 (Ph COR) 157.9 (NHCO), 
172.4 (CO); Umax(KBr)/cm-' 3357 (NH), 2992, 2971, 2927, 1745 (CO), 1703 (CO), 
1512, 1244, 1016, 827, 776, 768; m/z (EI) 456 ( [ M ] ^ 2x " C l , 0.03 %) , 454 ([M]\ Ix 
" C l , Ix ^^Cl, 0.06 % ) , 452 ( [ M ] ^ 2x ^^Cl, 0.05 %) , 355 ([M-C02C(CH3)3], 2x " C l , 0.6 
% ) , 353 ([M-C02C(CH3)3], Ix " C l , Ix ^^Cl, 0.8 %) , 351 ([M-C02C(CH3)3], 2x ^^Cl, 
0.4 %) 269 ([BnOCH2Ph(Cl)2, 2x " C l , 3.0 % ) , 267 ([BnOCH2Ph(Cl)2], Ix ^^Cl, Ix 
CI, 18.7 % ) , 265 ([BnOCH2Ph(Cl)2, 2x ^^Cl, 29.1 %) , 163 ([Bn(Cl2)], 2x " C l , 9.9 %) , 
161 ([Bn(Cl2)], Ix ^^Cl, Ix " CI, 58.5 %) , 159 ([Bn(Cl2)], 2x ^^Cl, 100.0 % ) , 107 
([Bn(OH)]^ 11.6 % ) , 77 ([Ph]^ 9.4 %) 57 ([C(CH3)3]^ 0.7 %) . 
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5.7.4 N-(3-Oxo-butyryl)-0-(2,6-dichlorobenzyl)-DL-tyrosine methyl ester 228 
O O 
OCH3 
0 
N-(/er/-Butoxycarbonyl)-0-(2,6-dichlorobenzyl)-DL-tyrosine methyl ester 227 (100 mg, 
0.22 mmol), pyridinium ;7(3ra-toIuene sulfonate (PPTS) (60 mg, 0.24 mmol) and 2,2,6-
trimethyl-4H-l,3-dioxin-4-one (34 mg, 0.24 mmol) were refluxed in toluene for 3.5 h. 
After cooling, the solvent was removed in vacuo and the product purified by column 
chromatography over silica gel (DCM:EtOAc, 5:2). Over 90 % of the tert-
butoxycarbonyl group was found by ' H N M R to have been cleaved. 
5H(270 M H Z ; C D C I 3 ) 1.45 (7 %) (9H, s, C(CH3)3), 2.14 (3H, s, CH3), 3.10 ( I H , m, 
CH2), 3.16 ( I H , m, CH2), 3.70 (3H, s, OCH3), 4.83 ( I H , m, CH), 5.21 (2H, s, CH2O), 
6.23 ( I H , s, CH=C(OH)), 6.95 (2H, d, J 9.5, Ph), 7.19 (3H, m, Ph), 7.36 (2H, m, Ph) 
10.21 ( lH,s , COH). 
5.7.5 N-(2,6-Dichlorobenzyl)-0-(2,6-dichlorobenzyl)-DL-tyrosine methyl ester 229 
CI o 
A suspension of DL-tyrosine methyl ester hydrochloride 216 (990 mg, 4.32 mmol), 2,6-
dichlorobenzylchloride (1.86 g, 9.5 mmol) and K2CO3 (2.98 g, 21.6 mmol) in DMF (10 
ml) were stirred at 60 °C for 12 h. The solvent was removed in vacuo and the residue 
dissolved in ethyl acetate (30 ml). The organic layer was washed with water (lOx 15 
ml) to remove any remaining DMF and then dried (MgS04). The solvent was removed 
169 
in vacuo and the product purified by column chromatography over silica gel 
(EtOAc:petroleum ether, 1:3). A white solid (1.32 g, 60.2 %) was obtained, mp 95-96 
°C. 
5H(400 M H Z ; CDCI3) 1.98 ( IH , s, NH), 2.77 ( IH, dd, Jvic 8.0, Jgem 14.0, CH2), 2.90 (IH, 
dd, Jv,c 6.0, Jgem 13.6, CH2), 3.47 ( IH, dd, Jvic 6.0, Jgem 8.0, CH), 3.57 (3H, s, OCH3), 
3.90 ( IH , d, J 13.2, CH2N), 4.02 ( IH, d, J 13.6, CH2N), 5.17 (2H, s, OCH2), 6.84 (2H, 
d, J 8.4, Ph), 7.01 (2H, d, J 8.4, Ph), 7.04 (IH, d, J 8.4, Ph), 7.18 (3H, m, Ph), 7.29 (2H, 
d, J 8.0, Ph); 5c(I00.6 MHz; CDCI3) 38.6 (CH2), 47.0 (CH2N), 51.8 (OCH3), 61.9 
(CH), 65.3 (CH2O), 115.0 (Ph CH), 128.3 (Ph CH), 128.5 (Ph CH), 130.0 (Ph CH), 
128.9 (Ph CH), 129.7-137.0 (Ph C & Ph CH), 157.7 (Ph COH), 174.5 (CO); 
Umax(KBr)/cm-' 3340 (NH), 3074, 3038, 2949, 2896, 1736 (CO), 1610, 1511, 1239, 
1018, 823, 767; m/z (EI) 515 ([M]^ 2x " C l , 2x ^^Cl, 0.2 %) , 513 ([M]^ Ix " C l , 3x 
^^Cl, 0.4 % ) , 511 ([M]^ 4x ^^Cl, 0.4 % ) , 458 ([M-C02CH3]^ 3x " C l , Ix ^^Cl, 1.0 %) , 
456 ([M-C02CH3]^ 2x ^^Cl, 2x ^^Cl, 4.0 %) , 454 ([M-C02CH3]^ Ix ^^Cl, 3x ^^Cl, 8.0 
% ) , 452 ([M-C02CH3]^ 4x ^'Cl, 6.1 % ) , 297 ([M-C02CH3-Bn(Cl)2]^ 2x " C l , 0.5 %) , 
295 ([M-C02CH3-Bn(Cl)2]^ Ix " C l , Ix ^^Cl, 2.3 %) , 293 ([M-C02CH3-Bn(Cl)2]\ 2x 
^^Cl, 3.3 % ) , 269 ([BnOCH2Ph(Cl)2]^ 2x ^'Cl, 0.9 %) , 267 ([BnOCH2Ph(Cl)2]\ Ix 
" C l , Ix ^^Cl, 2.4 % ) , 265 ([BnOCH2Ph(Cl)2]^ 2x ^^Cl, 2.2 %) , 250 ([M-
BnOCH2Ph(Cl)2]^ 2x ^^Cl, 7.8 %) , 248 ([M-BnOCH2Ph(Cl)2]^ Ix " C l , Ix ^^Cl, 45.9 
% ) , 246 ([M-BnOCH2Ph(Cl)2]^ 2x ^^Cl, 70.7 %) , 163 ([Bn(Cl)2]^ 2x " C l , 10.5 % ) , 
161 ([Bn(Cl)2]^ Ix " C l , Ix ^^Cl, 63.9 % ) , 159 ([Bn(Cl)2]^ 2x ^^Cl, 100.0 % ) , 77 
([Ph]^, 16.3 % ) . 
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5.7.6 N-(2,6-Dichlorobenzyl)-(3-oxo-butyryl)-0-(2,6-dichlorobenzyl)-DL-tyrosine 
methyl ester 230 
X I c r ^ x i q o 
CI ^ L c A ^ ^ ^ ^ O C H a 
O 
To a solution of 2,2,6-trimethyl-4H-l,3-dioxin-4-one (152 mg, 1.07 mmol) and N-(2,6-
dichlorobenzyl)-0-(2,6-dichlorobenzyl)-DL-tyrosine methyl ester 229 (498 mg, 0.97 
mmol) in toluene (7 ml) was added PPTS (243 mg, 0.97 mmol) and the mixture 
refluxed with stirring for 3 h. After cooling, the solvent was removed in vacuo and the 
product purified by column chromatography over silica gel (EtOAc; petroleum ether, 
2:3) and recovered as a white solid (431 mg, 74.4 %) , mp 99.5-100.0 °C. The NMR 
revealed a mixture of tautomers. 
5H(400 M H Z ; CDCI3) 3.17 ( IH, dd, J^c 8.8, Jgen, 14.2, CH2), 3.3 ( IH, dd, Jvic 5.2, Jgen, 
14.2, CH2), 3.63 (4H, m, OCH3 and CH), 4.58 ( IH, d, J 14.4, CH2N), 4.73 ( IH, d, J 
14.4, CH2N), 5.14 (2H, s, CH2O), 6.73 (2H, d, J 8.4, Ph), 6.77 (2H, d, J 8.8, Ph), 7.21 
(4H, m, Ph), 7.38 (2H, d, J 8.0, Ph), 14.34 ( IH, s, OH); 5c(100.6 MHz; CDCI3) 30.3 
(CH3), 34.2 (CH2), 49.3 (CH2N), 51.0 (CH2), 52.2 (OCH3), 61.4 (CH), 65.0 (OCH2), 
114.6 (Ph CH), 128.5-132.2 (Ph C and Ph CH), 137.0 (Ph CH), 157.2 (Ph COR), 167.8 
(NHCO), 170.8 (COCH3), 202.1 (CO); Umax(KBr)/cm-' 3452 (br), 3074, 3002, 2954, 
2848, 1741 (CO), 1640 (CO), 1583, 1510, 1437, 1231, 770; m/z (EI) 603 ( [ M f , 4x " C l , 
0.01 % ) , 601 ( [ M ] ^ 3x ^^Cl, Ix ^^Cl, 0.05 % ) , 599 ( [M]^ 2x " C l , 2x ^^Cl, 0.2 %) , 597 
([M]^, Ix " C l , 3x ^^Cl, 0.4 % ) , 595 ( [ M ] ^ 4x ^^Cl, 0.3 %) , 458 ([M+H-CO2CH3-
COCH2COCH3]^ 3x ^^Cl, Ix ^^Cl, 0.7 %) , 456 ([M+H-C02CH3-COCH2COCH3]\ 2x 
" C l , 2x ^^Cl, 2.7 % ) , 454 ([M+H-C02CH3-COCH2COCH3]^ Ix " C l , 3x ^^Cl, 5.5 % ) , 
452 ([M+H-C02CH3-COCH2COCH3]^ 4x ^^Cl, 4.3 %) , 340 ([M+H-COCH2COCH3-
OCH2Ph(Cl)2]^ 2x " C l , 1.8 % ) , 338 ([M+H-COCH2COCH3-OCH2Ph(Cl)2]^ Ix " C l , 
Ix ^^Cl, 10.1 % ) , 336 ([M+H-COCH2COCH3-OCH2Ph(Cl)2]^ 2x ^^Cl, 15.2 %) , 250 
([M+H-COCH2COCH3-BnOCH2Ph(Cl)2]^ 2x " C l , 5.8 % ) , 248 ([M+H-
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COCH2COCH3-BnOCH2Ph(Cl)2]^ Ix " C l , Ix ^^Cl, 34.0 % ) , 246 ([M+H-
COCH2COCH3-BnOCH2Ph(Cl)2]^ 2x ^^Cl, 53.9 % ) , 163 ([Bn(Cl)2]^ 2x " C l , 10.5 %) , 
161 ([Bn(Cl)2]^ Ix ^^Cl, Ix ^^Cl, 62.6 %) , 159 ([Bn(Cl)2]^ 2x ^^Cl, 100.0 %) . 
5.7.7 5-(4-(2,6-Dichlorobenzyloxy)-benzyl-l-(2,6-dichlorobenzyl)-3-(acetyl)-4-
hydroxy-1,5-dihydro-pyrrol-2-one 231 
To a stirred solution of potassium r-butoxide (56 mg, 0.50 mmol) in ^butanol (10 ml) 
was added a solution of N-(2,6-dichlorobenzyl)-(3-oxo-butyryl)-0-(2,6-dichlorobenzyl)-
DL-tyrosine methyl ester 230 (152 mg, 0.25 mmol) in /-butanol (6 ml). After 30 min, the 
resultant yellow solution was quenched with I M HCl (6 ml) and extracted into diethyl 
ether (2x 20 ml). The combined organic extracts were washed with water (Ix 5 ml), 
dried (MgS04) and evaporated in vacuo to afford the product as an orange solid (141 
mg, 97.4 % ) , mp 48 °C. Hexane was used to azeotropically remove final traces of t-
butanol. Spectra were complicated by the presence of tautomers. 
6H(400 M H Z ; CDCI3) 2.28 (85 %) (3H, s, CH3), 2.34 (15 %) (3H, s, CH3), 2.9 ( IH, dd, 
Jvic 5.2, Jgem 14.4, CH2), 3.0 ( IH, dd, Jvic 3.2, Jgem 14.4, CH2), 3.4 (85 %) ( IH, dd, Jvic 
4.8, Jvic 5.2, CH), 3.6 (15 %) ( IH, dd, Jvic 5.2, Jvic 5.6, CH), 4.70 ( IH, d, J 14.8, CH2N), 
5.15 (2H, s, CH2O), 5.27 ( IH, d, J 14.8, CH2N), 6.81 (2H, d, J 8.4, Ph), 6.97 (2H, d, J 
8.4, Ph), 7.17 (2H, m, Ph), 7.29 (4H, m, Ph); 6c(400 MHz; CDCI3) 19.3 (CH3), 19.8 
(CH3) 34.1 (CH2), 39.6 (CH2N), 64.6 (CH), 65.2 (CH2O), 101.9 (C=C), 105.9 (C=C), 
115.0 (Ph CH), 127.2-136.9 (Ph C & Ph CH), 157.8 (Ph COR), 172.9 (NRCO), 183.5 
(CO), 194.1 (CO); Umax(KBr)/cm"' 3440 (br), 2942, 2928, 2856, 1716(CO), 1660 (CO), 
1616, 1509, 1437, 1241, 1020, 770; m/z (EI) 571 ( [M]^ 4x ^'Cl, 0.1 % ) , 569 ( [M]^ 3x 
" C l , Ix ^^Cl, 0.6 % ) , 567 ( [ M ] ^ 2x " C l , 2x ^^Cl, 2.2 %) , 565 ( [M]^ Ix " C l , 3x ^ 'Cl, 
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4.3 % ) , 563 ( [ M ] ^ 4x ^^Cl, 3.3 %) , 269 ([BnOCH2Ph(Cl)2]^ 2x ^^Cl, 3.7 %) , 267 
([BnOCH2Ph(Cl)2]^ Ix " C l , Ix ^^Cl, 21.3 %) , 265 ([BnOCH2Ph(Cl)2]^ 2x ^^Cl, 33.8 
% ) , 163 ([Bn(Cl)2]^ 2x ^^Cl, 10.7 %) , 161 ([Bn(Cl)2]^ Ix ^^Cl, Ix ^^Cl, 65.2 %) , 159 
([Bn(Cl)2]^ 2x ^^Cl, 100.0 % ) , 107 ([Bn(OH)]^ 6.1 %) , 77 ([Ph]^ 2.0 % ) . 
5.7.8 5-(4-(Hydroxy)-benzyl-l-(2,6-dichlorobenzyl)-3-(acetyl)-4-hydroxy-l,5-
dihydro-pyrrol-2-one 232 
5-(4-(2,6-Dichlorobenzyloxy)-benzyl-1 -(2,6-dichlorobenzyl)-3-(acetyl)-4-hydroxy-1,5-
dihydro-pyrrol-2-one 231 (30 mg, 0.05 mmol) was stirred in boron tribromide ( I M 
solution in DCM) (0.27 ml, 0.27 mmol) at -78 °C and allowed to warm to room 
temperature over 24 h. The reaction was quenched with water (2 ml) and extracted into 
DCM (3x 10 ml). The organic extracts were combined and washed with I M NaOH (3x 
5 ml). The combined aqueous extracts were acidified and extracted into DCM (3x 10 
ml). After drying (MgS04), the solvent was removed in vacuo to give the product as a 
red oil. 
5H(400 MHz; CDCI3) 2.28 (3H, bs, CH3), 3.00 (2H, m, CH2), 3.46 (72 %) ( IH, m, CH), 
3.61 (28 %) ( IH, m, CH), 4.71 ( IH, d, J 14.8, CH2N), 5.28 ( IH, d, J 14.8, CH2N), 6.63 
( IH, bs, OH), 6.89 (2H, m, Ph), 7.19 (3H, m, Ph), 7.21 (2H, d, J 7.6, Ph); 8c(100.6 
MHz; CDCI3) 29.7 (CH3), 34.0 (CH2), 39.6 (CH2N), 64.6 (CH), 102.0 (C=C), 115.3 
(Ph CH), 126.2-136.5 (Ph C, Ph CH & C=C(OH)), 154.5 (Ph COH), 173.1 (NRCO), 
183.7 (CO), 194.3 (CO); Un,ax(KBr)/cm"' 3347 (br), 3058, 2974, 2930, 2852, 1710, 
1614, 1515, 1265, 1090, 738; m/z (EI) 409 ( [ M ] ^ 2x " C l , 1.4 % ) , 407 ( [M]^ Ix " C l , 
Ix ^^Cl, 7.4 %) , 405 ( [ M ] ^ 2x ^^Cl, 10.9 %) , 303 ([M+H-Bn(OH)]-', 2x " C l , 9.7 %) , 
301 ([M+H-Bn(OH)]^ 55.5 % ) , 299 ([M+H-Bn(OH)]^ 2x ^^Cl, 87.7 %) , 163 
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([Bn(Cl)2]^ 2x ' 'C l , 11.0 % ) , 161 ([Bn(Cl)2]^ Ix " C l , Ix ' 'C l , 61.2 %) , 159 
([Bn(Cl)2]^ 2x ^^CI, 95.7 %) , 140 ([M+H-Bn(Cl)2-Bn(0H)]^ 15.0 %) , 107 ([Bn(OH)]^ 
100.0 % ) , 77 ([Ph]^ 21.6 % ) , 43 ([CH3C0]^ 49.7 %) . 
5.7.9 N-2,4-Dimethoxybenzyl-DL-tyrosine methyl ester 221 
OCHa 
To a solution of DL-tyrosine methyl ester hydrochloride 216 (2.61 g, 11.3 mmol) in 
methanol (15 ml) was added 2,4-dimethoxybenzaldehyde (1.87 g, 11.3 mmol) and 
MgS04 (3.0 g). The mixture was stirred at room temp, for 24 h, filtered and then the 
solvent was removed in vacuo. The residue was redissolved in methanol (15 ml) and 
the solution cooled to 0 °C. NaBH4 (854 mg, 22.6 mmol) was carefiiUy added in small 
portions over 45 min and the mixture was left to stir for 1 h. The reaction was quenched 
with water (10 ml) and was then extracted into ethyl acetate (3x 50 ml). The combined 
organic extracts were dried (MgS04) and the solvent removed in vacuo to yield a yellow 
solid which was purified over silica gel (EtOAc: petroleum ether, 3:2) to give a white 
solid (2.55 g, 65.6 % ) , mp 94.5-95.5 °C. 
5H(400 M H Z ; CDCI3) 2.85 ( IH, dd, Jvic 8.0, Jgem 13.6, CH2), 2.92 (IH, dd, Jvic 6.4, Jgem 
13.6, CH2), 3.47 ( IH, dd, Jvic 6.4, Jv,c 7.6, CH), 3.62 (3H, s, ArOCHj), 3.62 (IH, d, J 
13.6, CH2N), 3.64 (3H, s, ArOCH3), 3.75 (IH, d, J 13.6, CH2N), 3.78 (3H, s, CO2CH3), 
6.37 (2H, m, Ph), 6.67 (2H, d, J 8.4, Ph), 6.96 (2H, d, J 8.8, Ph), 7.03 ( IH, d, J 8.0, Ph); 
6c(100.6 MHz; CDCI3) 38.5 (CH2), 47.3 (CH2N), 51.7 (CO2CH3), 55.1 and 55.3 (2x 
ArOCHa), 61.9 (CH), 98.3 (Ph CH), 103.5 (Ph CH), 115.4 (Ph CH), 119.4 (Ph C), 
128.6 (Ph C), 130.2 (Ph CH), 130.6 (Ph CH), 154.8 (Ph COH), 158.6 (Ph COCH3), 
160.3 (Ph COCH3), 174.7 (CO); Umax(KBr)/cm-' 3396 (br NH), 3304, 3006, 2950, 2836, 
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1735 (CO), 1615, 1516, 1208, 1033, 830; m/z (EI) 345 {[M]\ 1.3 %) , 286 ([M-
C02CH3]^ 2.5 % ) , 238 ([M-Bn(OH)]^ 18.9 %) , 166 ([NHBn(OCH3)2]^ 1.5 %) , 151 
([Bn(OCH3)2]^ 100.0 % ) , 137 ([Ph(OCH3)2]^ 2.0 % ) , 107 ([Bn(OH)]^ 13.1 %) , 77 
([Phr,6.4%). 
5.7.10 N-(2,4-Dimethoxy)benzyl-0-2,6-dichlorobenzyl-DL-tyrosine methyl ester 234 
0 
OCHT 
O C H , 
A mixture of N-(2,4-dimethoxy)benzyl-DL-tyrosine methyl ester 221 (4.80 g, 13.9 
mmol), 2,6-dichlorobenzyl chloride (2.99 g, 15.3 mmol) and K2CO3 (4.22 g, 30.6 
mmol) were stirred in DMF (40 mi) at 60 °C for 24 h. After cooling, water (20 ml) was 
added and the mixture extracted with ethyl acetate (3x 50 ml). The combined organic 
extracts were washed with water (lOx 20 ml) to remove any remaining DMF, dried 
(MgS04) and the solvent was removed in vacuo. After purification over silica gel 
(EtOAc: petroleum ether, 2:3), the product was recovered as a white solid (5.67 g, 80.9 
%) , mp 87-87.5 °C. 
6H(499.8 M H Z ; CDCI3) 1.65 ( IH, bs, NH), 2.86 ( IH, dd, Jvic 8.5, Jgem 14.0, CH2), 2.96 
( IH, dd, Jvic 6.0, Jgem 13.5, CH2), 3.47 ( IH, dd, Jvic 6.5, Jvic 8.0, CH), 3.60 ( IH, d, J 13.5, 
CH2N), 3.65 (6H, s, 2x ArOCHs), 3.75 ( IH, d, J 13.5, CH2N), 3.79 (3H, s, OCH3), 5.24 
(2H, s, CH2O), 6.38 (2H, m, Ph), 6.94 (2H, d, J 9.0, Ph), 7.03 ( IH, d, J 8.0, Ph), 7.09 
(2H, d, J 8.5, Ph), 7.26 ( IH, m, Ph), 7.37 (2H, d, J 7.5, Ph); 8c(125.7 MHz; CDCI3) 
38.6 (CH2), 47.3 (CH2N), 51.7 (CO2CH3), 55.1 & 55.3 (2x ArOCHs), 61.9 (CH), 65.2 
(OCH2), 98.3 (Ph CH), 103.4 (Ph CH), 114.8 (Ph CH), 120.0 (Ph C), 128.5 (Ph C), 
130.1 (Ph CH), 130.4 (Ph CH), 132.2 (Ph C), 137.0 (Ph CH), 157.6 (Ph COR), 158.6 
(Ph COCH3), 160.1 (Ph COCH3), 175.0 (CO2CH3); Un,ax(KBr)/cm-' 3355 (NH), 3048, 
175 
2994, 2949, 2931, 2833, 1741 (CO), 1611, 1587, 1509, 1241, 832, 788; m/z (EI) 505 
( [ M ] ^ Ix ' 'C l , Ix 3^C1, 0.04 % ) , 503 ( [ M ] ^ 2x ' 'C l , 0.1 % ) , 448 ([M-COzCHj]^ 2x 
' 'C I , 0.01 % ) , 446 ([M-COjCHsT, Ix " C l , Ix '^Cl, 0.1 %) , 444 ([M-CO2CH3T, 2x 
' 'C l , 0.2 % ) , 238 ([M-BnOCH2Ph(Cl)2]^ 1.4 %) , 163 ([Bn(Cl)2]^ 2x " C l , 0.4 %) , 161 
([Bn(Cl)2]^ Ix " C l , Ix ^^Cl, 2.1 % ) , 159 ([Bn(Cl)2]^ 2x ^'Cl, 3.2 % ) . 
5.7.11 N-(2,4-Dimethoxybenzyl)-(3-oxo-butyryl)-0-(2,6-dichlorobenzyl)-DL-tyrosine 
methyl ester 235 
OCH, 
CI CHsO^ "V^^ Q o 
CI '•^^i^-k^^-'^^^O^Hs 
0 
To a solution of 2,2,6-trimethyl-4H-l,3-dioxin-4-one 215 (343 mg, 2.42 mmol) and N-
(2,4-dimethoxy)benzyl-0-2,6-dichloro-benzyl-DL-tyrosine methyl ester 234 (1.06 g, 
2.10 mmol) in toluene (15 ml) was added PPTS (528 mg, 2.10 mmol) and the mixture 
refluxed with stirring for 3 h. After cooling, the solvent was removed in vacuo and the 
product was purified by column chromatography over silica gel (DCM; EtOAc, 6:1). 
The product was recovered as a white solid (980 mg, 79.2 % ) , mp 98-99 °C. 
5H(499.8 M H Z ; CDCI3) 2.27 (3H, s, CH3), 3.05 ( IH, dd, Jvic 9.0, Jgem 14.0, CH2), 3.35 
( IH, d, Jvic 6.0, Jgem 14.5, CH2), 3.63 (3H, s, OCH3), 3.75 (3H, s, OCH3), 3.80 (3H, s, 
OCH3), 4.00 (84 %) ( IH, d, J 15.5, CH2N), 4.05 (16 %) ( IH, d, J 17.5, CH2N), 4.21 
( IH, dd, Jvic 6.0, Jgem 9.0, CH), 4.25 (84 %) ( IH, d, J 16.0, CH2N), 4.33 (16 %) ( IH, d, J 
17.0, CH2N), 5.25 (2H, s, CH2O), 6.39 (2H, m, Ph), 6.89 (2H, d, J 8.5, Ph), 6.93 ( IH, d, 
J 8.5, Ph), 7.00 (2H, d, J 8.5, Ph), 7.26 ( IH, d, J 8.5, Ph), 7.37 (2H, d, J 8.0, Ph); 
6c(125.7 MHz; CDCI3) 30.4 (CH3), 34.6 (CH2), 49.0 (CH2N), 50.4 (CH2), 52.3 
(CO2CH3), 55.3 (ArOCH3), 55.7 (ArOCHj), 60.7 (CH), 65.5 (CH2O), 98.8 (Ph CH), 
104.0 (Ph CH), 115.1 (Ph CH), 116.0 (Ph CH), 128.7 -137.2 (Ph C & Ph CH), 157.7 . 
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(Ph COR), 158.9 (Ph COCH3), 161.3 (Ph COCH3), 167.8 (NRCO), 171.1 (CO), 202.8 
(CO); Umax(KBr)/cm"' 3431, 3020, 2949, 2820, 1740 (CO), 1637, 1587, 1509, 1238, 
1209, 833, 760; m/z (El) 591 ( [ M ] ^ 2x " C l , 0.1 %) , 589 ( [ M ] ^ Ix " C l , Ix ^^Cl, 0.2 % ) , 
587 ( [ M ] ^ 2x ^^Cl, 0.2 % ) , 506 ([M-COCH2COCH3]^ 2x " C l , 0.7 %) , 504 ([M-
COCH2COCH3]^ Ix ^^Cl, Ix ^^Cl, 1.8 %) , 502 ([M-COCH2COCH3]^ 2x ^^Cl, 1.6 %) , 
448 ([M-COCH2COCH3-C02CH3]^ 2x " C l , 0.2 %) , 446 ([M-COCH2COCH3-
C02CH3]^ Ix ^^Cl, Ix ^^Cl, 1.0 % ) , 444 ([M-COCH2COCH3-C02CH3]^ 2x ^'Cl, 1.4 
% ) , 336 ([M-PhOCH2Ph(Cl)2]^, 7.5 % ) , 251 ([(OCH3)2BnNHCOCH2COCH3]^ 26.3 
% ) , 163 ([Bn(Cl)2]^ 2x " C l , 9.2 % ) , 161 ([Bn(Cl)2]'", Ix ^'Cl, Ix ^^Cl, 53.8 %) , 159 
([Bn(Cl)2]^ 2x ^^Cl, 77.8 %) , 151 ([Bn(OCH3)2]^ 100.0 %) , 78 ([PhH]^ 14.7 %) , 77 
([Phf, 11.9%). 
5.7.12 5-(4-(2,6-dichlorobenzyloxy)-benzyl-l-(2,4-dimethoxybenzyl)-3-(acetyl)-4-
hydroxy-l,5-dihydro-pyrrol-2-one 236 
CH3O ^ OCH3 
To a stirred solution of potassium ^erZ-butoxide (190 mg, 1.70 mmol) in /-butanol (20 
ml) was added a solution of DL-N-(2,4-dimethoxybenzyl)-(3-oxo-butyryl)-0-(2,6-
dichlorobenzyl)-DL-tyrosine methyl ester 235 (500 mg, 0.85 mmol) in r-butanol (10 ml). 
After 30 min, the resultant yellow solution was quenched with I M HCl (6 ml) and 
extracted into diethyl ether (2x 25 ml). The combined organic extracts were washed 
with water (Ix 10 ml), dried (MgS04) and evaporated in vacuo to afford an orange solid 
(461 mg, 97.5 % ) , mp 48 °C (decomp.). Hexane was used to azeotropically remove 
final traces of /-butanol. ' H and '^ C spectra were complicated by the presence of 
tautomers. 
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5H(400 M H Z ; C D C I 3 ) 2.29 (88 %) (3H, s, CH3) , 2.35 (12 %) (3H, s, CH3) , 3.05 (88 %) 
(2H, d, J 4.8, CH2), 3.07 (12 %) (2H, d, J 4.4, CH2), 3.73 (3H, s, ArOCHj), 3.74 (3H, s, 
ArOCH3), 3.78 ( IH , t, J 4.8, CH), 4.14 (88 %) ( IH, d, J 14.8, CHjN), 4.17 (12 %) ( IH, 
d, J 14.4, CH2N), 4.91 (88 %) ( IH, d, J 14.8, CH2N), 4.98 (12 %) ( IH, d, J 14.4, 
CH2N), 5.17 (2H, s, CH2O), 6.37 (2H, m, Ph), 6.82 (2H, d, J 8.4, Ph), 6.97 (2H, d, J 
8.8, Ph), 7.01 ( IH , d, J 8.8, Ph), 7.16 ( IH, d, J 8.8, Ph), 7.29 (2H, d, J, 8.0, Ph); 
6c(100.6 MHz; C D C I 3 ) 19.5 (CH3), 34.1 (CH2), 38.3 (CHjN), 55.3 (Ar OCH3), 55.4 
(Ar OCH3), 62.3 (CH), 65.3 (CH2O), 98.4 (Ph CH), 102 (C=C), 104.3 (Ph CH), 115.0 
(Ph CH), 116.0-137.0 (Ph C & Ph CH), 157.7 (Ph COR), 158.5 (Ar COCH3), 160.9 (Ar 
COCH3), 173.2 (NRCO), 183.5 (C=COH), 194.7 (CO); m/z (EI) 559 ( [ M ] ^ 2x "C l , 1.9 
% ) , 557 ( [ M ] ^ Ix ^^Cl, Ix ^^Cl, 9.2 % ) , 555 ( [M]^ 2x ^^Cl, 13.4 % ) , 397 ([M+H-
Bn(Cl)2]^ 1.3 % ) , 269 ([BnOCH2Ph(Cl)2]^ 2x " C l , 4.5 % ) , 267 ([BnOCH2Ph(Cl)2]^ 
Ix ^^Cl, Ix ^^Cl, 29.4 % ) , 265 ([BnOCH2Ph(Cl)2]^ 2x ^^Cl, 45.0 % ) , 163 ([Bn(Cl)2]^ 
2x " C l , 5.7 % ) , 161 ([Bn(Cl)2]^ Ix " C l , Ix ^^Cl, 33.5 % ) , 159 ([Bn(Cl)2]^ 2x ^ ^Cl, 
52.0 %) , 151 ([Bn(OCH3)2]^ 100.0 %) , 78 ([PhH]^ 4.5 % ) , 77 ([Ph]^ 6.8 % ) , 43 
([CH3C0]^ 26.5 % ) ; Found 556.1289, C29H27NO6CI2 (M^) requires 556.1293. 
5.7.13 5-(4-(Hydroxy)-benzyl-l-(2,4-dihydroxybenzyl)-3-(acetyl)-4-hydroxy-l,5-
dihydro-pyrrol-2-one 237 
5-(4-(2,6-Dichlorobenzyloxy)-benzyl-l-(2,4-dimethoxybenzyl)-3-(acetyl)-4-hydroxy-
l,5-dihydro-pyrrol-2-one 236 (526 mg, 0.95 mmol) was stirred in a solution of BBr3 
( I M in DCM, 6.6 ml, 6.62 mmol) at -78 °C and allowed to warm to room temperature 
over 6 h. I M HCl (20 ml) was added and extracted with diethyl ether (3x 20 ml). The 
combined organic extracts were washed with I M NaOH (2x 10 ml), the aqueous 
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extracts were acidified and were then extracted with diethyl ether (3x 15 ml). The 
combined organic extracts were dried (MgS04) and the solvent was removed in vacuo 
to give an orange/brown solid (352 mg, 98.6 %) , mp 88 °C (decomp.). ' H N M R 
indicated that approximately 70 % of the benzyl methyl ether groups had also been 
removed. 
6H(299.9 M H Z , CD3OD) 2.29 (3H, s, CH3), 3.05 (2H, m, CH2), 3.78 (3H, m, CH2N and 
OCH3 (30 %)), 4.24 ( IH , t, J 15.6, CH), 4.89 ( IH, m, CH2N), 6.32 (2H, m, Ph), 6.62 
(2H, d, J 6.6, Ph), 6.87 (2H, d, J 7.8, Ph), 6.9 ( IH, t, J 8.4, Ph); 5c(75.4 MHz, CD3OD) 
20.4 (CH3), 35.5 (CH2), 40.4 (CH2N), 56.6 (CH), 100.7-133.6 (Ph C, Ph CH & C-C), 
158.2-161.0 (Ph COH and CO); Un,ax(neat)/cm"' 3347 (br), 3034, 2974, 2932, 1617, 
1515, 1241, 846; m/z (El) 397 ([M-2H+CH3+CH3]^ 1.4 % ) , 383 ([M-H+CHa]^ 25.2 
% ) , 370 ([M+H]^ 16.9 % ) , 369 ( [ M ] ^ 57.6 % ) , 327 ( [ M + H - C 0 C H 3 ] ^ 4.5 % ) , 277 
([M+H-Ph(OH)]^, 48.9 % ) , 263 ([M+H-Bn(OH)]^ 61.6 % ) , 247 ([M+H-Bn(0H)2]^ 
60.9 % ) , 123 ([Bn(0H)2]^ 89.0 % ) , 108 ([BnH(OH)]^ 68.8 % ) , 107 ([Bn(OH)]'', 100.0 
% ) , 78 ([PhH]^ 30.4 % ) , 77 ([Ph]^ 68.1 %) , 43 ( [ C H 3 C 0 ] ^ 68.2 %) . 
5.7.14 5-(4-(Hydroxy)-benzyl)-3-(acetyl)-4-hydroxy-l,5-dihydro-pyrrol-2-one 
213'" 
5-(4-(Hydroxy)-benzyl-l-(2,4-dihydroxybenzyl)-3-(acetyl)-4-hydroxy-l,5-dihydro-
pyrrol-2-one 237 (150 mg, 0.41 mmol) was stirred in trifluoroacetic acid (TFA) (6 ml) 
at room temperature for 30 min. The reaction was then quenched with ice and extracted 
into DCM (2x 10 ml). The combined organic extracts were dried (MgS04) and the 
solvent was removed in vacuo to give an orange solid, mp 150 °C (decomp.). 
5H(299.9 MHz; CD3OD) 2.33 (3H, s, COCH3), 2.85 (IH, dd, Jvic 6.0, Jgem 14.1, CH2), 
2.98 ( IH , dd, Jvic 4.2, Jgem 13.8, CH2), 4.07 ( IH, t, J 5.4, CH), 6.65 (2H, d, J 8.4, Ph), 
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6.97 (2H, d, J 8.4, Ph); 5c(75.4 MHz; C D 3 O D ) 20.2 ( C H 3 ) , 37.4 ( C H 2 ) , 64.0 (CH), 
103.6 ( C - C ) , 116.1 (Ph CH), 127.6 (Ph C), 129.4 (C=C), 131.8 (Ph CH), 157.3 (Ph 
COH), 187.5 (CO), 198.2 (CO); Un,ax(neat)/cm-' 3404 (br), 3238 (br), 3058, 2962, 2928, 
2856, 1699 (CO), 1641 (NHCO), 1601, 1515, 1267, 802; m/z (EI) 248 ( [M+Hf , 1.4 %) , 
247 ( [ M ] ^ 8.2 % ) , 141 ([M+H-BnOH]^ 13.7 %) , 107 ([Bn(OH)]^ 100.0 %) , 77 ([Ph]^ 
8.7 % ) , 43 ( [ C H 3 C 0 ] ^ 12.8 %) . 
5.7.15 (1,1-DimethyI-N-propylidene) ethylamine 240'^ '' 
N 
Propionaldehyde 239 (14.50 g, 0.25 mol) was added dropwise over 2 h to r-butylamine 
238 (18.25 g, 0.25 mol) stirring at 0 °C. When addition was complete, stirring was 
stopped and potassium hydroxide pellets (10 g) were added. The mixture was left at -20 
°C for 12 h and was then distilled twice at atmospheric pressure (bp 95-97 °C, 760 
mmHg). The distillate was collected under nitrogen as a clear, colourless oil (13.7 g, 
48.5 % ) . The product was stored over molecular sieves at -20 °C. 
6H(400 M H Z ; C D C I 3 ) 0.92 (3H, 2x t, J 7.6, C H 2 C H 3 ) , 1.02 (9H, s, C (CH3)3) , 2.09 (2H, 
m, C H 2 C H 3 ) , 7.44 ( I H , dd, Jvic 5.2, Jvic 8.8, CH); 6c(100.6 MHz; C D C I 3 ) 10.4 
( C H 2 C H 3 ) , 29.54 (C(CH3)3), 56.0 ( C H 2 C H 3 ) , 77.3 (C(CH3)3), 159.5 (CH=N); 
Umax(neat)/cm"' 2970, 2934, 2908, 2874, 1676 (C=N), 1476, 1462, 1222, 1095, 888; m/z 
(EI) 114 ([M+H]^ 1.3 % ) , 113 ([M+H]"", 4.1 % ) , 98 ( [ M - C H 3 ] ^ 50.0 %) , 57 
([C(CH3)3]'*', 100.0 % ) , 41 ( [ N = C H C H 2 ] ^ 77.5 %) , 29 ( [ C H 2 C H 3 ] ^ 21.0 %) . 
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5.7.16 £^-2,4-Dimethyl-2-hexenal 242'*^ 
O 
H 
Butyllithium (1.6 M in hexanes, 34.5 ml, 55 mmol) was added dropwise to a solution of 
freshly distilled (1,1-dimethyl-N-propylidene) ethylamine 240 (5.65 g, 50 mmol) in THF 
(30 ml) (under nitrogen) at -78 °C via a dry nitrogen flushed syringe over 10 min. The 
solution was warmed to 0 °C, stirred for 20 min and then cooled to -78 °C. 2-
Methylbutyraldehyde 241 (3.88 g, 45 mmol) was added dropwise and then the solution 
was allowed to warm to 0 °C with continuous stirring for 4 h at this temperature. An 
aqueous slurry of oxalic acid (30 g in 110 ml H 2 O ) was added and the biphasic mixture 
was stirred vigorously for 72 h. The mixture was then filtered and extracted into DCM 
(3x 75 ml). The combined organic extracts were dried (MgS04) and the solvent 
evaporated in vacuo to yield a colourless oil (3.43 g, 60.3 %) . The oil was purified over 
silica gel (DCM), kept at -20 °C and repurified by column chromatography directly 
before use. 
5H(200 MHz; C D C I 3 ) 0.88 (3H, t, J 7.4, C H 2 C H 3 ) , 1.06 (3H, d, J 6.6, C H C H 3 ) , 1.41 
(2H, m, C H 2 C H 3 ) , 1.75 (3H, s, H C = C C H 3 ) , 2.62 ( IH, m, CH (CH3)) , 6.25 ( IH, d, J 9.8, 
CH=C), 9.40 ( IH , s, CHO); 5c(50.3 MHz; C D C I 3 ) 9.7 ( C H 2 C H 3 ) , 12.2 (CH(CH3)) , 
19.9 (C (CH3) ) , 29.9 ( C H 2 C H 3 ) , 35.6 (CH(CH3)) , 138.6 ((CH3)C=CH), 160.8 
(CH=C(CH3)), 196.0 (CO); Un,ax(neat)/cm"' 2966, 2930, 2880, 2822, 2708, 1691 (CO), 
1642, 1459, 1119, 1005; m/z (EI) 126 ( [ M ] ^ 10.6 %) , 111 ([M-CHs]^ 20.8 %) , 97 ([M-
CH2CH3]^ 68.1 % ) , 69 ([M-C4H9]^ 44.6 %) , 55 ([M+H-C4H9-CH3]^ 64.0 %) , 41 
([C^Hst, 100.0 % ) , 29 ([C2H5]^ 77.3 % ) . 
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5.7.17 2,2-Dimethyl-6-chloromethyl-l,3-dioxin-4-one 243*^° 
Freshly distilled 2,2,6-trimethyl-4H-l,3-dioxin-4-one 215 (5.0 g, 35.2 mmol, bp 59.5 
°C, 1.5 mmHg) in THF (20 ml) was added dropwise to a solution of lithium 
diisopropylamide (LDA) (2M solution in THF, 24.0 ml, 48.0 mmol) in THF (100 ml) at 
-78 °C. The resultant bright yellow suspension was stirred for 30 min and then 
transferred via cannula to a stirred solution of hexachloroethane (12.5 g, 52.8 nrniol) in 
THF (100 ml) (under nitrogen) at -55 °C. The resultant red solution was stirred for 1 h 
and allowed to warm to -20 °C over this time. The reaction was then quenched with I M 
HCl (30 ml) and extracted into diethyl ether (3x 100 ml). The combined organic 
extracts were dried and the solvent was removed in vacuo to yield a yellow oil which 
was purified by column chromatography over silica gel (DCM). The product was 
recovered as a colourless oil (4.30 g, 69.2 %) . 
5H(200 M H Z ; C D C I 3 ) 1.72 (6H, s, C(CH3)2), 4.02 (2H, s, C H 2 C I ) , 5.56 ( IH, s, CH); 
5c(75.4 MHz; C D C I 3 ) 25.2 (C(CH3)2), 41.3 ( C H 2 C I ) , 96.0 (CH=C), 107.9 (C(CH3)2), 
160.8 (CO), 164.8 ( H C = C C H 2 C 1 ) ; Un,ax(neat)/cm-' 3449, 3106, 3002, 2945, 1732 (CO), 
1646, 1394, 1212, 1016, 741; m/z (EI) 178 ( [M]^ ^^Cl, 4.0 %) , 176 ( [ M f , ^^Cl, 12.4 
% ) , 163 ([M-CH3]^ ^^Cl, 0.6 % ) , 161 ([M-CHa]^ ^^Cl, 1.7 %) , 142 ([M+H-Cl]^ 0.9 %) , 
121 ([M+H-(CH3)2CO]^ ^^Cl, 8.3 % ) , 119 ([M+H-(CH3)2CO]^ ^^Cl, 26.2 % ) , 84 
([M+H-(CH3)2C0-C1]^ 3.4 % ) , 69 ([M-(CH3 )2C0-CH2C1]^ 61.9 % ) , 59 ([CjHyO]^ 
93.5 % ) , 58 ([C3H60r, 12.8 %) . 
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5.7.18 2,2-Dimethyl-6-(diethylphosphonomethyl)-l,3-dioxin-4-one244'^° 
0 ^ 0 o 
^ OEt 
To a sfirred suspension of NaH (60 % in mineral oil, 636 mg, 15.9 mmol) in THF (30 
ml) at 0 °C was added distilled diethyl phosphite (2.44 g, 17.7 mmol, bp 50 C, 2.0 
mmHg). After stirring for Ih, 2,2-dimethyl-6-chloromethyl-l,3-dioxin-4-one 243 (1.03 
g, 5.84 mmol) in THF (4 ml) was added dropwise over 10 min, and the resultant orange 
solution stirred at 0 °C for 90 min. I M HCl (10 ml) was added to the reaction and the 
mixture extracted into diethyl ether (3x 50 ml). The combined organic extracts were 
dried (MgS04) and the solvent was removed in vacuo. The product was purified by 
column chromatography over silica gel (diethyl ether, then ethyl acetate), yielding a 
colourless oil (836 mg, 51.5 % ) . Diethyl phosphite was present in the early elution 
fractions. 
5H(200 M H Z ; CDCI3) 1.30 (6H, t, J 7.0, (OCH2CH3)2), 1.66 (6H, s, C(CH3)2), 2.76 (2H, 
d, V P 22.2, CH2P(0)(OCH2CH3)2), 4.10 (4H, 2x q, \.p 7.2, (OCH2CH3)2), 5.34 ( IH, 
d, V P 3.6, CH); 5c(50.3 MHz; CDCI3) 16.6 (d, ^JC-P 6.2, (OCH2CH3)2), 25.2 
(C(CH3)2), 32.6 (d, 'Jc-P 137.4, CH2P(0)(OCH2CH3)2), 62.9 (d, 'JC-P 6.6, (OCH2CH3)2), 
96.5 (d, J^c-P 8.0, CH=C), 107.4 (C(CH3)2), 160.8 (CO), 163.3 (d, ^JC-P 9.9, 
HC=CCH2P); 6p(81 MHz; CDCI3) 21.58 (CH2P(0)(OCH2CH3)2); Umax(neat)/cm"' 3468, 
3097, 2987, 2911, 1731 (br, CO), 1634, 1392, 1260 (PO), 1023; m/z (EI) 279 ([M+H]^ 
0.1 % ) , 278 ([M]"", 0.3 % ) , 220 ([M-(CH3)2CO]^ 38.5 % ) , 192 (M+H-(CH3)2CO-
CH2CH3]^ 56.1 % ) , 164 (M+H-(CH3)2CO-(CH2CH3)2+H]^ 19.0 %) , 152 
([CH3P(0)(OCH2CH3)2]^ 32.3 % ) , 137 ([P(0)(OCH2CH3)2f, 13.6 % ) , 109 
([P(0)(OH)(OCH2CH3)]^ 19.7 %) , 81 ([P(0)(0H)2]", 21.5 %) , 59 ([C3H70]^ 9.6 %) , 
58 ([C3H60]\ 23.4 % ) , 43 ([C2H30]^ 100.0 %) . 
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5.7.19 2,2-Dimethyl-6-(£'^-3,5,dimethylhepta-l,3-dienyl)-l,3-dioxin-4-onel74^° 
Butyllithium (2 M solution in hexanes, 1.89 ml, 3.78 mmol) was added dropwise to a 
stirred solution of 1,1,1,3,3,3-hexamethyldisilazane (0.8 ml, 3.78 mmol) in THF (30 ml) 
under nitrogen at 0 °C. After 10 min, a solution of 2,2-dimethyl-6-(diethylphosphono-
methyl)-l,3-dioxin-4-one 244 (1.01 g, 3.63 mmol) in THF (8 ml) was added. The 
resultant deep red solution was stirred for 20 min at 0 °C and then cooled to -78 °C. 
Freshly purified £'-2,4-dimethyI-2-hexenal 242 (454 mg, 3.60 mmol) was added 
dropwise and the reaction allowed to warm to room temperature over 4 h, followed by 
stirring for a further 8 h at this temperature. The solvent was removed in vacuo, the 
residue dissolved in DCM and the solution filtered to remove any insolubles. The 
filtrate was reduced in vacuo and the residue purified by column chromatography over 
silica gel (DCM) to give the product as a colourless oil (386 mg, 42.9 % ) . 
5H(200 MHz; C D C I 3 ) 0.83 (3H, t, J 7.4, C H 2 C H 3 ) , 0.97 (3H, d, J 6.6, CH(CH3)), 1.33 
(2H, m, C H 2 C H 3 ) , 1.70 (6H, s, C (CH3)2) , 1.78 (3H, s, C=C(CH3)), 2.44 ( IH, m, 
CH(CH3)), 5.29 ( IH , s, CH=COR), 5.63 ( IH, d, J 9.8, C=CHCH(CH3)CH2CH3), 5.92 
( IH, d, J 15.6, CH=CHC(CH3)) 6.95 ( IH, d, J 15.6, CH=CHC(CH3)); 6c(50.3 MHz; 
C D C I 3 ) 12.2 ( C H 2 C H 3 ) , 12.6 (CH(CH3)) , 20.5 (C (CH3)) , 25.3 (C(CH3)2), 30.3 
( C H 2 C H 3 ) , 35.3 (CH(CH3)), 93.9 (CH=COR), 106.4 (C(CH3)2), 117.4 
(CH=C(CH3)CH2CH3), 132.1 (C(CH3)=CH), 143.7 (HC=CHC(CH3)), 148.3 
(HC=CHC(CH3)), 162.4 (HC=COR), 164.5 (CO); Un,ax(neat)/cm-' 3055, 2995, 2961, 
2926, 2871, 1726 (br, CO), 1624, 1388, 1272, 1017; m/z (EI) 251 ( [M+Hf , 8.9 %) , 250 
( [ M ] ^ 33.8 % ) , 235 ([M-CH3]^ 1.0 %) , 229 ([M-CH2CH3]^ 0.7 %) , 192 ([M-
(CH3)2CO]^ 14.6 % ) , 177 ([M-(CH3)2CO-CH3]^ 16.6 %) , 163 ([M-(CH3)2CO-
CH2CH3]^ 37.1 % ) , 135 ([M-(CH3)2CO-CH(CH3)CH2CH3)]^ 81.5 %) , 123 
([CH=CHC(CH3)CH-CH(CH3)CH2CH3]^ 100.0 %) , 57 ([CH(CH3)CH2CH3]^ 21.9 %) . 
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5.7.20 N-(2,4-Dimethoxybenzyl)-N-(E,E-3-oxo-6,8-dimethyldeca-4,6-dienoyl)-0-(2,6-
dichlorobenzyl)-DL-tyrosine methyl ester 245 
OCH 
CI CH3O 
PPTS (77 mg, 0.31 mmol) was added to a solution of 2,2-dimethyl-6-(^,£-3,5-
dimethylhepta-l,3-dienyl)-l,3-dioxin-4-one 174 (70 mg, 0.28 mmol) and N-(2,4-
dimethoxy)benzyl-0-2,6-dichlorobenzyl-DL-tyrosine methyl ester 234 (155 g, 0.31 
mmol) in toluene (2 ml) and the mixture refluxed with stirring for 3.5 h. After cooling, 
the solvent was removed in vacuo and the product purified by column chromatography 
over silica gel (DCM, then DCM:diethyl ether, 20:1). A pale yellow solid (174 mg, 
89.3 %) was produced, mp 41-62 °C (undefined). The NMR revealed a mixture of 
tautomers. 
6H(299.9 MHz; C D C I 3 ) 0.75 & 0.77 (3H, 2x t, J 7.5, CH2CH3), 0.88 & 0.91 (3H, 2x d, J 
6.9, CH(CH3)), 1.30 (2H, m, CH2CH3), 1.67 & 1.74 (3H, 2x s, C(CH3)), 2.36 ( IH, m, 
CH(CH3)), 3.04 ( IH , m, CH2) , 3.26 ( IH, dd, Jvic 6.0, Jgem 14.1, CH2) , 3.52 & 3.55 (3H, 
2x s, O C H 3 ) , 3.67 & 3.68 (3H, 2x s, OCH3) , 3.71 & 3.72 (3H, 2x s, OCH3) , 4.03 ( IH, 
m, CH), 4.28 ( IH , m, CH2N) , 5.11 ( IH, s, COCH=COH), 5.16 (2H, s, CH2O) , 5.48 
( IH, d, J 9.6, C=CHCH(CH3)CH2CH3), 5.70 ( IH, m, CH2C0CH=CH), 6.17 ( IH, d, J 
15.6, C H 2 C 0 C H = C H ) , 6.30 (2H, m, Ph), 6.81 (2H, m, Ph), 6.96 (3H, m, Ph), 7.17 ( IH, 
d, J 7.2, Ph), 7.27 (2H, d, J 8.1, Ph); 5c(75.4 MHz; C D C I 3 ) 12.2 (CH2CH3), 12.8 
(CH(CH3)), 20.4 & 20.7 (C(CH3)), 30.3 & 30.5 (CH2CH3), 34.7 & 35.0 (CH(CH3)), 
35.5 (CH2) , 47.1 & 48.2 (CH2N), 52.3 & 52.5 (OCH3), 55.4 (ArOCHs), 55.7 
( A r O C H 3 ) , 61.1 (CH), 65.6 (CH2O), 89.8 (COC=COH), 98.5 (Ph CH), 104.0 (Ph C), 
115.2 (Ph CH), 116.3-137.3 (Ph C, Ph CH & CH), 141.5-151.0 (CH), 157.7 & 157.8 
(PhCOR), 158.1 & 159 0 (Ph C O C H 3 ) , 160.7 «fe 161.3 (Ph C O C H 3 ) , 168.0 (NRCO), 
170.5 & 171.2 (CO2CH3) 173.3 (C=COH), 194.2 (CO); Umax(neat)/cm-' 3001, 2960, 
2934, 2870, 2838, 1741 (CO), 1632, 1584, 1510, 1238, 819, 733; m/z (EI) 699 ( [ M ] \ 
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2x " C l , 0.1 % ) , 697 ( [ M ] ^ Ix ^^Cl, Ix ^^Cl, 0.2 %) , 695 ( [M]^ 2x ^^Cl, 0.5 %) , 506 
([M-R]^, 2x ^'Cl, 0.2%), 504 ([M-R]^ Ix ^^Cl, Ix ^^Cl, 0.8 % ) , 502 ([M-R]^ 2x ^^Cl, 
0.9 % ) , 448 ([M+H-R-C02CH3]^ 2x " C l , 0.1 % ) , 446 ([M+H-R-COjCHs]^ Ix ^^Cl, Ix 
^'Cl, 0.7 % ) , 444 ([M+H-C02CH3]^ 2x ^^Cl, 0.9 %) , 238 
([(C02CH3)CHNCH2Ph(OCH3)2]^ 10.0 % ) , 151 ([Bn(OCH3)2]^ 100.0 %) , 77 ([Ph]^ 
7.0 % ) , where R = COCH2COCH=CHC(CH3)=CHCH(CH3)CH2CH3. Found 696.2495, 
C38H43NO7CI2 (M"") requires 696.2495. 
5.7.21 5-(4-(2,6-Dichlorobenzyloxy)-benzyl)-l-(2,4-dimethoxybenzyl)-3-(E,E-4,6-
dimethyl-octa-2,4-dienoyl)-4-hydroxy-l,5-dihydro-pyrrol-2-one 246 
CH3O 
A solution of N-(2,4-dimethoxybenzyl)-N-(£',£-3-oxo-6,8-dimethyldeca-4,6-dienoyl)-0-
(2,6-dichlorobenzyl)-DL-tyrosine methyl ester 245 (90 mg, 0.13 mmol) in /-butanol (3 
ml) was added to a stirred solution of potassium f-butoxide (29 mg, 0.26 mmol) in t-
butanol (5 ml). After 30 min, the reaction was quenched with I M HCl (3 ml) and then 
extracted with diethyl ether ( Ix 20 ml). The organic extract was washed with water (Ix 
3 ml), dried (MgS04) and evaporated in vacuo to yield a brown oil. Excess ^butanol 
was azeotropically removed with hexane to give the product as an orange/brown solid 
(67 mg, 78.6 % ) . 
5H(400 M H Z ; C D C I 3 ) 0.77 (3H, 2x t, J 7.2, CH3) , 0.92 (3H, d, J 6.8, CH3) , 1.25 (2H, m, 
CH2), 1.82 (3H, s, CH3), 2.42 ( IH, m, CH), 3.05 (2H, d, J 4.4, CH2), 3.71 (3H, s, 
ArOCH3), 3.72 (3H, s, ArOCHa), 3.77 (82 %) ( IH, dd, Jvic 4.0, Jvic 4.8, CH), 3.92 (18 
%) ( I H , t, J 4.4, CH), 4.11 (82 %) ( IH , d, J 14.8, CH2N), 4.18 (18 %) ( I H , d, J 15.2, 
CH2N), 4.92 (82 %) ( IH, d, 14.8, CH2N), 5.01 (18 %) , ( IH, d, J 14.8, CH2N), 5.14 ( IH, 
s, COCH=COH), 5.15 (2H, s, CH2O), 5.73 ( IH, d, J 9.6, CH), 6.36 (2H, m, Ph), 6.80-
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7.18 (7H, m, Ph & CH), 7.27 (2H, d, J 8.0, Ph), 7.38 ( IH, d, J 15.6, CH); 5H(400 MHz; 
CDCI3) 12.3 (CH2CH3), 12.8 (CH(CH3)), 20.4 (C(CH3)), 30.3 (CH2CH3), 34.7 
(CH(CH3)), 35.6 (CH2N), 38.8 (CH2), 55.72 (2x ArOCH3), 65.3 (CH), 65.3 (CH2O), 
98.7 (Ph CH), 100.7 (COC=COH), 104.6 (Ph C), 115.3 (Ph CH), 116.5-137.3 (Ph C, 
Ph CH, C 8c CH), 149.9 (CH), 151.8 (CH), 158.0 (Ph COCH3), 158.9 (Ph COCH3), 
161 (PhCOR), 174.2 &174.8 (NRCO & C=COH), 194.8 (CO); Umax(KBr)/cm ' 3068, 
2958, 2926, 2868, 1696 (CO), 1615, 1579, 1507, 1238, 1036, 772, 820; m/z (EI) 667 
( [ M ] ^ 2x ^^Cl, 4.6 % ) , 665 ( [ M ] ^ Ix " C l , Ix ^^Cl, 18.3 % ) , 663 ( [ M ] ^ 2x ^^Cl, 23.9 
% ) , 610 ([M-CH(CH3)CH2CH3]^ 2x ^'Cl, 0.2 %) , 608 ([M-CH(CH3)CH2CH3]^ Ix 
" C l , Ix ^^Cl, 2.0 % ) , 606 ([M-CH(CH3)CH2CH3]^ 2x ^^Cl, 2.8 % ) , 398 ([M-
BnOCH2Ph(Cl)2]^ 3.5 % ) , 269 ([BnOCH2Ph(Cl)2]^ 2x " C l , 1.8 %) , 267 
([BnOCH2Ph(Cl)2f, Ix " C l , Ix ^^Cl, 7.1 %) , 265 ([BnOCH2Ph(Cl)2]^ 2x ^^Cl, 10.8 
% ) , 163 ([Bn(Cl)2]'", 2x ^^Cl, 3.7 % ) , 161 ([Bn(Cl)2]^ Ix ^^Cl, Ix ^^Cl, 29.7 %) , 159 
([Bn(Cl)2]^ 2x ^^Cl, 35.2 % ) , 151 ([Bn(OCH3)2]^ 100.0 %) , 107 ([Bn(OH)]^ 5.4 %) , 
77 ([Ph]^ 4.9 % ) . Found 664.2222 C37H39NO6CI2 (M^) requires 664.2232. 
5.7.22 5-(4-hydroxybenzyl)-3-(E,E-4,6-dimethyl-octa-2,4-dienoyl)-4-hydroxy-l,5-
dihydro-pyrrol-2-one 177 
5-(4-(2,6-dichlorobenzyloxy)-benzyl-l-(2,4-dimethoxybenzyl)-3-(£',£'-4,6-dimethyl-
octa-2,4-dienoyl)-4-hydroxy-l,5-dihydro-pyrrol-2-one 246 (60 mg, 0.09 mmol) was 
stirred in I M BBrj ( I M solution in DCM) (0.63 ml, 0.63 mmol) at -78 °C for 6h. The 
reaction was quenched with water (5 ml) and extracted with diethyl ether (3x 10 ml). 
The organic extracts were extracted with I M NaOH (3x 10 ml), then the combined 
aqueous extracts acidified and extracted with diethyl ether (3x 10 ml). The solvent was 
removed in vacuo to yield an orange oil. ' H NMR showed that the 2,6-dichlorobenzyl 
had been cleaved. 
187 
The orange residue was dissolved in TFA (2 ml) and stirred under nitrogen at room 
temperature for 1 h. The reaction was quenched with ice and extracted with DCM (3x 
10 ml). The combined organic extracts were dried (MgS04) and the solvent removed in 
vacuo. The product was isolated as an orange oil (285 mg, 89.1 %) . 
5H(499.8 MHz; C D 3 O D ) 0.77 (3H, t, J 7.0, C H 2 C H 3 ) , 0.92 (3H, d, J 6.4, CH(CH3)), 
1.38 (2H, m, CH2CH3), 1.79 (3H, s, C(CH3)), 2.45 ( IH, m, CH(CH3)), 2.85 (2H, m, 
CH2), 4.00 ( IH , bs, CH), 5.62 (18 %) ( IH, d, J 10.2, CH), 5.78 (82 %) ( IH, d, J 10.4, 
CH), 6.59 (2H, d, J 6.6, Ph), 6.90 (2H, d, J 6.8, Ph), 6.97 ( IH, d, J 15.8, CH), 7.42 (83 
%) ( IH , d, J 15.5, CH), 7.83 (17 %) ( IH , d, J 15.5, CH); 62H(46.0 MHz; CH3OH) 6.67 
(Ph C^H); 5c(125.7 MHz; CD3OD) 12.0 & 12.4 (CH2CH3), 12.5 (C(CH3), 20.4 
(CH(CH3), 29.9 & 31.0 (CH2CH3), 35.5 & 36.5 (CH(CH3)), 37.6 & 40.3 (CH2), 64.5 
(CH), 115.8 (t, J 23.0, Ph C^H), 116.1 (Ph CH), 116.6 (CH), 127.7 (Ph C), 131.6 (Ph 
CH), 134.4 (CH), 151.1 (CH), 153.2 (CH), 157.2 (Ph COH & NHCO), 175.9 (CO); 
Umax(KBr)/cm"' 3378, 3205, 3042, 2978, 2866, 1685, 1637, 1601, 1515, 1228, 821; m/z 
(EI) 356 ([M+H]^ 6.5 % ) , 355 ([M]"", 22.1 % ) , 298 ([M-CH(CH3)CH2CH3r, 53.1 % ) , 
249 ([M+H-BnOH]^ 21.3 %) , 232 ([M-R]^ 5.6 %) , 192 ([M-CH(CH3)CH2CH3-
Bn(OH)]^ 18.1 % ) , 126 ([M+H-BnOH-R]^ 18.2 % ) , 107 ([Bn(OH)]^ 100.0 % ) , 77 
([Ph]^, 20.3 % ) , where R= CH=CHC(CH3)=CHCH(CH3)CH2CH3. 
5.8 Synthesis of labelled tetramic acid 177 
5.8.1 [3',5'-^H2]-Tyrosine methyl ester hydrochloride 216a' 
NH3 CI 
Thionyl chloride (1.4 ml, 12.0 mmol) was added dropwise to dry, distilled methanol (8 
ml) and stirred rapidly at -5 °C. DL-Tyrosine 111 (2.0 g, 10.9 mmol) was added and the 
solution heated under reflux for 3 h. After cooling, the solution was diluted with diethyl 
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ether (35 ml), resulting in the precipitation of the product. The white solid was 
collected by filtration, washed with diethyl ether and dried to yield the product as the 
hydrochloride salt (2.55 g, 99.9 %) , mp 190 ° C (decomp.). The product was found by 
*H NMR to be 86 % deuterated. 
6H(299.9 M H Z ; CD3OD) 3.10 ( IH, dd, Jvic 7.2, Jgem 14.4, CH2), 3.17 (IH, dd, Jvic 6.3, 
Jgem 14.7, CH2), 3.79 (3H, s, OCH3), 4.25 ( IH, dd, Jvic 6.3, Jvic 6.9, CH), 6.79 (14 %) 
(2H, d, J 9.0, Ph), 7.07 (2H, s, Ph); 5H(75.4 M H Z ; CD3OD) 37.4 (CH2), 54.4 (OCH3), 
56.3 (CH), 117.4 (t, J 24.3, Ph C^H), 117.7 (Ph CH), 126.4 (Ph C), 132.2 (86 %) (Ph 
CH), 132.4 (14 %) (Ph CH), 159.0 (Ph COH), 171.3 (CO); Umax(KBr)/cm-' 3378 (NH), 
3341 (NH), 3100 (br), 3010, 2950, 2480, 1741 (CO), 1602, 1497, 1476, 1246, 1057, 
771; m/z (EI) 197 ( [ M ] ^ ^H2, 7.1 %) , 196 ( [ M ] ^ ^H,, 2.2 %) , 195 ( [M]^ 0.3 %) , 138 
( [ M - C 0 2 C H 3 ] ^ ^H2, 28.1 % ) , 137 ([M-COzCHj]^ ^H,, 12.9 % ) , 136 ( [ M - C 0 2 C H 3 ] ^ 
3.8 % ) , 109 ([Bn(OH), ^H2, 100.0 %) , 108 ([Bn(OH)]^ ^H,, 31.2 %) , 107 ([Bn(OH)]^ 
3.8 % ) , 88 ([M-Bn(OH)]^ 43.1 % ) , 79 ([Ph]^ ^H2, 8.5 %) , 78 ([Ph]^ ^H,, 8.1 %) , 77 
([Phr,2.3%). 
5.8.2 N-2,4-Dimethoxybenzyl [3\5 '-^H2j-tyrosine methyl ester 221a 
O 
OCH3 
D ^ O C H , 
O C H . 
To a solution of [3',5'-^H2]-tyrosine methyl ester hydrochloride 216a (1.21 g, 5.14 
mmol) in methanol (20 ml) was added 2,4-dimethoxybenzaldehyde (896 mg, 5.40 
mmol) and MgS04 (3.0 g). The mixture was stirred at room temperature for 24 h, 
filtered and then the solvent removed in vacuo. The residue was redissolved in 
methanol (15 ml) and cooled to 0 ° C . NaBH4 (408 mg, 10.8 mmol) was carefially added 
in small portions over 45 min and the mixture left to stir for 12 h. The reaction was 
189 
quenched with water (10 ml) and then extracted into ethyl acetate (3x 50 ml). The 
combined organic extracts were dried (MgS04) and the solvent removed in vacuo to 
yield an orange oil which was purified over silica gel (EtOAc: petroleum ether, 3:2) to 
give a white solid (955 mg, 53.1 % ) , mp 95-96 °C. 
5H(299.9 MHz; CDCI3) 2.84 ( IH, dd, Jvic 8.4, Jgen. 13.8, CH2), 2.92 ( IH, dd, Jvic 6.0, Jgen, 
13.8, CH2), 3.47 ( IH , t, J 6.3, CH), 3.55 (3H, s, ArOCHj), 3.58 (3H, s, ArOCH3), 3.63 
( IH , d, J 13.5, CH2N), 3.71 (3H, s, COOCH3), 3.76 ( IH, d, J 13.5, CH2N), 6.33 (2H, m, 
Ph), 6.68 (14 %) (2H, d, J 8.7, Ph), 6.90 (2H, s, Ph), 6.97 ( IH, d, J 9.0, Ph); 5c(75.4 
MHz; C D C I 3 ) 38.4 (CH2), 47.4 (CH2N), 51.8 (OCH3), 55.0 (ArOCHa), 55.3 (ArOCH3), 
61.7 (CH), 98.4 (Ph CH), 103.7 (Ph CH), 115.6 (m, Ph C^H), 115.8 (Ph CH), 118.8 (Ph 
CH), 127.5 (Ph C), 130.0 (84 %) (Ph CH), 130.1 (16 %) (Ph CH), 130.9 (Ph CH), 155.7 
(Ph COH), 158.7 (Ph COCH3), 160.5 (Ph COCH3), 174.5 (CO); Umax(KBr)/cm-' 3280 
(NH), 3100 (Br), 2998, 2947, 2836, 1726 ( C O ) , 1615, 1512, 1206, 1035, 816; m/z (EI) 
347 ( [ M ] ^ 2H2, 0.26 % ) , 346 ( [ M ] ^ ^Hi, 0.28 %) , 345 ( [M]^ 0.12 %) , 288 ([M-
CO2CH3]"', ^H2, 1.4 % ) , 287 ([M -C02CH3 ]^ ,^H, , 0.5 %) , 286 ( [M -C02CH3]^ 0.17 %) , 
238 ([M-Bn(OH)]^ 13.5 % ) , 151 ([Bn(OCH3)2]^ 100.0 %) , 137 ([Ph(OCH3)2]^ 1.4 %) , 
109 ([Bn(OH)]\ ^H2, 7.3 % ) , 108 ([Bn(OH)]^ ^H,, 4.0 %) , 107 ([Bn(OH)]^ 0.9 % ) , 79 
([Ph]^ ^H2, 2.0 % ) , 78 ([Ph]^ ^Hi, 3.8 %) , 77 ([Ph]\ 3.4 %) . 
5.8.3 N-(2,4-dimethoxy)benzyl-0-2,6-dichlorobenzyl[3',5'-H2]-tyrosine methyl 
ester 234a 
N-(2,4-dimethoxy)benzyl [3',5'-^H2]-tyrosine methyl ester 221a (950 mg, 2.74 mmol), 
2,6-dichlorobenzyl chloride (589 mg, 3.01 mmol) and K2CO3 (831 g, 6.02 mmol) were 
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stirred in DMF (15 ml) at 60 °C for 24 h. After cooling, water (10 ml) was added and 
the mixture extracted with ethyl acetate (3x 30 ml). The combined organic extracts 
were washed with water (lOx 20 ml) to remove any remaining DMF, dried (MgS04) and 
the solvent removed in vacuo. After purification over silica gel (EtOAc: petroleum 
ether, 2:3), a white solid (955 mg, 69.0 % ) , mp 85.5-86.5 °C, was produced. 
6H(299.9 M H Z ; CDCI3) 2.87 ( IH, dd, J^c 7.8, Jgem 13.8, CH2), 2.97 ( IH, dd, Jvic 6.0, Jgen, 
13.5, CH2), 3.49 ( IH , dd, Jvic 6.3, Jvic 7.8, CH) , 3.62 ( IH, d, J 13.8, CH2N), 3.65 (6H, s, 
2x ArOCHa), 3.78 (3H, s, CH3), 3.79 ( IH, d, J 13.8, CH2N), 5.24 (2H, s, CH2O), 6.39 
(2H, m, Ph), 6.94 (14 %) (2H, d, J 9.0, Ph), 7.05 ( IH, d, J 7.8, Ph), 7.10 (2H, s, Ph), 
7.22 ( IH , m, Ph), 7.35 (2H, d, J 8.1, Ph); 5c(75.4 MHz; CDCI3) 38.9 (CH2), 47.5 
(CH2NH), 51.8 (OCH3), 55.2 (ArOCH3), 55.5 (ArOCH3), 62.1 (CH), 65.3 (CH2O), 
98.5 (Ph CH), 103.7 (Ph CH), 114.7 (t, J 23.5, Ph C^H), 115.0 (Ph CH), 120.1 (Ph C), 
128.6 (Ph CH), 130.2 (Ph CH), 132.3 (Ph C), 137.1 (Ph CH), 157.7 (Ph COH), 158.7 
(Ph COCH3), 160.3 (Ph COCH3), 175.1 (CO); On,ax(KBr)/cm-' 3446 (br), 3356 (NH), 
3084, 2996, 2954, 2938, 2832, 1740, 1612, 1500, 1208, 830; m/z (EI) 509 ( [ M ] ^ 2x 
^'Cl, 'H2, 0.05 % ) , 508 ([Mt, 2x ^^Cl, ^H,, 0.1 % ) , 507 ( [ M ] ^ 2x " C l & Ix " C I , Ix 
^^Cl, ^Hj, 0.21 % ) , 506 ( [ M ] ^ Ix ^^Cl, Ix ^^Cl, ^H,, 0.23 %) , 505 ( [M]^ Ix ^^Cl, Ix ^^Cl 
& 2x ^^Cl, ^Hi, 0.34 % ) , 504 ( [ M ] ^ 2x ^^Cl, ^Hi, 0.25 % ) , 503 ( [M]^ 2x ^^Cl, 0.19 %) , 
450 ([M-C02CH3]^ 2x " C l , 'H2, 0.17 % ) , 449 ([M-CO2CB2T, 2x " C l , ^H, , 0.23 
% ) , 448 ( [ M - C O z C H s ] ^ 2x " C l & Ix " C l , Ix ^^Cl, ^H2, 0.60 %) , 447 ([M-C02CH3]^ 
Ix " C l , Ix ^^Cl, ^H,, 0.52 % ) , 446 ([M-C02CH3]^ Ix " C l , Ix ^^Cl & 2x ^^Cl, ^^2, 1.1 
% ) , 445 ([M-C02CH3]^ 2x ^^Cl, ^Hj, 0.37 %) , 444 ([M-C02CH3]^ 2x ^^CI, 0.22 %) , 
271 ([BnOCH2Ph(Cl)2]^ , 2x " C l , ^Hj, 0.41 % ) , 270 ([BnOCH2Ph(Cl)2]^ 2x ^ ^Cl, 
^Hi, 0.54 % ) , 269 ([BnOCH2Ph(Cl)2]^ 2x " C l & Ix " C l , Ix ^'Cl, 'H2, 1.9 % ) , 268 
([BnOCH2Ph(Cl)2]^ Ix ^^Cl, Ix ^^Cl, ^H,, 1.2 %) , 267 ([BnOCH2Ph(Cl)2]^ Ix " C l , Ix 
^^Cl & 2x ^^Cl, ^H2, 2.9 %) , 266 ([BnOCH2Ph(Cl)2]^ 2x ^^Cl, ^ H,, 0.92 %) , 265 
([BnOCH2Ph(Cl)2]^ 2x ^^Cl, 0.13 % ) , 238 ([(CHC02CH3)NHBn(OCH3)2]^ 13.2 % ) , 
163 ([Bn(Cl)2]^ 2x ^^Cl, 1.5 %) , 161 ([Bn(Cl)2]"', Ix ^^Cl, Ix ^^Cl, 8.6 %) , 159 
([Bn(Cl)2]^ 2x 3^ C1, 13.4 % ) , 79 ([Ph]^ ^Hz, 0.89 %) , 78 ([Ph]^ ^H,, 1.6 % ) , 77 ([Ph]^ 
1.6 % ) , Found 506.1463, C26H25D2NO5CI2 (M"*") requires 506.1470. 
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5.8.4 DL-N-(2,4-dimethoxybenzyl)-N-(E,E-3-oxo-6,8-dimethyldeca-4,6-dienoyl)-0-
(2,6-dichlorobenzyl) f3',5'-^H2j-tyrosine methyl ester 245a 
CH3O 
CH3O 
To a solution of 2,2-dimethyl-6-(£',£'-3,5,diniethylhepta-l,3-dienyl)-l,3-dioxin-4-one 
174 (415 mg, 1.66 mmol) and N-(2,4-dimethoxy)benzyl-0-2,6-dichlorobenzyl [3',5'-
^H2]-tyrosine methyl ester 234 (800 g, 1.58 mmol) in toluene (2 ml) was added PPTS 
(417 mg, 1.66 mmol) and the mixture refluxed with stirring for 1.5 h. After cooling the 
solvent was removed in vacuo and the product purified by column chromatography over 
silica gel (DCM, then DCM:diethyl ether, 20:1). A pale yellow solid (508 mg, 46.0 %) 
was produced, mp 38 °C (decomp.). 
6H(299.9 M H Z ; C D C I 3 ) 0.83 «fe 0.85 (3H, 2x t, J 7.0, CH2CH3) , 1.00 (3H, 2x d, J 6.5, 
CH(CH3)), 1.35 (2H, m, CH2CH3), 1.76 8c 1.83 (3H, 2x s, C(CH3)), 2.44 ( IH, m, 
CH(CH3)), 3.10 ( IH, dd, Jvic 9.0, 14.5, CH2), 3.35 ( IH, dd, Jvic 6.0, Jge^  14.0, CH2), 
3.61 & 3.64 (3H, 2x s, OCH3), 3.75 & 3.77 (3H, 2x s, OCH3), 3.79 & 3.80 (3H, 2x s, 
OCH3), 3.94 (43 % ) , ( IH, dd, Jvic 3.5, Jgem 15.5, CH), 4.08 ( IH, m, CH2N), 4.36 ( IH, m, 
CH2N), 4.50 (57 %) ( IH, m, CH), 5.20 (43 %) ( IH, s, COCH=COH), 5.25 (2H, s, 
CH2O), 5.57 (43 %) ( IH, d, J 9.5, CH), 5.76 (57 %) ( IH, d, J 16.0, CH), 5.79 (43 %) 
( IH, d, J 10.0, CH), 6.26 (33 %) ( IH, d, J 15.5, CH), 6.39 (2H, m, Ph), 7.02 (3H, m, Ph 
& CH), 7.09 (57 %) ( IH, d, J 15.0, CH), 7.24 (2H, m, Ph & CH), 7.36 (3H, m, Ph & 
CH); 5c(75.6 MHz; CDCI3) 12.2 (CH2CH3), 12.8, (CH(CH3)), 20.4 8c 20J (C(CH3)), 
30.2 & 30.4 (CH2CH3), 34.7 & 35.4 (CH(CH3)), 35.0 & 35.1 (CH2), 47.0 & 48.1 
(CH2N), 49.2 (CH), 52.3 & 52.4 (OCH3), 55.4 & 55.5 (OCH3), 55.6 (OCH3), 60.7 
(CH), 61.0 (CH2N), 65.5 (CH2O), 89.8 (COCH=COH), 98.5 8c 98.8 (Ph CH & CH), 
104.0 (Ph C), 114.9 (t, J 27.9, Ph C^H), 115.2 (Ph CH), 116.3 (Ph C), 116.9 (Ph C), 
120.7 (CH), 123.9 (CH), 128.7 (Ph CH), 1130.0-132.5 (Ph C, Ph CH & CH), 137.2 (Ph 
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C), 141.5 (CH), 145.9 (CH), 150.2 & 150.9 (CH), 157.7 (Ph COR), 158.1 (Ph COCH3), 
159.0 (Ph COCH3), 160.7 & 161.3 (NRCO), 170.5 & 171.1 (OCH3), 171.7 & 173.3 
(C=C-OH), 194.1 (CO); Un,ax(KBr)/cm-' 3446 (br), 2958, 2926, 2872, 1741 (CO), 1635, 
1583, 1507, 1463, 1237, 834, 767; m/z (EI) 701 ([M]^ 2x ^^Cl, ^H2, 0.07 % ) , 700 
( [ M ] ^ 2x ^^Cl, ^Hi, 0.14 % ) , 699 ([M]^ 2x ^^Cl & Ix ^^Cl, Ix ^^Cl, ^H2, 0.34 %) , 698 
([M]^ Ix " C l , Ix ^^Cl, ^Hi, 0.27 % ) , 697 ([M]^ Ix " C l , Ix ^^Cl 8c 2x ^^Cl, ^Hj, 0.46 
% ) , 696 ([M]^ 2x ^^Cl, ^Hi, 0.12 %) , 672 ([M-CH2CH3]^ 2x ^^Cl, ^ H2, 0.35 % ) , 671 
([M-CH2CH3]'', 2x " C l , ^Hi, 0.31 % ) , 670 ([M-CH2CH3]^ 2x " C l 8c Ix ^^Cl, Ix ^^Cl, 
^H2, 1.2 % ) , 669 ([M-CH2CH3]^ Ix " C l , Ix ^^Cl, ^ Hi, 0.43 %) , 668 ([M-CH2CH3]^ Ix 
" C l , Ix ^^Cl & 2x ^^Cl, ^Hj, 1.7 %) , 667 ([M-CH2CH3]^ 2x ^^Cl, ^H,, 0.29 %) , 666 
([M-CH2CH3]^ 2x ^^Cl, 1.2 %) , 508 ([M-R]^ 2x " C l , ^H2, 0.37 % ) , 507 ([M-R]^ 2x 
" C l , ^Hi , 0.32 % ) , 506 ([M-R]^ 2x " C l & Ix " C l , Ix ^^Cl, ^Hj, 0.61 %) , 505 ([M-
R ] ^ Ix ^'Cl, Ix ^^Cl, ^ Hi, 0.52 % ) , 504 ([M-R]^ Ix " C l , Ix ^^Cl & 2x ^'Cl, ^H2, 0.79 
% ) , 503 ([M-R]^ 2x ^^Cl, ^Hi, 0.31 %) , 359 ([NHRBn(OCH3)2]'', 2.9 %) , 271 
([BnOCH2Ph(Cl)2]^ 2x ^^Cl, ^Hz, 0.53 % ) , 270 ([BnOCH2Ph(Cl)2]'", 2x ^^Cl, ^H,, 
0.63 % ) , 269 ([BnOCH2Ph(Cl)2]^ 2x " C l & Ix ^^Cl, Ix ^^Cl, ^H2, 2.2 %) , 268 
([BnOCH2Ph(Cl)2]^ Ix ^^Cl, Ix ^^Cl, ^ Hi, 1.4 %) , 267 ([BnOCH2Ph(Cl)2]^ Ix " C l , Ix 
^^Cl & 2x ^^Cl, ^H2, 3.4 % ) , 266 ([BnOCH2Ph(Cl)2]^ Ix " C l , Ix ^^Cl & 2x ^^Cl, ^H2, 
1.1 % ) , 151 ([Bn(OCH3)2]\ 100.0 %) , 79 ([Ph]^ ^H2, 4.9 %) , 78 ([Ph]^ ^H,, 2.8 %) , 77 
([Ph]^ 5.7 % ) ; Found 698.2611, C38H41D2NO7CI2 (M )^ requires 698.2620. 
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5.8.5 5-(4-(2,6-dichlorobenzyloxy)-[3 ',5'-^H2]-benzyl-l-(2,4-dimethoxybenzyl)-3-
(E,E-4,6-dimethylocta-2,4-dienoyl)-4-hydroxy-l,5-dihydro-pyrrol-2-one 246a 
CH3O' 
To a stirred solution of potassium ^-butoxide (173 mg, 1.55 mmol) in /-butanol (10 ml) 
was added a solution of N-(2,4-dimethoxybenzyl)-N-(£',£-3-oxo-6,8-dimethyldeca-4,6-
dienoyl)-0-(2,6-dichlorobenzyl) [3',5'-^H2]-tyrosine methyl ester 245 (540 mg, 0.77 
mmol) in /-butanol (5 ml). After 30 min, the reaction was quenched with I M HCl (5 
ml) and extracted with diethyl ether (Ix 20 ml). The organic portion was washed with 
water (Ix 3 ml), dried (MgS04) and evaporated in vacuo to yield an orange solid (465 
mg, 90.1 % ) , mp 56 °C (decomp.). Excess ^butanol was azeotropically removed with 
hexane. 
5H(299.9 MHz; CDCI3) 0.76 (3H, t, J 7.5, CH2CH3), 0.91 (3H, d, J 6.6, CH(CH3)), 1.25 
(2H, m, CH2CH3), 1.80 (3H, s, C(CH3)), 2.40 ( IH, m, CH(CH3)), 3.04 (2H, d, J 4.5, 
CH2), 3.70 (6H, s, 2x ArOCHa), 3.76 (83 %) ( IH, t, J 4.8, CH), 3.91 (17 %) ( IH, t, J 
4.5, CH) , 4.11 (83 %) ( IH, d, 14.7, CH2N), 4.16 (17 %) ( IH, d, 15.0, CH2N), 4.92 (83 
%) ( IH , d, J 15.0, CH2N), 5.01 (17 %) ( IH, d, J 14.7, CH2N), 5.14 (2H, s, CH2O), 5.55 
(7 %) ( IH , d, J 10.8, CH) , 5.72 (93 %) ( IH, d, J 9.9, CH), 6.35 (2H, m, Ph), 6.80 (14 
%) (2H, d, J , Ph), 6.97 (3H, m, Ph & CH), 7.13 (2H, m, Ph & CH), 7.25 (2H, d, J 7.5, 
Ph), 7.37 ( IH, d, J 15.6, CH); 5c(75.4 MHz; CDCI3) 12.2 (CH2CH3), 12.7 & 12.8 
(CH(CH3)), 20.4 (C(CH3)), 29.4 8c 30.3 (CH2CH3), 34.2 & 34.6 (CH2), 35.6 
(CH(CH3)), 38.0 & 38.7 (CH2N), 55.6 & 55.7 (OCH3), 63.1 (CH), 65.3 & 65.5 (CH2O), 
98.7 (Ph CH), 100.7 (CH), 104.6 (Ph CH), 115.3 (t, J 29.1, Ph C^H), 116.3 (Ph CH), 
116.0-133.7 (Ph C, Ph CH & CH), 137.3 (Ph C), 149.8 & 150.6 (CH), 151.7 & 152.1 
(CH), 157.8 (Ph COR), 158.7 & 158.8 (Ph COCH3), 160.8 & 161.1 (NRCO), 174.1 «& 
175.0 (C=COH), 194.7 (CO), 203.2 (CO); Un,ax(KBr)/cm-' 3446, (br OH), 3070, 2959, 
2930, 2868, 2832, 1700 (CO), 1653 (CO), 1616, 1574, 1507, 1458, 1239, 844, 768; m/z 
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(EI) 669 ( [ M ] ^ 2x ^^Cl, ^Hj, 0.74 %) , 668 ( [ M ] ^ 2x ^^Cl, ^H,, 3.3 % ) , 667 ( [ M ] ^ 2x 
^^Cl & Ix " C l , Ix ^^Cl, ^H2, 0.79 % ) , 666 ( [ [M]^ Ix ^^Cl, Ix ^^Cl, ^Hj, 2.8 %) , 665 
( [ M ] ^ Ix ^^Cl, Ix ^^Cl 8c 2x ^^Cl, ^Hi, 1.7 % ) , 664 ( [M]^ 2x ^^Cl, ^H,, 1.1 %) , 663 
( [ M ] ^ 2x ^^Cl, 0.86 % ) , 271 ([BnOCH2Ph(Cl)2]^ 2x ^'Cl, ^Hz, 0.58 %) , 270 
([BnOCH2Ph(Cl)2]^, 2x ^^Cl, ^H,, 0.60 % ) , 269 ([BnOCH2Ph(Cl)2]^ 2x " C l , Ix ^^Cl & 
Ix ^^Cl, ^ H2, 2.3 % ) , 268 ([BnOCH2Ph(Cl)2]^ Ix " C l , Ix ^^Cl, ^ H, , 1.3 % ) , 267 
([BnOCH2Ph(Cl)2]^ Ix ^^Cl, Ix ^^Cl 8c 2x^^Cl, ^Hj, 3.3 %) , 266 ([BnOCH2Ph(Cl)2]^ 
2x ^^Cl, ^Hi, 1.24 % ) , 265 ([BnOCH2Ph(Cl)2]\ 2x ^^Cl, 0.23 % ) , 163 ([Bn(Cl)2]^ 2x 
^^Cl, 1.6 % ) , 161 ([Bn(Cl)2]^ Ix ^^Cl, Ix ^^Cl, 5.1 % ) , 159 ([Bn(Cl)2]^ 2x ^^Cl, 7.5 %) , 
151 ([Bn(OCH3)2]^ 100.0 % ) , 109 ([Bn(OH)]^ ^U:,, 8.9 %) , 108 ([Bn(OH)]^ ^H,, 3.1 
% ) , 107 ( [Bn (OH)]^ 1.1 % ) , 79 ([Ph]^ 'H2, 2.7 %) , 78 ([Ph]^ ' H , , 2.8 % ) , 77 ([Ph]-", 
3.4 % ) , 57 ( [CH(CH3)CH2CH3]^ 5.9 % ) ; Found 666.2352, C37H37D2NO6CI2 (M^) 
requires 666.2358. 
5.8.6 5-(4-(hydroxy)-[3\5'-^H2l-benzyl-3-(E,E-4,6-dimethylocta-2,4-dienoyl)-4-
hydroxy-l,5-dihydro-pyrrol-2-one 177a 
5-(4-(2,6-dichlorobenzyloxy)-[3' ,5'-^H2]-benzyl-1-(2,4-dimethoxybenzyl)-3-(£,£-4,6-
dimethylocta-2,4-dienoyl)-4-hydroxy-l,5-dihydro-pyrrol-2-one 246 (715 mg, 1.07 
mmol) was stirred in I M BBr3 ( I M solution in D C M ) (7.51 ml, 7.51 mmol) at -78 ° C 
for 6h. The reaction was quenched with water (10 ml) and extracted with diethyl ether 
(2x 30 ml). The organic extracts were extracted with I M NaOH (2x 20 ml), then the 
combined aqueous extracts acidified and extracted with diethyl ether (3x 30 ml). The 
solvent was removed in vacuo to yield an orange oil. ' H N M R showed that the 2,6-
dichlorobenzyl had been cleaved. 
The orange residue was dissolved in TFA (20 ml) and stirred under nitrogen at room 
temperature for 1 h. The reaction was quenched with ice and extracted with diethyl 
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ether (3x 30 ml). The combined organic extracts were dried (MgS04) and the solvent 
removed in vacuo. The product was afforded as an orange oil (338 mg, 85.8 %) . 
6H(499.8 MHz; CD3OD) 0.85 (3H, 2x t, J 7.0, CH2CH3), 0.99 (91 %) (3H, d, J 6.5, 
CH(CH3)), 1.07 (9 %) (3H, d, J 6.5, CH(CH3)), 1.38 (2H, m, CH2CH3), 1.86 (91 %) 
(3H, s, C(CH3)), 1.93 (9 % ) , (3H, s, C(CH3)), 2.52 (87 %) ( IH, m, CH(CH3)), 2.65 (13 
% ) , ( IH , m, CH(CH3)), 2.83 ( IH, dd, Jvic 5.5, Jgen, 14.0, CH2), 2.98 ( IH, dd, Jvic 3.5, Jgem 
14.0, CH2), 4.04 ( I H , bs, CH), 5.69 (88 %) ( IH, d, J 10.5, CH), 5.84 (12 %) ( IH, d, J 
9.5, CH), 6.66 (16 %) (2H, d, J 8.5, Ph), 6.98 (2H, s, Ph), 7.06 (83 %) ( IH, d, J 16.0, 
CH), 7.14 (17 %) ( IH, d, J 15.5, CH), 7.48 (89 %) ( IH, d, J 15.5, CH), 7.90 (11 %) 
( IH , d, J 15.5, CH); 52H(46.0 MHz; CH3OH) 6.67 (Ph C^H); 5c(125.7 MHz; CD3OD) 
12.0 & 12.4 (CH2CH3), 12.5 (CH(CH3)), 20.4 (C(CH3)), 29.9 «fe 31.0 (CH2CH3), 35.5 & 
36.5 (CH(CH3)), 37.6 & 40.3 (CH2), 64.5 (CH), 115.8 (t, J 23.0, Ph C^H), 116.1 (Ph 
CH), 116.6 (CH), 127.7 (Ph C), 131.6 (Ph CH), 134.4 (CH), 151.1 (CH), 153.2 (CH), 
157.2 (Ph COH & NHCO), 175.9 (CO); Uniax(KBr)/cm-' 3382 (br), 3072, 3022, 2961, 
2925, 2871, 1684, 1653, 1609, 1561, 1429, 1251, 858; m/z (EI) 358 ([M+H]^ ^Wi, 10.1 
% ) , 357 ( [ M ] ^ ^H2, 35.4 % ) , 356 ( [ M ] ^ ^H,, 13.2 %) , 355 ( [ M ] ^ 2.6 %) , 300 ([M-
CH (CH3)CH2CH3]^ ^H2, 71.3 % ) , 299 (([M-CH(CH3)CH2CH3]^ ^H,, 26.8 %) , 298 
(([M-CH(CH3)CH2CH3]^ 4.7 % ) , 249 ([M+H-Bn(OH)]^ 39.1 % ) , 151 ([R]^ 12.7 %) , 
124 ([R+H-CO]^ 53.2 % ) , 109 ([Bn(OH), ^H2, 100.0 %) , 108 ([Bn(OH)]^ ^Hj, 52.1 %) , 
107 ([Bn(OH)]^ 29.5 % ) , 95 ([R+H-CH(CH3)CH2CH3]^ 53.0 %) , 79 ([Ph]^ ^H2, 33.7 
% ) , 78 ([Ph]^ ^Hi, 11.1 % ) , 77 ([Ph]^ 38.2 % ) , where R = C0CH=CH(CH3) 
=CHCH(CH3)CH2CH3. Found 358.1991 C21H23D2NO4 [M^] requires 358.1987. 
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5.9 Synthesis of [2-^H]-tyrosine 111b 
5.9.1 /7-Methoxybenzyl bromide 251 '^ ^ 
To a solution ofp-methoxybenzyl alcohol 250 (710 mg, 5.1 mmol) and pyridine (0.4 ml, 
5.1 mmol) in Et20 (10 ml) at 0 °C was added a solution of phosphorus tribromide 
(PBr3) (0.19 ml, 2.0 mmol) in Et20 (10 ml). The mixture was stirred for 2 h at room 
temperature and then quenched with ice-water (10 ml). The organic layer was 
separated, washed with ice-cold I M HCl (5 ml) and dried (MgS04). Evaporation of the 
solvent in vacuo yielded the crude bromide (902 mg, 87 %) as a pale yellow oil which 
was used directly in the next step without further purification. 
6H(400 MHz; CDCI3) 3.81 (3H, s, OCH3), 4.51 (2H, s, CH2), 6.87 (2H, d, J 8.4, Ph), 
7.32 (2H, d, J 8.8, Ph); 5c(100.6 MHz; CDCI3) 34.0 (CH2), 55.3 (OCH3), 114.8 (Ph 
CH), 129.9 (Ph C), 130.4 (Ph CH), 159.6 (Ph COCH3); Umax(neat)/cm-' 3308, 3006, 
2958, 1609, 1513, 831, 741, 721; m/z (EI) 202 ( [M]^ ^'Br, 2.3 %) , 200 ( [ M ] ^ ^ V , 2.3 
% ) , 121 ([M-Br]^ 100 % ) , 106 ([M-Br-CH3]^ 3.6 %) , 91 ([C6H5CH2]^ 6.0 %) , 78 
([CfiHef, 27.8%). 
5.9.2 Diethyl 2-acetamido-2-/7-methoxybenzyImaIonate 252'^ ^ 
XOzEt 
X02Et 
C H a O ^ ^ NHAc 
To a solution of sodium ethoxide in ethanol prepared from sodium (27 mg, 1.17 mmol) 
and ethanol (3.25 ml), was added diethyl acetamidomalonate (250 mg, 1.15 mmol). The 
solution was cooled to 0 °C and /7-methoxybenzyl bromide 251 (230 mg, 1.15 mmol) 
slowly added. After stirring for 5 h, water (12 ml) was added to precipitate the product 
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and then the mixture stored in the refrigerator for 1 h before the product was filtered to 
give shiny, white crystals (350 g, 91.0 % ) , mp 96-96,5 °C (lit. 96-98 °C) . ' " 
5H(499,8 M H Z ; CDCI3) 1.29 (6H, t, J 7.5, (CH2CH3)2), 2.03 (NCOCH3), 3.58 (2H, s, 
CH2), 3.77 (3H, s, OCH3), 4.26 (4H, 2x q, J 7.0, (CH2CH3)2), 6.53 ( IH, s, NH), 6.78 
(2H, d, J 8.5, Ph), 6.92 (2H, d, J 9.0, Ph); 6c(125.7 MHz; CDCI3) 14.3 ((CH2CH3)2), 
23.3 (COCH3), 37.2 (CH2), 55.4 (OCH3), 62.9 (C), 67.6 ((CH2CH3)2, 114.0 (Ph CH), 
127.3 (Ph C), 131.1 (Ph CH), 159.0 (Ph COCH3), 167.9 (CO), 169.3 (CO); 
Umax(KBr)/cm"' 3423 (br, NH), 2949, 2858, 2809, 2759, 2544, 1617, 1457, 1351, 1081, 
810; m/z (EI) 337 ( [ M ] ^ 5.5 %) , 292 ([M-OC2H5]^ 2.5 %) , 278 ([M+H-OC2H5-CH3]^ 
73.8 % ) , 222 ([M+H-(OC2H5)2-CH3], 9.9 %) , 174 ([NH2C(C02C2H5)2], 2.5 %) , 121 
([CHsOBn]^ 100.0 % ) , 78 ([CeHe]^ 4.9 % ) , 43 ([COCH3], 14.8 %) . 
5.9.3 DL-[2-^H,]-Tyrosine 111b' 
CO2H 
D NH2 
To deuterium oxide (9.5 ml) at 0 C was added PBr3 (2.9 ml) and the mixture allowed to 
warm to room temperature and stirring continued until the solution was homogenous. 
Diethyl 2-acetamido-2-p-methoxybenzylmalonate 252 (1.80 g, 5.34 mmol) was addede 
and the solution refluxed for 2 h. The pale yellow solution was concentrated in vacuo 
and then water (5 ml) added. This solution was decolourised with activated carbon and 
filtered through Celite. The pH was adjusted to 5 with concentrated ammonium 
hydroxide, the mixture cooled and the resulting precipitate filtered and dried to give a 
white powder (832 mg, 84.7 %) , mp 220 °C (decomp.). The ' H N M R spectrum showed 
the product to be deuterated at the 2-position and also at the positions ortho to the 
phenolic hydroxyl. 
6H(200 M H Z ; D2O) 2.95 ( IH , d, J 14.6, CH2), 3.07 ( IH, d, J 14.8, CH2), 6.98 (2H, s, 
Ph); Sc(75.4 MHz; CD3OD/TFA) 35.3 (CH2), 54.1 (t, J 22.7, C-^H), 115.7 (Ph C H ) , 
124.7 (Ph C ) , 130.3 (Ph C H ) , 157.0 (Ph C O H ) , 170.2 ( C O ) . 
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To remove the aromatic deuterium atoms, the product (525 mg, 2.85 mmol) was 
refluxed in 2N HCl (12 ml) for 17 h. The solution was then concentrated and the pH 
adjusted to 6 with ammonium hydroxide. The precipitate formed was filtered and dried 
to give a white powder (164 mg, 31.6 % ) . 
5H(200 MHz; CD3OD/TFA) 3.07 ( IH, d, J 14.7, CH2), 3.24 ( IH, d, J 14.7, CH2), 6.81 
(2H, d, J 8.4, Ph), 7.13 (2H, d, J 8.1, Ph); 6c(75.4 MHz; CD3OD/TFA) 37.3 (CH2), 52.3 
(t, J 22.7, C^H), 117.8 (Ph CH), 126.8 (Ph C), 132 (Ph CH), 159.1 (Ph COH), 172.3 
(CO); Umax(KBr)/cm-' 3404 (br, NH), 3205, 3048, 2958, 1586, 1512, 1401 1245, 1109, 
838. 
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